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The thymus plays a critical role in adaptive immunity by providing a suitable microenvironment 
for developing and selecting the functional self-tolerant T-cell population. Thymic epithelial cells 
play an essential role in the development of a naïve, self-tolerant T-cell population. Paradoxically 
thymus undergoes acute age-related involution, which in turn causes loss of functional T-cell 
populations. Involution reduces the functionality of the thymus markedly, but the thymus can still 
develop self-tolerant naïve T-cells. It is crucial to understand how the thymic microenvironment 
is maintained to provide a suitable T-cell population for life. It has been previously demonstrated 
that the thymic epithelial homeostasis is maintained by the thymic epithelial progenitor cells 
(TEPCs). Apart from TEPCs, thymic microenvironment maintenance is also regulated via different 
signal transduction pathways. In this current study, we focused on understanding the key players 
in maintaining the thymic epithelial microenvironment.  Our study challenged the established 
dogma of thymus organogenesis. It demonstrated a unique hematopoietic stem cell derived bone 
marrow population expressing pan-hematopoietic marker, CD45, and thymic epithelial cell 
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marker, EpCAM, that can migrate to the thymus and differentiate into keratin-expressing thymic 
epithelial cells.   
Canonical Wnt signaling has been previously shown to be critical for thymocyte maturation 
and proliferation in addition to maintenance of thymic epithelial architecture. Overexpression of 
DKK1, a Wnt inhibitor, leads to loss of thymic progenitor and rapid thymic degeneration in the 
thymus. Thus, Wnt signaling has involved the maintenance of adult thymic epithelial progenitor 
cells. Therefore, we hypothesized Wnt signaling could also be involved in the fetal thymic 
epithelial progenitor cell maintenance and development. But no characterization of the fetal thymic 
epithelial cell undergoing Wnt signaling is documented. In this study, using a new H2BGFP Wnt 
reporter model, we identified which specific thymic epithelial cell populations were undergoing 
active canonical Wnt signaling during the critical crosstalk dependent stages of fetal thymic 
development.  
In summary, this study addresses the dual aspect of thymic epithelial microenvironment 
maintenance. Identification of bone marrow derived TEPC and deciphering which TEC 
populations undergo active Wnt signaling during fetal development equip future studies with a 
better understanding of TEC development and maintenance. These data should provide additional 
targets for overcoming thymic atrophy and hence the development of more strategic therapies for 
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       This study explores the newfound plasticity of bone marrow (BM)- derived cell population. It 
identifies a subpopulation in the bone marrow cell that can migrate to the thymus and contribute 
to the thymic stroma's non-hematopoietic component. The thymus plays a critical role in T-cell 
development, which is a significant component of adaptive immunity. Thymic epithelial cells 
(TECs) and their interaction with the T-cell progenitor populations are essential for developing a 
naïve, self-tolerant T-cell population (1). Interestingly, the thymus undergoes acute age-associated 
involution, which in turn causes a loss of functional naïve T-cells; and even after such an 
involution, the thymus remains capable of developing a limited number of self-tolerant naïve T-
cells. Few studies have identified the fetal and adult thymic epithelial progenitor cell (TEPC) 
population and the role of different signal transduction pathways in developing and maintaining 
the thymic epithelial microenvironment. For example, It has been demonstrated before that the 
postnatal thymus contains a medullary thymic epithelial stem cell population that maintains the 
medullary homeostasis to provide a lifelong T-cell self-tolerance (1). Other studies also identified 
the adult bi-potent TEC progenitor's presence, but their role in maintaining the thymic 
microenvironment is still unclear (2, 3). Apart from the TEPCs, different signal transduction 
pathways, specifically Wnt signaling, plays a vital role in maintaining the TEC cellularity. 
Heinonen et al. 2011 demonstrated that the Wnt4 ligand is critical for maintaining TEC numbers 
and forming proper medulla during fetal thymopoiesis and post-natal thymic expansion (4). 
This research primarily focuses on identifying and characterizing a novel TEPC population 
found within the hematopoietic stem cell (HSC)-derived bone marrow population. It also 
demonstrates this population's migration to the thymus and its contribution to thymic stromal 
components, including true EpCAM and Keratin-expressing TECs. The results presented 
 x 
challenge our current understanding of the thymic epithelial progenitors' origin, which are thought 
to be exclusively derived from the third pharyngeal pouch's endodermal layer.  
The work presented here also extends previously published work showing a critical role 
for canonical Wnt signaling in maintaining the thymus and the thymic involution (5, 6). The work 
presented here utilizes a new H2BGFP Wnt Reporter mouse to provide the first characterization 
of active Wnt signaling during fetal thymic stroma development.    
This dissertation discusses the following: Chapter 1 discusses the background information 
about thymus organogenesis and function during T-cell development. Additionally, it describes 
the plasticity of BM-derived cell populations and their capacity to contribute to various organs and 
tissues.  It also discusses what is known about the Wnt signaling pathway's role in the maintenance 
of the thymic epithelial cells. Wnt signaling is the most affected pathway during thymic 
involution(7).  The chapter concludes with an overview and significance of this research. Chapter 
2 focuses on explaining the different experimental procedures in my research. Chapter 3 describes 
the identification of BM-derived thymic epithelial cell population and its ability to differentiate 
into keratin-expressing TEC populations. Chapter 4 shows that the CD45+EpCAM+ cell from 
bone-marrow is a thymic epithelial progenitor cell population and is derived from the 
hematopoietic stem cell population. Chapter 5 focuses on characterizing what specific cells are 
undergoing active canonical Wnt signaling during fetal thymus development. The study illustrates 
changes in cells undergoing Wnt signaling during the period that crosstalk between the developing 
thymocytes and the TECs shapes the development of distinct functional regions of the thymus 
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This study aims to identify and characterize a bone marrow population exhibiting both 
hematopoietic and epithelial characteristics. This population can migrate to the thymus and 
contribute to the thymic stroma. The next goal is to determine whether the CD45+EpCAM+ 
population in both thymus and BM is affected by aging as well as thymic reconstitution. The next 
aim is to identify the lineage of CD45+EpCAM+ cells. Apart from TEPCs, the thymic epithelial 
microenvironment is also maintained by several signal transduction pathways. Previously our lab 
identified that the suppression of canonical Wnt signal transduction pathway causes loss of adult 
thymic epithelial progenitor cell (6). This study's secondary goal is to determine which specific 
fetal thymic epithelial cell population undergoes active Wnt signaling.  
This chapter will provide the background information to explain the logic and motivation 
behind this research. It is organized as follows. First, I will provide brief background information 
about thymus organogenesis, thymic epithelial cell development, fetal and adult thymic progenitor 
cell population, thymic involution, thymic function (T-cell development). Second, I will highlight 
the discussion on the newfound plasticity of bone marrow cells (8)  and ways my research will 
support the presence of bone marrow derived epithelial stem cell population and dispute the current 
understanding of the origin of thymic epithelial progenitors, which are thought to be exclusively 
derived from the endodermal layer of the third pharyngeal pouch. Lastly, I will explain the Wnt 
signaling pathway and its role in TEC maintenance in the postnatal thymus to provide an 




1. BACKGROUND INFORMATION 
1.1.THYMUS ORGANOGENESIS 
The thymus plays a major role in building the adaptive immune system by controlling the 
development of functional T-cells with a diverse repertoire of TCRs that can respond to a vast 
array of foreign antigens (7). It is a bi-lobed primary lymphoid organ located in the thoracic cavity, 
directly above the heart and behind the sternum (9).  An accessory thymus in the cervical region 
has been documented in both mice and humans (10, 11). The thymus is a sponge-like structure 
filled with different types of hematopoietic cells in a network of stromal (non-hematopoietic) cells. 
The thymus' non-hematopoietic cells mainly consist of epithelial cells, endothelial cells and 
fibroblasts, and non-fibroblast mesenchymal cells (12). The hematopoietic cells mainly consist of 
T-cells at different developmental stages and B-cells, macrophages, and dendritic cells. 
Understanding the organogenesis of the thymus can lead to a better comprehension of how T-cell 
development is regulated. 
Thymus organogenesis in vertebrates is a complex, multi-step process that depends on the 
interaction between different embryonic germ layers, including endoderm derived epithelium, 
neuroectoderm derived neural crest cell mesenchyme, mesoderm derived hematopoietic cells, and 
endothelial cells of the blood vessels. The first sign of thymus organogenesis is observed as early 
as embryonic day 10 (E10) in mice, even though the initiation signaling starts at E9(13). In 
humans, thymus organogenesis is initiated during the 6th  gestational week(10, 14). Both mouse 
and human thymi are derived from the anterior region of the foregut, the pharynx (15). The thymus 
and parathyroid glands are derived from the bilateral organ primordia that arise from the 3rd  
pharyngeal pouch in mice, and for humans, both the 3rd and 4th  pharyngeal pouches are involved 
(16). The common primordium is formed by the invagination of the pharyngeal pouches and 
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extending into the underlying tissue layer of the pharyngeal cleft. The ventral aspect of the 
pharyngeal pouch gives rise to the thymic primordia. At E9.5-E10.5, the ectoderm and endoderm 
layers come into contact with each other. At E11, the 3rd pharyngeal pouch area, which is destined 
to be the thymus and the parathyroid gland begins to extend away from the pharyngeal arch.  
Specific transcription factors are responsible for separating the common thymus and 
parathyroid gland primordia. From E11.5 to E12.5, the thymic and parathyroid rudiments begin to 
separate into different domains. The transcription factor, Forkhead box N1, FoxN1, drives the 
thymus development, while another transcription factor, Glial cells missing homolog 2, Gcm2, 
drives the parathyroid gland development. It is still not clear how this differential expression is 
established in the common primordia (17). But it has been shown that in terms of thymic rudiment 
development, BMP (18-20), Shh (21), and Wnt signaling (22) play an important role (23).  By E 
13 in mouse embryos, the thymus primordia separate from the pharynx and travel to the anterior 
chest cavity, also separating from the parathyroid primordia at the same time. The thymic 
primordium gives rise to the thymic epithelial rudiment, the primary source of thymic epithelial 
cells. 
The thymic epithelial cells and the thymic mesenchymal cell are derived from different 
parts of the pharynx. The endodermal layer of the 3rd pharyngeal pouch gives rise to the entire 
thymic epithelial rudiment (12). The pharyngeal arch also plays a role in the formation of the 
thymus primordia. The mesenchymal cells in the pharyngeal arch are derived from neural crest 
cells (NCCs) (13, 23). The thymic primordia's epithelial rudiment is encapsulated with the 
mesenchymal cells derived from the NCCs (24). Apart from forming perivascular regions of the 
thymus, mesenchymal cells also contribute to the interlobular septae. Mesenchymal cells derived 
from the NCCs are essential for the proper development of the thymus through inductive effects 
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of the growth factors (23, 25). Studies have shown that surgical removal of the chicken neural 
crest, which helps develop the 3rd,4th, and 6th pharyngeal arch, results in impaired thymus 
development (26). The thymic epithelial primordia of these NCCs impaired animals either do not 
develop or are comparatively smaller than normal animals (26). These defective epithelial 
primordia are not capable of inducing lymphoid precursor cell proliferation and differentiation 
(26). A lineage study in transgenic mice confirmed NCCs contributes to the capsule and 
perivascular space. Also, mesenchymal cells present in the thymic anlage help develop the thymic 
stroma (27).   
Apart from the interaction of different germ layers, thymus development is also dependent 
on a variety of different signaling molecules expressed in the endoderm layer that are involved in 
thymus organ formation, including Homeobox A3 (Hoxa3); eyes absent homolog 1(Eya1); Paired 
Box protein 1/9(Pax1/9); sine oculis homolog1/4(Six 1/4); T-box 1(Tbx1)(28-30).  Transcription 
factors Hoxa-3, Pax1/9, Eya1, and Six 1 are expressed simultaneously in the endoderm. Studies 
working on mutant phenotypes of Hoxa3, Pax1/9, Eya1, and Six1 have shown that endodermal 
primordia's development requires the cascade of transcription factors Hoxa3-Pax1/9-Eya1-Six1 to 
initiate patterning of the pharyngeal pouch and also to initiate thymus organogenesis (23). Wnt 
signaling plays an essential role in FoxN1 expression during the development of the thymus (31). 
The thymus' size depends on Fibroblast Growth factor Receptor IIIb (FGFR-IIIb) signaling (32).  
1.2. STRUCTURE OF THYMUS & THYMIC CELLULARITY 
Thymic epithelial cells play an integral role in presenting self-MHC and self-peptides to 
develop T cells and ensure MHC restriction and self-tolerance of the mature T cell repertoire. They 
also assure the emergence of an appropriate number of naïve T-cells to the periphery. Thus, proper 
organization and maintenance of the TECs are critical for a properly functioning adaptive immune 
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system. Understanding the signals and cell-to-cell interactions that control both the development 
and postnatal maintenance of thymic epithelial cells is essential in the field of immunology.   
The thymic anlage patterning creates regional division in the thymus and divides the thymic 
stroma into three main compartments: 1) Cortex, 2) Medulla, and 3) Cortico-medullary junction. 
The main component of each compartment is thymic epithelial cells. It should be noted here that 
the thymic epithelial cells are very diverse in nature and function. Each compartment has a unique 
TEC population along with other types of cells. The cortex is mainly composed of cortical thymic 
epithelial cells (cTEC) and immature thymocyte subsets, and it is involved in the positive selection 
during T-cell development.  The thymic medulla is primarily composed of medullary thymic 
epithelial cells (mTEC) and is involved in the negative selection of thymocytes expressing 
autoreactive T-cell antigen receptors. The cortico-medullary junction is the perivascular space 
between the cortex and the medulla. It is the entry point of the DN thymocytes into the thymus. 
Fully mature SP naïve T-cells also exit to the peripheral blood vessels through this region (33). A 
detailed discussion of the TECs, thymic mesenchymal cells, and their importance to the T-cell 
development is provided in the following sections. 
1.2.1. CORTEX & CORTICAL THYMIC EPITHELIAL CELL (cTEC) 
                    The thymic cortex is made up of cortical thymic epithelial cells, cTECs, surrounded 
by immature thymocytes. The cTECs provide a suitable microenvironment for the T cell 
commitment, the αβ versus γδ lineage commitment, and the positive selection of double-positive 
(CD4+CD8+) thymocytes (34). A unique set of proteins and receptors expressed by the cTECs 
plays a crucial role in the function of the cortex. The cTECs are characterized by the expression of 
epithelial cell adhesion molecule (EpCAM), cytokeratin 8 (K8), cytokeratin 18 (K18). Mature 
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cTECs are characterized by a unique profile of surface markers, including Ly51/BP1, CD205, and 
MHCII (34). 
      Mature cTECs express CC-chemokine ligand 25 (CCL25) and CX-chemokine ligand-12 
(CXCL-12), which promote the homing of the DP thymocytes to the cortex (34-36). The cTECs 
also express cytokines, including IL-7 (37, 38) and stem cell factor (SCF), which are essential for 
the proliferation and survival of the T-cells (35).  The cTECs also express the Notch ligand Delta-
like ligand 4, which plays a critical role in thymocyte lineage commitment (35, 39, 40). Curiously, 
DLL4 is not expressed homogenously in the cTECs. The DLL4 expression decreases with age and 
may contribute to the decline of the T cells’ production, observed in the aging thymus (36, 39, 40). 
The cTECs also express some unique proteins, including the thymoproteosome subunit β5t, 
Ly51/BP1, Cathepsin L, thymus-specific serine proteases (TSSP) (34). This set of proteins are 
essential for antigen processing and presentation for the positive selection of the developing T-
cells. 
For the positive selection of T-cells, the cTECs present self-antigen via MHC I and MHC 
II molecules. During the Positive selection, a DP thymocyte must interact successfully with an 
MHC II molecule and self-peptide complex to become a CD4+ T-cell, whereas CD8+ T-cells 
interact with MHC I molecule and self-peptide complexes. Different proteins are involved in 
producing the self-peptides presented on the MHCI or MHC II molecules (34). The Psmb11 gene 
encodes the cTEC specific proteasome β5t, which is essential for the MHC I loading (34, 41). β5t 
breaks down endogenous proteins and degrades them to be packaged into the MHC I molecule. In 
Psmb11-/- mice, there was a marked reduction in the presence of the CD8+ thymocytes. 
Additionally, while there was a small population of CD8+ cells, they showed impaired immune 
function giving credence to the essential role of β5t in the CD8+ T-cell production and function 
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(42-44). On the other hand, the MHC II loading is driven by the proteases cathepsin-L (uniquely 
expressed in cTEC) (45) and the thymic specific serine protease (TSSP), which break down the 
cytosolic proteins (44, 46, 47). These degraded products are then loaded into the MHC II molecule 
in the endoplasmic reticulum and then transported to the cell's surface to be presented to the 
developing thymocytes (44, 48).   
A subset of cTECs forms multicellular complexes with developing DP thymocytes and is 
termed thymic nurse cells (TNCs). The TNCs are several viable lymphoid cells completely 
enveloped by the large cortical epithelial cells. This cell population was first reported by Wekerle 
et al. in 1980 (49). The Thymic nurse cells provide a suitable microenvironment for the DP 
thymocytes to undergo TCR (T-cell receptors) secondary rearrangements (50). Specific TNC 
characteristics are not entirely defined. However, it has been observed that these complexes 
express high levels of CXCL12 and vascular cell adhesion molecule 1 (VCAM1) (51). 
1.2.2. MEDULLA & MEDULLARY THYMIC EPITHELIAL CELLS (mTEC) 
           The thymic medulla is composed of the medullary thymic epithelial cells and the medullary 
dendritic cells, and the SP thymocytes. The mTEC population is highly heterogeneous in nature. 
In the fetal thymus, the immature mTEC population expresses a high level of Claudin 3 and 4 
(CLDN3/4). A subset of the CLDN3hiCLDN4hi population also expresses SSEA-1(stage specific 
embryonic antigen-1) (34). This fetal mTEC population shows some clonogenic capacity (1). The 
mature mTEC population is characterized as the Ulex Europaeus Agglutinin Type 1 (UEA-1) 
binding subpopulation within the EpCAM+ TEC population. Apart from UEA-1 binding, mTECs 
are also defined by cytokeratin 5 (K5), cytokeratin 14 (K14), CD80, AIRE (autoimmune 
regulator), and Cathepsin-S (52). Mature mTECs also express K8. Postnatal mTECs, having two 
major subpopulations defined by the expression level of MHC II and CD80: mTEC lo (MHC 
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IIloCD80lo) and mTEChi (MHCIIhiCD80hi) (52).  It was first assumed that the mTEC lo population 
consists of immature cells only (53, 54). But later, it was shown that the mTEClo population is 
heterogeneous in nature (52, 55). One mTEClo subpopulation expresses a high level of podoplanin 
(PDPN) and the chemokine ligands Ccl21a, Ccl21b, Ccl21c (56). This subpopulation primarily 
localizes in the cortico-medullary junction. Another mTEClo subpopulation expresses cytokeratin 
10 (K10) and involucrin. It has been demonstrated that this population is a terminally differentiated 
mTEC subset, which arises from the mTEChiAIRE+ population (34, 57). The mTEChi population 
is also heterogeneous in nature. There two main subpopulations in the mTEChi population: 1) 
AIRE+mTEChi, and 2) AIRE-mTEChi. mTEChi can be again subdivided according to tissue 
restricted antigen (TRA) presentation. TRA antigen presentation can be AIRE-dependent or AIRE-
independent (58). Additionally, the Aire+mTEChi population can be further subdivided into two 
populations depending on osteoprotegerin (OPG) expression. OPG maintains the size of the 
thymus's medullary region by regulating the cellularity of the mTECs (52). The thymic medulla is 
important for the T-cell development, as it provides the microenvironment for the development of 
a self-tolerant T-cell antigen receptor repertoire (33). Thymocytes that have undergone proper 
positive selection enter the medulla by following the chemokine signals produced by the mTECs, 
mainly CCL21. In the medulla the mTECs and the mDCs drive the negative selection of SP 
thymocytes. 
         The medullary thymic epithelial cells are critical for ensuring that the T-cell repertoire is 
self-tolerant through the process of promiscuous gene expression (PGE). PGE is mediated by the 
transcription factors Fez family Zinc finger protein 2, Fezf2 and the Autoimmune regulator, AIRE 
(59-61). PGE promotes the expression of other tissue-specific genes that would not otherwise be 
expressed in the thymus. These exogenous genes are termed as the Tissue specific antigens (TSA) 
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or Tissue restricted antigens (TRAs). Presentation of TRAs informs the SP thymocytes on self vs. 
non-self. Fezf2 and AIRE seem to produce some gene products that overlap but have many 
mutually exclusive genes to either AIRE or Fezf2 (59).  
 As discussed previously, AIRE+ and Fezf2+ mTECs are responsible for the development 
and survival of T-cells. Counterintuitively, for the mTECs to become an AIRE or Fezf2 expressing 
cell, they also require T-cells signaling. It has been shown that the AIRE and Fezf2 are maintained 
by the NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling pathway 
(59, 62, 63). Rossi et al. 2007 have shown that the RANKL signals from CD4+ T-cells regulate 
the development of AIRE+ mTECs (62). Takaba et al. 2015 have demonstrated that the LTβR 
signaling leads to the Fezf2+ mTECs (59). In a contradictory study, Cosway et al. 2017 
demonstrated that RANKL signaling promotes the development of Fezf2+ mTECs (63).  
1.2.3. CORTICO-MEDULLARY JUNCTION 
The cortico-medullary junction is the perivascular space between the cortex and medulla 
of the thymus. This space is characterized by the presence of high numbers of blood vessels and 
mature and immature thymocytes (64). It serves as the entry point of lymphoid progenitor cells to 
the thymus through the blood vessels. From this region, the DN1 T-cell migrate towards the cortex 
as they differentiate into DN2, DN3 cells rearrange and express the TCR as they progress. The 
CMJ is also the mature single positive T-cells' exit point to the peripheral blood vessel (65). It has 
been thought that the cortico-medullary junction contains the medullary TEC progenitor cells. 
Klug et al.1998, showed a small population of the K5+K8+ TECs mostly present in the cortico-
medullary junction, which can give rise to the cortical thymic epithelial cells(K5-K8+) (66). Onder 
et al. 2015 observed the cortico-medullary junction has a distinct population of mTEClo podoplanin 
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expressing cells. They characterized this cell population as lineage-committed mTEC progenitor 
cells (67). 
1.2.4. THYMIC MESENCHYMAL DERIVED CELLS 
             Apart from the thymic epithelial cells, the thymic stroma also contains mesenchymal cells. 
It has been demonstrated that the thymic mesenchymal cells originate from the neural crest (NC) 
by utilizing the bird embryos (68). During the thymic organogenesis at embryonic day 12 (E12), 
the thymic epithelial rudiment gets surrounded by the NC derived mesenchymal cells. At E13, this 
peri-thymic mesenchyme then migrates into the epithelial rudiment, forms a fibroblast network, 
and contributes to the thymic capsule and septae (12, 69-71). The thymic mesenchymal cells are 
essential for T-cell development (72, 73). Suniara et al. 2000 showed that E12 fetal thymus without 
mesenchymal cells could not support T cell development beyond the double-negative stage (72). 
Studies have shown that the NC cells are essential for thymus organogenesis (12, 74). It appears 
that the mesenchymal cells not only induce T-cell development by providing soluble growth 
factors on the extracellular matrix but also play a critical role in the development of the thymic 
epithelial cells. There are two distinct mechanisms by which the mesenchymal cells can induce the 
TEC development: 1) by helping T-cell maturation beyond the double-negative stage, which then 
provides crosstalk for the TEC development; and 2) by directly supporting the development of the 
immature thymic epithelial cells. Fibroblast growth factor (FGF) secreted by mesenchymal cells 
can induce proliferation of FGF-receptor bearing epithelial cells. This epithelial-mesenchymal 
interaction is critical during the development of epithelial cells in the limb bud and the 
organogenesis of several organs like the lung and ear (70, 75). During embryogenesis, 
mesenchymal cells in the thymus anlage produce FGF7 and FGF10, which helps in the 
proliferation of epithelial cells expressing FGFR2IIIb (fibroblast growth factor receptor 2IIIb) (27, 
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73, 76). Mesenchymal cells also induce the expression of the MHC class II molecules on the TECs 
(77). 
From the above discussion, it is evident that mesenchymal cells play an important role in 
fetal thymus development. It is crucial for the embryonic immature thymic epithelial cell 
development and differentiation. Mesenchyme derived fibroblasts also play an essential role in 
thymocyte development in the adult thymus (73). Keratinocyte growth factor, KGF, also known 
as Fibroblast growth factor 7, FGF7, administration in mice helps in regeneration of the thymus 
following irradiation (78, 79). Rossi et al. 2007, showed that KGF helps in the proliferation of 
mature and immature TECs in the adult thymus. KGF activates both the NF-κB and the p53 
signaling pathways, which induce the production of several target genes, including BMP4, Wnt5b, 
and Wnt10b. Both BMP4 and Wnt signaling are essential for TEC function (78). In a recent study, 
Sun et al., 2015, have shown that in the adult thymus, a subpopulation of fibroblasts expressing 
FSP1(Fibroblast specific protein 1) is involved the maintenance and proliferation of mTECs (80). 
FSP1 is a cytoplasmic calcium-binding protein and belongs to the S100 superfamily. It is mainly 
expressed in fibroblasts, but macrophages also express this protein (81). Previous studies have 
shown the involvement of FSP-1 in the regeneration of the myocardium following injury (82). 
Deletion of the FSP-1 gene disrupts the thymic structure and lowers the MHC class II expression 
in TECs. FSP1-expressing fibroblasts induce TEC proliferation via IL-6, FGF7, and FSP1 
signaling (80).  FSP1 knock-out mice exhibit dramatical reduction in the mTEC number. It can 
cause TEC regeneration following thymic injury (80). FSP1 is also recognized as an epithelial-
mesenchymal transition marker (83). The thymus undergoes age-related involution and 
consequently weakening of adaptive immunity. Understanding the source of FSP1 cells and the 
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mechanisms by which FSP1 promotes the TEC regeneration will help introduce new approaches 
to regeneration of the aged thymus. 
1.3. THYMIC EPITHELIAL PROGENITOR CELLS 
1.3.1. FETAL THYMIC EPITHELIAL PROGENITOR CELLS 
The origin of the thymic epithelial cell has always been a controversial issue. Previously it 
was proposed that the TECs have a dual origin. The dual origin theory stated that the cTECs have 
an ectodermal origin, whereas the mTECs are derived from the endoderm  (23, 84-86). Different 
morphological and histological studies, including analysis of nude mouse embryos (85) and the 
study of chick-quail chimeras (68), supported the dual origin of the thymic epithelial cells. Later 
it was demonstrated that the thymic epithelial cells are all derived from endoderm during fetal 
development. Several lineage studies were done to prove the single origin of both cTECs and 
mTECs (19, 87, 88). Rodewald et al. 2001 showed a common origin of cTEC and mTECs by 
injecting embryonic stem cells in the blastocyst with different MHC II types (88). Later, Gordon 
et al. 2002 experimentally proved that the thymic epithelial rudiment originates from the 
endodermal layer of the third pharyngeal pouch by injecting tracking dye in the ectoderm and 
observing its fate during embryogenesis (19, 84, 88). Gordon et al. 2004  transplanted the 3rd 
pharyngeal pouch endodermal tissue under a nude mouse's kidney capsule in another study. 23-36 
days post-transplantation, the endodermal layer gave rise to a functional thymic tissue. This study 
definitively proved that the thymic epithelial rudiment is only derived from the endodermal layer.  
It was previously demonstrated that even though the ectodermal layer does not contribute to the 
thymic epithelial primordia, contact between endoderm and ectoderm is vital for the induction of 
thymus organogenesis (13).  
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Although the thymic epithelial rudiment's single origin was established, the developmental 
processes leading to mature cTECs and mTECs are still not transparent. The single-origin theory 
led to the hypothesis that both cTEC and mTEC populations originate from a common bi-potent 
progenitor population in the thymus. A few studies have shown that in the fetal murine thymus, at 
E12.5, all thymic epithelial cells express the same proteins, EpCAM1.   In the 7-week-old fetal 
human thymus, all epithelial cells express the A2B5 protein (a medullary thymic epithelial cell 
marker in humans) (87). In the mouse fetal thymus, at E14.5, all the TECs express 4F1(a murine 
cortical thymic epithelial cell marker) (89, 90). Several experimental approaches gave direct 
evidence of subpopulations of cells expressing both cTEC and mTEC markers. First, Ropke et al. 
1995, showed that the fetal murine thymic epithelial cells from E14.5 to E16.5 contain a small 
subpopulation of cells that express both TR4( a cTEC marker) and TR5 (an mTEC marker) (87). 
Later, Klug et al.1998, showed a small population of K5+K8+ TECs mostly present in the cortico-
medullary junction, which can give rise to cortical thymic epithelial cells(K5-K8+) (66).  
In pursuit of further characterizing the thymic epithelial progenitor cell (TEPC), Gill et al. 
2002 (91) and Bennet et al. 2002 (90) showed that MTS24 could be used as a marker for the thymic 
epithelial progenitor cells. But their finding was disputed by Rossi et al. 2006, who later showed 
that both MTS24+ and MTS24- cell populations isolated from murine fetal thymus could give rise 
to the functional thymus (92).  They also demonstrated the uniform expression of Plet-1 in the bi-
potent TEPCs (92). Depeter et al. 2008, showed that Plet-1 could be used as a marker for TEPCs 
(93). The presence of a bi-potent progenitor cell population for the TECs was proven by Rossi et 
al. 2006 when they performed a clonal analysis assay on individual EpCAM+eYFP+ E12 fetal 
thymic cells and showed that EpCAM+eYFP+ thymic epithelial progenitor cell could give rise to 
both cTECs and mTECs (92). From the studies mentioned above, it is apparent that during 
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embryonic development, the fetal thymus contains a bi-potent thymic epithelial progenitor cell, 
which gives rise to both cTECs and mTECs during thymus organogenesis. However, this 
progenitor cell population's characteristics or whether it persists in the postnatal thymus are not 
completely clear. Apart from identifying the fetal thymic epithelial progenitor cell population, 
previous studies also recognized FoxN1 as an essential transcription factor for the fetal TEC 
development. 
FoxN1 seems to be the critical transcription factor for developing the thymic epithelial 
cells, as shown by the lack of a functional thymus in FoxN1-/- (nude) mice. Although FoxN1 is not 
required for the thymus organogenesis, it is essential for the epithelial rudiment committing to the 
TEC lineage (94-96). Furthermore, in the FoxN1 rescue experiments, where the FoxN1 is turned 
on later in the development, the adult mice have fully functioning thymuses (95, 97). Interestingly, 
even though the thymic primordium is formed in the FoxN1-/- mice, committed TECs were not 
observed. These data imply that the FoxN1 expression is not needed for early thymus 
organogenesis (97), but it is crucial for developing and maintaining the thymic epithelial cells (94-
96). Blackburn et al. 1996, demonstrated with nude/wild-type chimeras that the Foxn1 gene acts 
cell-autonomously in the thymic epithelial cell development (95, 96). Additionally, Rode et al. 
2015 have shown that at least 94% of the thymic epithelial cells (defined by EpCAM) express 
FoxN1 throughout gestation(96, 98). In the nude mouse, where the Foxn1 gene is mutated, 
functional thymus development is inhibited. It has been shown that the FoxN1 gene is expressed 
autonomously in the epithelial progenitor cells derived from the endoderm (95). O'Neil et al. 2016 
showed FoxN1 is heterogeneously expressed in the fetal thymus. For example, Dec205+MHCIIhi 
cells expressed more FoxN1 than UEA1+MHCIIhi cells. They also demonstrated downregulation 
of FoxN1 expression is essential for mTEC divergence (99). Thymic epithelial progenitor cells 
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lacking Foxn1 expression do not develop fully, but if the Foxn1 expression is rescued, it can give 
rise to the fully developed thymus in adults (94, 100). Though the function of Foxn1 in the thymus 
has been shown in different studies, how the Foxn1 expression is regulated in the thymic anlage 
during embryogenesis is not fully understood. Bone Morphogenic Protein (BMP) expressed in the 
endoderm plays a regulatory role in the Foxn1 expression. It has been shown that inhibition of 
BMP signaling caused inhibition of Foxn1 expression in the thymic primordium (18, 101). Studies 
have shown that the Wnt signal transduction pathway also plays a critical role in the FoxN1 
expression (22). Studies have shown that Foxn1 is important in maintaining the adult thymic 
epithelial cells in a dosage-dependent manner. Deleting Foxn1 in the adult thymic epithelial cells 
causes rapid degeneration of the thymic architecture (94). 
1.3.2. ADULT THYMIC EPITHELIAL PROGENITOR CELLS 
While the presence of bi-potent TEC progenitors is apparent in the fetus, its existence in 
the postnatal thymus is still the subject of debate.  Earlier, it was believed that the adult thymus 
does not have an epithelial progenitor cell population, unlike other epithelial tissues. Some studies 
have shown an epithelial progenitor cell population in the adult thymus (102-104). Bleul. et al. 
2006, showed that in the postnatal mouse, reversion of a Foxn1 mutant allele to wild type (WT) in 
individual TECs could give rise to a fully functional thymus with both cortical and medullary areas 
(100). Later, Ucar et al. 2014, argued that adult thymus stromal cells that exhibit a low cycling rate 
and self-renewal capacity could form thymospheres containing both cTECs and mTECs (103). 
Further, lineage-tracing experiments showed that they originate from FoxN1- cells (103). 
Ulyanchenko et al. 2016, presented that the Ly-51+Plet-1+MHCIIhi cells are the TEPC population 
in the adult thymus and exhibit stem cell-like properties (104). Several studies have shown that 
some cTEC markers like Dec205 and β5t define the progenitor cell population of thymic epithelia 
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(105, 106). These studies supported the serial progression model for the TEC development. The 
first evidence of a lineage-committed TEC progenitor was shown by Rodewald et al. 2001 when 
they showed the thymus medulla's formation from clonal islets (88). Hamazaki et al. 2007, later 
revealed that the mTEC lineage-committed progenitor cells express a high level of Claudin 3 and 
4 (107). In the case of a cTEC lineage-committed progenitor population, it was first thought that 
DEC205+ cells are committed to the cTEC lineage. However, it was later shown that DEC205+ 
cells could give rise to both cTECs and mTECs (106). Two different studies reported that a β5t-
expressing progenitor population could give rise to most mTEC subpopulations (105, 108). Osada 
et al. 2013, have previously utilized label retention to identify a stem cell-like population within 
the postnatal thymus, which can differentiate into both TEC subsets in vivo as well as multiple 
mesenchymal lineages including adipocyte, chondrocyte, and osteoblasts in vitro (109). The 
following markers characterize this thymic mesenchymal stem cell-like(TMSC) population: Sca1, 
CD49f, CD29, PDGFRα and CD90 (109). Wong et al. 2014, showed that an EpCAM+ 
subpopulation, which expresses an MHCIIlo Sca1+CD49f+ phenotype, of the adult thymus was 
capable of self-renewal and can differentiate into cTECs and mTECs. Though there have been 
extensive studies on the presence of adult TEPCs, no consensus has been formed on the definitive 
characteristics of this population.  Characterizing the TEPC population is important as they could 
be used in therapeutics to improve thymic function. 
1.4. FUNCTION OF THYMUS 
 The thymus's primary function is developing a functional self-tolerant T-cell repertoire 
critical for the adaptive immune system (110). It has been shown that thymectomy in adult mice 
results in severe immune deficiency (111, 112). At E12.5, the thymus receives its first influx of 
the lymphoid progenitors fated to become T-cells. This first influx of cells originates from the fetal 
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liver, where the bone marrow is yet to form (113). Another wave of the lymphoid progenitors 
colonizes the thymus around E18 when the bone marrow has been appropriately formed (98). A 
detailed discussion of T-cell development is provided in the following section. 
1.4.1.T-CELL DEVELOPMENT 
T-cell development exclusively happens in the thymus. The T-cell development process is 
very dynamic and depends on the interaction of the thymocytes with a properly organized thymic 
stroma (48). The thymus gives rise to two distinct T-cell lineages: αβ and γδ T-cells, which are 
defined by the expression of αβ– or γδ–T cell receptor (TCR) complexes.   
The lymphoid progenitor cells go through different developmental stages in the thymus to 
form mature αβ–T-cells and γδ–T cells. The αβ–T-cell lineage gives rise to two distinct cell 
lineages CD4+T -helper cells and CD8+ cytotoxic T-cells. The peripheral T-cell pool mainly 
consists of αβ T-cells.  In addition to αβ T –cells, the thymus is also involved in γδ–T cell 
development. γδ–T cells are primarily found in epithelial and mucosal sites and lack expression of 
the CD4 and CD8 co-receptors.  
During the developmental process, T-cell undergoes a series of selection steps that direct 
the differentiation process and determine the TCR repertoire. The distinct stages of T-cell 
development include, 1) entry of the lymphoid progenitor cells at the cortico-medullary junction 
of the thymus; 2) rearrangement and expression of the TCR genes during the progression through 
the four double negative stages of T cell development defined by expression of CD44 and CD25; 
3) α/β TCR+ CD4+CD8+ T-cell population (DP); 4) Positive selection of the double-positive T-
cells in the thymus cortex;5) Negative selection of the positively selected SP T-cells in the thymic 
medulla to produce self-tolerant T-cells; 5) emergence of mature naive T-cells from the thymus to 
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the peripheral blood circulation (114-116). A detailed account for all the T-cell developmental 
steps is given below. 
In the first step of T-cell development, lymphocyte progenitor cells arrive in the thymus 
through the blood system. Prenatally, lymphoid progenitor cells are derived from the fetal liver 
and postnatally from the bone marrow. In mice, lymphoid progenitor cells arrive in the thymus as 
early as embryonic day 12 (E12). The seeding of lymphoid progenitor cells in the thymus happens 
in two different pathways of a vasculature-independent pathway and/or vasculature-dependent 
pathway (114). In the vasculature independent pathway, before vascularization of the embryonic 
thymus, lymphocyte progenitors are guided to the thymus in a chemotactic manner. Chemokines 
including CCL21, CCL25, and Cxcl12 expressed in the early thymic primordia guide the T-cell 
progenitors to the thymus and are critical to T-cell development (117, 118). Receptors for the three 
chemokines- Ccr7, Ccr9, and Cxcr4 are expressed on the lymphocyte progenitors. Analysis of T-
cell development in Ccl21 deficient mutant embryos decreased colonization of the thymus 
rudiment at embryonic day 14.  It has also been shown that the lack of expression of Ccr7, the 
receptor for Ccl21, in T-lymphocyte progenitor cells has the same impact on recruitment (58). The 
absence of both Ccr7 and Ccr9 results in a more substantial effect on the colonization of T-cells in 
the thymus; however, postnatally, this deficiency does not impact the T-cell migration (119). These 
studies show that both Ccl21 and Ccl25 are important for T-cell migration in the prenatal thymus 
but are not required in the postnatal thymus. The deficiency of another chemokine, Cxcl12, and its 
receptor Cxcr2 do not cause any substantial impairment in the T-cell colonization, still their 
absence affects the expansion of thymocytes at the DN3, DN4, and DP stages during 
embryogenesis (120, 121). In the postnatal thymus, T-lymphocyte progenitors enter the thymus 
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through blood vessels at the cortico-medullary junction. Additionally, P-selectin contributes to the 
homing of T-cell progenitors to the adult thymus (122). 
After the T-cell progenitors enter the thymus' cortico-medullary junction, they move 
through the cortex to the subcapsular zone (SCZ) of the outer cortex. During this movement, they 
transition through distinct developmental stages defined by differential expression of CD44 and 
CD25 including: DN1(CD4-CD8-CD44+CD25-); DN2(CD4-CD8-CD44+CD25+); DN3(CD4-CD8-
CD44-CD25+) DN4(CD4-CD8-CD44-CD25-). Once the lymphocyte progenitor cells enter the 
thymus, they are known as early thymic progenitors (ETPs). These DN1 cells will receive Notch 
signals from the cTECs to commit to the T-cell fate, at which point they will become DN2 cells. 
DN1 and DN2 stage is mainly characterized by the active proliferation of the T-cell progenitor 
population.  Here the ETPs lose the potential to become myeloid and B fated cells.  At DN2 stage, 
β, γ, and δ loci start undergoing gene rearrangement by V-D-J recombination for TCR. The β locus 
undergoes D β and J β rearrangement by Recombination Activating Gene, RAG-1 and RAG-2 
(123). At the DN3 stage, the thymocytes continue their V-D-J rearrangement with Vβ to DJβ. ATt 
this stage, these cells are fully and irreversibly committed to the T-cell fate. At this stage, invariant 
Pre-TCRα chains are expressed on the cell surface. The DN3 thymocytes that can rearrange the 
TCRβ properly can pass the first checkpoint of T-cell development. However, if this is 
unsuccessful, the cell will undergo apoptosis (β-selection). 
Furthermore, if the β-chain is rearranged first, the rearrangement of the β chain will cease, 
and the γ-chain will be silenced if the γ-chain is rearranged first. Only 20% of the DN population 
express γδ-TCR. Notch signaling plays a vital role in the development of αβ lineage. γδ–T cells 
are less sensitive to the Notch signaling. Inhibitor of DNA binding 3, Id3 plays a prominent role 
in γδ T-cell differentiation by integrating Notch and TCR signaling. Strong TCR signal promotes 
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the γδ lineage, whereas pre-TCR signals, in collaboration with Notch, cause the repression of E 
protein, E47, and promote the αβ lineage (33, 124). Notch 1, Notch-3 ligands are expressed 
prominently during the DN3 stage. The pre-TCR-αβ pair is then associated with the CD3 molecule. 
The pre-TCR: CD3 complex provides constitutive signaling without any interaction with ligand.  
DN3 cells expressing the pre-TCR complex will induce inhibition of β-locus rearrangement. After 
the DN3 to DN4 transition, cells undergo rapid proliferation and repression of RAG-1 and RAG-
2. After the rapid proliferation stage ends, RAG-1 and RAG -2 are transcribed again. Chemokine 
receptors such as Ccr7, Ccr9, and Cxcr12 help in the migration of DN4 lymphocytes to the 
thymus's cortex (114, 125, 126). Then the DN4 thymocytes transition to the DP cells by expressing 
the co-receptors CD4 and CD8.  
The DP stage of T-cell development is marked by the expression of co-receptor CD4 and 
CD8 (33, 127). Usually, CD8 is expressed first, followed by CD4 expression. During the DP stage, 
the α-chain, locus starts to rearrange and replaces the pre-T-α. The α-chain locus is structured in a 
way that multiple V/J recombination events can happen simultaneously on the same allele, each 
time resulting in the excision of previously recombined DNA (127). From this subset of DP 
thymocytes, the final stages of the T- cell development start: Positive selection, MHC restriction, 
CD4/CD8 lineage commitment, and Negative selection occur to form single positive thymocytes 
with functional and self-tolerant T-cell receptors. Notch signal also plays a significant role in the 
SP T-cell lineage commitment (127). The positive selection of the DP thymocytes is dependent on 
both T-cell receptors and co-receptors. In the cortex, interleukin-7 signaling is vital for further T-
cell development (128).  
Positive selection of the DP thymocyte is vital for understanding if the rearranged TCR is 
functional or not. The Cortical thymic epithelial cells and the dendritic cells mediate the positive 
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selection process. These two antigen presenting cell (APC) populations express self-antigen and 
MHC molecule complex on their surface. If the TCR on the DP thymocytes can recognize peptide-
MHC molecule complexes with low-avidity, DP thymocytes receive signals for further 
development (114, 116). The threshold for TCR and peptide-MHC complex interaction is very 
small. If the interaction is too strong or if there is no interaction, those DP cells will undergo death 
by neglect. This interaction between the TCR of DP thymocytes and self-peptide: MHC molecule 
complex represented on the surface of cTECs was observed utilizing two-photon laser 
fluorescence microscopy (129). Positive selection induced signaling causes the DP thymocytes to 
downregulate CD8 and develop CD4+CD8lo cells regardless of their interaction with MHC I or 
MHC II molecules. Suppose the TCR on the thymocyte is specific to MHC II molecules. In that 
case, the CD4 expression will provide a stronger signal, mediated by a lymphocyte-specific 
protein-tyrosine kinase (Lck), which will cause further differentiation along the CD4 lineage. 
However, if the cell is interacting with MHCI, it will not lead to CD4 signaling mediated by Lck, 
which in turn will determine CD8 lineage commitment. Two transcription factors ThPOK (T-
Helper-Inducing POZ/Krueppel-Like Factor) and Runx3 (Runt Related Transcription Factor 3), 
play a regulatory role in CD4 vs. CD8 lineage commitment (127). After positive selection and 
CD4/CD8 lineage determination, SP thymocytes undergo negative selection. 
Negative selection of the SP thymocyte is essential for the development of a self-tolerant 
T-cell population. Thymocytes that have undergone successful positive selection will then express 
the chemokine receptors CCR7 and CCR4 and move toward the cell population expressing CCR7 
ligands, CCL19, and CCL21 in the medulla (58). In the medulla, the T-cells will undergo negative 
selection. During negative selection, T-cells will bind onto the mTECs that uniquely express 
exogenous peptides in their MHC molecules that are not native to the thymus. The mTECs and the 
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medullary dendritic cells express tissue-restricted antigens on their surface through a process 
called promiscuous gene expression (PGE). PGE is carried out by the transcription factors AIRE 
(60, 61) and Fezf2 (59); AIRE allows the transcription of genes from areas found in 
heterochromatic regions of mTECs, whereas FezF2 binds directly to promoter elements of TRA 
genes. These gene products will be translated into proteins, processed into smaller peptides, and 
then packaged into the MHC molecules of the mTECs, mDCs and expressed on the cell surface. 
The thymocyte TCR binds to the MHC: self-peptide complex represented on the APCs. Depending 
on the binding affinity, the T-cell will either undergo apoptosis (binding too tightly) or go on to 
the periphery to mount an immune response. This process ensures that the population of naïve T-
cells that leave the thymus is self-tolerant and will not attack its own tissues. In figure 1.1 a 
schematic diagram elucidating the different steps of T-cell development is demonstrated (130). 
Apart from the αβ-lineage, the thymus is involved in development of other less abundant T-cell 
populations, including γδ–T cells, regulatory T-cells and iNKT cells. 
At the beginning of the T-cell development section, γδ-T-cells were mentioned. Unlike αβ-
T-cell, γδ-T-cells act as the first line of defense. This cell population is mainly found in the 
epithelial layer of tissues underlying internal and external surfaces of the body, such as the skin, 
intestinal epithelium, lung, and tongue (131, 132). Γδ-T-cells recognize conserved non-peptide 
antigens that are upregulated by stressed cells (132). One notable feature of the γδ-T-cells is that 
these cells acquire a pre-activated phenotype associated with the upregulation of memory markers 
during development. This phenomenon enables them to rapidly induce effector function, followed 
by tissue stress detection (132). 
To maintain a proper immune system, another class of T-cells can ablate an over-reactive 
immune response. A unique subset of T-cells, called Tregs, can modulate the autoreactive T-cells 
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by making them anergic. Tregs are defined as CD4+ CD25+ Foxp3+, with Foxp3 being the 
definitive marker of a regulatory T-cell. CD4+ Foxp3+ Tregs are generated in the medulla 
alongside the conventional αβ T-cells. It has been shown that a subset of CD4+ thymocytes can 
give rise to CD4+ Foxp3+ cells. However, the mechanisms that govern the lineage that lymphoid 
progenitors follow to become a CD4+ Foxp3+ cell is yet to be elucidated (133). 
Apart from these cells, one more “unconventional T-cell” lineages arise from the αβ 
lineage, namely the iNKT (invariant natural killer T) cells. The role of TECs in unconventional 
lineage generation is only partially understood. Currently, it is known that this T-cell population 
is developed in the cortex from the DP cells. iNKT DP progenitors are selected by CD1d 
expressing cortical DP thymocyte. This cell population expresses NK1.1 and has a limited TCR 
repertoire, and behaves more like innate cells, which can immediately respond to antigens and 
secrete cytokines when activated (134). 
1.4.2. THYMIC CROSSTALK 
T-cells develop in sequential order through the help of specialized epithelial cells in the 
thymus. As described above, several levels of selection occur to allow the development of self-
tolerant T-cells that can mount an appropriate immune response against a pathogen. These 
selection processes are dependent on a properly organized thymic epithelial architecture (135). 
The crosstalk between the thymocytes and the TECs allows the development of both thymocytes 
and the TECs (136). During embryogenesis, until the first lymphoid progenitor appears in between 
E11.5-E12.5, the thymic epithelial anlage starts to differentiate into the cortex and subsequently 
the medulla. The need for thymic crosstalk is apparent when looking at knockout mouse models 
that impede T-cell development. For example, SCID mice (thymocytes arrested at DN2) (135), 
RAG-/- mice (arrested at DN3) (137), and CαKO mice (arrested at DP stage) (138) all have varying 
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degrees of cortical cellularity and organization, and all lack fully formed medullas. When the DN 
T-cells are taken from a wild type mouse and injected into the peritoneal cavity of any one of these 
mouse models, both the cortex and the medulla develop similar to a wild-type thymus (138). These 
rescue experiments demonstrate that the T-cells and the TEC development are intimately locked 
together. Despite its critical role in the  T-cell development, the thymus undergoes age-associated 
atrophy, resulting in loss of functional TEC microenvironments, decreased T-cell production, and 
naïve T-cells in the periphery capable of responding to infection. 
1.5. THYMIC INVOLUTION 
As opposed to its crucial role in maintaining an essential part of the adaptive immunity, the 
thymus is one of the first organs to undergo involution. 3% of thymic tissue is estimated to be lost 
per year at puberty and then at 1% per year in middle life (139, 140). The thymus also undergoes 
increased atrophy due to malnutrition, infection, glucocorticoid treatment, chemotherapy, and 
radiotherapy (141). These causal factors primarily affect the T-cell population. For example, 
glucocorticoid treatment induced apoptosis of the DP thymocytes or chemotherapy and 
radiotherapy to cause significant loss of hematopoietic cells, including T-cell at different 
developmental stages. Acute loss of developing T-cell causes loss of thymic cross-talk, which in 
turn causes premature thymic involution (142) 
The mammalian thymus undergoes distinct morphological changes during involution, 
which include loss of TEC population and thymic adiposity (143, 144). A decreased thymic 
capacity for hemopoiesis accompanies thymic atrophy and adiposity. With progressive aging, the 
thymus starts losing its epithelial cell populations, while the number of non-TEC thymic stromal 
cells increases. Several studies have confirmed that both intrinsic and extrinsic factors play a role 
in thymic involution. Some of these intrinsic factors include hematopoietic cytokines, including 
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IL6, Leukemia inhibitory factor (LIF), Stem-cell factor (SCF), and Macrophage Colony 
Stimulating Factor (M-CSF) (145). Elevated levels of IL6, LIF, M-CSF, and SCF mRNA 
correlates with a decreased level of sjTRECs (single joint T-cell receptor excision circle) (145). 
Levels of sjTRECs correlate with the thymus' functionality; that is, decreased levels of sjTRECs 
represent reduced levels of naïve T-cell production in the aged thymus, which is directly attributed 
to thymic atrophy (145). One of the extrinsic factors that contribute to the thymic involution is 
elevated androgen and estrogen. Increased levels of sex-hormones cause atrophy of the thymus. 
Castration can cause partial restoration of the size of the involuted male thymus (146).  
It is known that thymic epithelial cells have a rapid turnover rate, i.e., they proliferate 
extensively during the period of thymic growth. Gray et al. 2006 revealed that during aging, the 
thymic epithelial cells' turnover rate decreases, suggesting that TEC proliferation might be the key 
regulator of thymus size (147).  This leads to the assumption that the decreased turnover rate of 
TECs might be one of the factors of thymic atrophy during aging. In this study, it was also shown 
that thymus involution could be reversed following sex steroid ablation. Seven to fourteen days 
after castration surgery, an aged mouse can achieve an expansion of both thymocyte and TEC 
numbers with an increased ratio of mTEC/cTEC (147).  More recent work by Griffith et al. 2012, 
has suggested that although the aging thymus size recovers transiently in response to castration or 
androgen blockade, it maintains many functional characteristics of the aged thymus (7). Capacity 
for thymic regeneration supports the presence of thymic epithelial progenitor cells in the adult 
thymus, which are activated to regenerate the thymus following sex steroid ablation (146). 
1.6. PLASTICITY OF BONE-MARROW DERIVED CELL POPULATIONS  
Stem cells are a unique self-renewing cell population that can differentiate into one or more 
mature cell types (148). Stem cell populations can differentiate into one or more mature cell types 
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depending upon their differentiation potency. Embryonic stem cell populations are more 
pluripotent than adult stem cell populations (149). An adult Stem cell population maintains many 
self-renewing tissues like the skin, intestinal epithelium, liver, mammary gland, and hematopoietic 
system (149). Two well-characterized adult stem cell populations include the hematopoietic stem 
cell (HSC) and mesenchymal stem cell (MSC) populations. Both of these stem cell populations 
are mainly found in the bone marrow. 
Bone marrow is one of the two primary lymphoid organs. Bone marrow is a semi-solid 
tissue located within bone. It consists of several distinct cell populations, including osteoblasts, 
osteoclasts, adipocytes, endothelial cells, hematopoietic stem cells, and mesenchymal stem cells. 
The rare population of self-renewing hematopoietic stem cells undergoes a tightly regulated 
process of generating mature blood cells, hematopoiesis, in the unique microenvironment provided 
by the bone marrow stroma throughout life (150). Hematopoietic stem cells are a well-
characterized population of self-renewing cells that produce progenitors that differentiate into 
every type of mature blood cell (150). Bone-marrow also contains mesenchymal stem cells. This 
cell population was characterized as adherent cells and shown the ability to differentiate into 
osteoblast, chondroblast, and adipocytes when treated with proper stimuli (151, 152).  
Apart from these two stem cell populations, recent studies have revealed a unique 
pluripotent population in adult bone-marrow that can undergo trans-differentiation and contribute 
to different tissue. Jiang et al. 2002 have shown this population can be cultured in vitro in specific 
growth media (153). They also showed that this population could differentiate into different cells, 
including hepatocytes, neurons, and endothelial cells in vitro (153). This characteristic is unique 
for an adult stem cell population. It is commonly believed that adult stem cells are tissue-specific, 
and their main function is to maintain tissue homeostasis (8). But this new bone marrow-derived 
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stem cell population can cross-lineage barriers and can transdifferentiate into other tissue-specific 
cells. Apart from Jiang et al. 2002, several other studies showed that bone marrow-derived cell 
populations could home to different organs (153-155). These studies (reviewed below) also 
demonstrated that a BM-derived population could differentiate into mature hepatocyte (156, 157), 
cardiac muscle (158), skeletal muscle cells (159), skin epithelial cells (160), air-way epithelial 
cells (161), GI tract epithelial cells (162), pancreatic endocrine β-cells, uterus endometrial 
epithelial cells(155), renal tubule epithelial cells (163), and neurons of the central nervous 
system(154, 164).  
1.6.1. BONE-MARROW DERIVED SKELETAL MUSCLE & CARDIAC MUSCLE 
It was predominantly believed that satellite cells of muscle fibers are the primary mediator 
of muscle regeneration. Still, Ferrari et al. 1998 demonstrated that regenerating muscles recruit 
progenitor cells from the bone marrow (159). They showed bone marrow-derived cells could 
migrate to degenerating muscle, differentiate into myocytes, and participate in the regeneration of 
the damaged fibers. Later Bittner et al. 1999 and Gussoni et al. 1999,  showed that during Duchene 
muscular dystrophy, tissue-specific stem cell reservoir is exhausted to repair and maintain tissue 
homeostasis. They demonstrated that both skeletal and cardiac muscles recruit cells from bone 
marrow to repair the injured tissue. They demonstrated that when the Satellite cell (muscle stem 
cell) reservoir is exhausted, both skeletal muscle and cardiac muscle recruit cells from the bone 
marrow to contribute to the progenitor cell pool (165, 166). Their study also showed that bone-
marrow-derived cells do not need to be injected locally for muscle engraftment, intravenous 
injection works efficiently for bone marrow cell engraftment in dystrophic muscle fibers (165). 
This study demonstrated under the condition of demand injected bone marrow cells can migrate 
to injury locations and differentiate into tissue specific cell populations. Later LeBarge et al. 2002, 
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showed that when GFP expressing BM cells were transplanted in a total body irradiated non-GFP 
recipient mice, GFP+ satellite cells are observed in the recipient's muscle tissue (167).  
Apart from the skeletal muscle, BM-derived cells also contribute to the cardiac muscle. 
Tomita et al. 19999 and Makino et al. 1999 showed the BM-derived stromal cells and 
mesenchymal stem cells can differentiate into cardiac myocytes in vitro (158, 168). Later Jackson 
et al. 2001 showed that bone-marrow-derived side population cells enriched in the hematopoietic 
stem cell population (CD34–/low, c-Kit+, Sca-1+)  when injected into the lethally irradiated mice, 
can migrate to injured cardiac muscle and blood vessels and differentiate into cardiomyocytes and 
endothelial cells (169). Orlic et al. 2001 injected Lin-c-kit+ BMC cells in the border zone of acute 
infarcts and demonstrated that these cells could differentiate into myocytes and vascular structures 
and increase the function of the infarcted heart (170). Kocher et al. 2001 showed that the adult 
human bone-marrow contains endothelial precursors, which can be directly used for new blood 
vessel formation and proliferation of existing vasculature after experimental myocardial infarction 
(171). 
1.6.2. BONE-MARROW DERIVED CELLS IN LIVER REGENERATION 
 BM-derived cells were also shown to contribute to liver regeneration (156, 157). It was 
perceived that the liver is repaired and maintained by the proliferation of existing hepatocytes and 
cholangiocytes as well as the proliferation and differentiation of bi-potent liver progenitors, oval 
cells (8). Petersen et al. 1999 showed two weeks after BM cells from dipeptidyl peptidase IV 
positive (DDPIV+) rats are injected into DDPIV null (DDPIV-ve) rats following hepatic injury 
with 2-acetylaminofluorene (2-AAF), CCl4 DDPIV+ donor-derived oval cells and hepatocytes 
developed (172). Their data showed that 0.76%-2.2% of the total hepatocytes were derived from 
BM-derived cells (172). Theise et al. 2000 and Alison et al. 2000 showed that after BMT, human 
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recipients developed BM-derived hepatocytes and cholangiocytes (157, 173). Lagasse et al. 2000 
demonstrated that BM-derived hepatocytes' functionality using the metabolic liver disease 
tyrosinemia type 1 mouse model (174). These mice are deficient in the enzyme 
fumarylacetoacetate hydrolase (FAH) and need to be maintained on the drug 2-(2-nitro-4-
trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC) to survive.  When these FAH deficient 
mice undergo BMT from wild-type FAH+ donors, three weeks after BMT when they were taken 
off NTBC, the mice showed improved liver function (174). In an attempt to understand if a single 
cell can give rise to cells at different organs, Krause et al. 2001 showed that lineage depleted cells 
isolated from the bone marrow when transplanted into irradiated mice homed to bone marrow after 
two days(154). These cells are then recovered from the recipient mouse. New irradiated hosts are 
then re-transplanted with these recovered cells so that each host received just one cell. After 11 
months, the long-term survivors have shown the presence of the transplanted cells in different 
organs, including the liver, stomach, lungs, and skin. IHC studies showed that these cells had 
differentiated into epithelial cells in multiple organs (154). 
1.6.3. BONE-MARROW DERIVED CELLS IN GI TRACT REGENERATION 
GI tract homeostasis is maintained by a multipotent intestinal stem cell population that can 
give rise to all types of epithelial cells, columnar absorptive enterocytes, Paneth cells, goblet cells 
enteroendocrine cells (8, 162, 175). But later, Krause et al. 2001, in their single-cell study, 
demonstrated the presence of BM-derived intestinal epithelial cells (154). Also, Okamoto et al. 
2002 showed that when four cancer patients who are demonstrating symptoms of GVHD, peptic 
ulcer, and inflammation of GI tract underwent a BMT from a sex mismatched donor, donor-
derived epithelial cells were found in all sections of the GI tract, including the esophagus, stomach, 
small intestine, and colon (176). They also performed karyotyping to rule out the possibility of a 
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fusion of the BM-derived cells (176). Brittan et al. 2002, also showed that BMDCs could give rise 
to intestinal myofibroblasts in both the mouse and the human small intestine and colon (165). 
1.6.4. BONE-MARROW DERIVED CELLS IN SKIN REGENERATION 
 It has been shown that adult skin contains a multipotent stem cell population present in the 
bulge region of hair follicles that can self-renew and differentiate into the epidermis, sebaceous 
glands, and hair follicles (160, 177). Borue et al. 2004 argued that BMDCs could differentiate into 
cytokeratin positive epithelial cells of the epidermis in response to skin injury(178). Additionally, 
Korbing et al. 2002 demonstrated that when HSC from peripheral blood were transplanted into 
human patients, biopsies of their liver, GI tract, and skin showed that 0-7% of the epithelial cells 
in the histological section were derived from donor cells (179). Donor-derived cells were detected 
in liver tissue as early as day 13 and as late as day 354 after transplantation (179). 
1.6.5. BONE-MARROW DERIVED CELLS IN LUNG REGENERATION 
Among the two types of surface epithelial cells of the alveoli, type I and type II 
pneumocytes, type II pneumocytes have self-renewing properties (180). Type II pneumocytes are 
responsible for alveolar tissue turnover. Type II pneumocytes can proliferate and differentiate into 
type I pneumocytes in response to injury (180). A single BM cell transplantation study done by 
Krause et al. 2001 showed that BM-derived cells could migrate to the lungs and differentiate into 
type II pneumocytes in alveoli (154). Kotton et al. 2001 created alveolar tissue damage by using a 
bleomycin injury protocol and showed that when plastic-adherent BMC cultured for ten days were 
injected into the bleomycin-treated mice, the injected cells form a cluster of type I pneumocytes 
30 days post-injection (161). Additionally, Theise et al. 2002 showed that within 5-7 days after 
lethal irradiation and BMT, donor cells start to repopulate injured alveolar tissue, and within two 
months, donor-derived cytokeratin expressing epithelial cells are observed in lungs (181). These 
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data demonstrated that bone-marrow cells enriched in HSC could engraft into injured lung tissue 
as pneumocytes (181). Interestingly, Davies et al. 2002 showed contradictory results in their study. 
It was shown that after sex-mismatched BMT in humans, nasal brushing samples demonstrated 
the presence of Donor-derived cells, but none of them were able to exhibit cytokeratin staining 
(182). This result showed that bone marrow stem cells could not contribute to the healthy upper 
respiratory tract's epithelial cell population. Later, Wong et al. 2007 showed that short-term 
cultured bone marrow cells migrated to the naphthalene injured lung, localized there, and 
differentiated into airway epithelial cells(183). They showed a unique population of cells in the 
bone marrow, which express a marker of airway progenitors, Clara cell secretory protein (CCSP), 
and the hematopoietic cell marker CD45 (183). Furthermore, they also demonstrated that this 
population's frequency increases in response to lung injury (183). This cell population can migrate 
to the lungs and differentiate into airway epithelial cells (183).  
1.6.6. BONE-MARROW DERIVED CELLS IN REGENERATION OF PANCREAS 
Ianus et al. 2003 found that BM-derived cells can also differentiate into pancreatic 
endocrine β-cells when BMCs from wild-type mice are transplanted into lethally irradiated 
mice(184). Donor-derived cells were observed in islets, and these cells expressed insulin and 
transcription factors specific to B -cells (184). Hess et al. 2003 showed that when BMDCs express 
c-kit in mice with streptozotocin-induced pancreatic damage, it reduces their hyperglycemia (185). 
They demonstrated that the donor cells were mainly clustered in ductal and islet structures, which 
induced endogenous cells' proliferation and produced insulin (185). 
1.6.7. BONE-MARROW DERIVED CELLS IN KIDNEY REGENERATION 
Poulsom et al. 2001 showed that lethally irradiated female mice receiving BMT from male 
donors have kidney cells that co-stain with both the Y chromosome and the epithelial cell–binding 
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lectin Ricinus communis, Lens culinaris, and Pisum sativum (186). This study also showed that 
when male patients had been transplanted with kidneys from a female donor, their kidney biopsies 
showed that a significant number of renal tubule epithelial cells were BM-derived (186).   Kale et 
al. 2003, showed that Lin–Sca-1+ cells from the adult mouse bone marrow are mobilized into the 
circulation by transient renal ischemia and home specifically to injured regions of the renal 
tubule(163). These BM cells differentiate into renal tubular epithelial cells in the renal tubule and 
appear to constitute most of the cells present in the previously necrotic tubules (163). Loss of stem 
cells following bone marrow ablation results in a more significant rise in blood urea nitrogen after 
renal ischemia. In contrast, stem cell infusion after bone marrow ablation reverses this effect (163). 
Later, Prodromidi et al. 2006 used a mouse model of autosomal recessive Alport syndrome. In this 
model, podocytes fail to synthesize normal glomeruli causing progressive glomerular damage 
leading to renal failure (187). In this study, female mice with Alport syndrome underwent BM 
transplantation with whole BM from wild-type male mice. Twenty weeks of post-transplant kidney 
function improved, and glomerular scarring decreased. They also observed donor-derived cells, 
and some of those cells showed phenotypes of podocytes (187). 
1.6.8. BONE-MARROW DERIVED CELLS IN UTERUS REGENERATION 
 In the uterus, during each menstrual cycle, endometrium regeneration takes place. The 
Endometrial stem cells remain in the basalis layer and differentiate into endometrial cells. In search 
of non-uterine endometrial stem cells, Taylor et al. 2004 revealed that bone marrow transplant 
patients with mismatched HLA type showed the presence of 0.2%-48% donor-derived endometrial 
cell (188).  Later, Du et al. 2007 showed that after bone marrow cells from male mice were 
transplanted into female mice, donor-derived BMCs were found in female mice's uterine 
endometrium (189). They also demonstrated that <0.01% of the donor population differentiate into 
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epithelial cells (189). Alawadhi et al. 2014 showed that BMDCs could engraft into the 
endometrium under the condition of uterus injury (155). Liu et al. 2018 revealed that injection of 
BMDCs rather than uterine-derived cells caused better uterine engraftment(190). This study also 
elucidated the systemic administration of BMDCs causes more effective uterine engraftment than 
a local intrauterine injection of BMDCs (190). 
1.6.9. BONE-MARROW DERIVED CELLS IN REGENERATION OF THE CNS 
 Previously central nervous system cells were believed to be non-renewable (191). But 
recent studies suggested that BMCs can differentiate into CNS cells, including neurons, 
oligodendrocytes, and astrocytes, both in vivo and in vitro. In vitro studies on BMCs to CNS 
plasticity focus on the stromal BMC population's capacity to self-renew and differentiate into 
neuronal phenotypes. Mezey et al. 2000, showed that adult bone marrow cells could migrate to the 
brain and differentiate into the cells that express neuron-specific antigens (192). Jiang et al. 2002 
highlighted that Bone-marrow-derived cells could undergo morphological changes to evolve into 
astrocyte-, oligodendrocyte-, and neuron-like cells in vitro when induced by cytokines (153).   Hao 
et al. 2003 demonstrated that when CD34+CD133+CD3– human fetal hematopoietic stem cells 
are cultured in an astrocyte-conditioned medium, they differentiate into nestin and BMP-2 
expressing neuronal progenitor-like cells(164). They also observed a similar result when the BMCs 
are cocultured with astrocytes (164). Eglitis et al. 1997 showed that in vivo BM cells can 
differentiate into GFAP (an astrocyte marker) expressing astrocytes in both gray and white matter 
when bone marrow cells were injected into irradiated mice (193).  Saski et al. 2001 and Akiyama 
et al. 2002 showed that bone-marrow-derived cells could repair spinal cord injury by 
remyelination. Moreover, they argued that in a demyelinating rat model, when myelination 
34 
 
maintaining oligodendrocytes are destroyed with ethidium bromide injection followed by X-ray 
irradiation, BMC administration causes remyelination on the neuronal axons (194, 195).  
Taken together, these results suggest that adult bone marrow cells have more plasticity than 
it was previously understood. Bone-marrow derived cells can differentiate into epithelial cells in 
different organs. This capacity of bone-marrow-derived cells can be used for targeted cell 
replacement therapy for different organs (8, 149). 
1.6.10. CELL FUSION OR TRANSDIFFERENTIATION 
Some studies have disputed the differentiation of BM-derived cells into other tissue-
specific cells and argued that fusion rather than trans-differentiation is the source of bone marrow 
plasticity(196-199). These studies were mainly performed in response to the study by Krause et 
al. 2002, where they demonstrated that a single bone-marrow-derived stem cell can produce 
progeny that migrate to different organs and differentiate into different epithelial cell populations, 
including gut, lung, liver, and uterine epithelial cells (154). Interestingly, Ying et al. 2002, showed 
that when mouse brain cells are cocultured with pluripotent embryonic stem cells (ESCs), the stem 
cells spontaneously fuse with the brain cells and express brain cell markers (196). Karyotyping of 
these cells revealed polyploidy (196). This data disputed all the previous results showing the 
plasticity of bone marrow cells.  Terada et al. 2002 showed that mouse BM  mononuclear cells 
from female transgenic mice expressing GFP and the puromycin-resistance gene when co-cultured 
with male embryonic stem cells in an IL-3 containing growth media, within three weeks BM cells 
started expressing embryonic stem cell-like properties, but further analysis showed polyploidy of 
these cells (199). Previously Lagasse et al. 2000 demonstrated the functionality of BM-derived 
hepatocytes by using metabolic liver disease tyrosinemia type 1 mouse model (174). In response 
to that, Wang et al. 2003 showed that when they performed serial transplantation of bone-marrow-
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derived hepatocytes, they found polyploidy in the bone-marrow-derived hepatocytes (197). 
Additionally, Vassilopoulos et al. 2003 showed that when the Fah deficient mouse model was 
injected with wild-type mice BM cells, the recipient mice liver was repopulated with liver cells. 
But interestingly, these donor cells had both mutant and wild type Fah alleles, and these cells 
exhibited polyploidy (198). These studies indicated the possibility that BMC plasticity is the result 
of the fusion of hematopoietic cells to tissue-specific cells. 
Herzog et al. 2003 suggested that newfound bone marrow plasticity can result from more 
than one possible mechanism. One of the possibilities includes the presence of a unique pluripotent 
stem cell population that is not part of the HSC population. Other possibilities include 
transdifferentiation, where the hematopoietic stem cells can first dedifferentiate then follow the 
alternative pathway to differentiate into completely different cell populations. Transdifferentiation 
can also happen directly, where the HSC can directly differentiate into cell populations other than 
hematopoietic cells. Lastly, fusion can also be one of the mechanisms where the HSC can 
spontaneously fuse with nonhematopoietic cells to form polyploids with characteristics of both 
donor and recipient cells (149). Figure 1.2 shows the schematics of these four mechanisms (149). 
As explained in this section, bone marrow derived cells can differentiate into different adult 
tissue-specific cell populations. Some of the studies demonstrating this newfound plasticity 
exploited either the BM-derived HSC population (154, 183) or whole BM (165, 192).  Some 
studies also used more defined BM-derived subsets, for example, Lin-CD34+ BMCs (163). One 
most prominent study by Krause et al. showed that a single bone-marrow-derived stem cell could 
produce progeny that migrate to different organs and differentiate into different epithelial cell 
populations, including gut, lung, liver, kidney, and uterine epithelial cells (154). Other studies also 
demonstrated the contribution of bone marrow in the pancreas (184) and CNS (192). But 
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interestingly, none of these studies examined the thymic stroma. This current study will assess if 
bone marrow cells can contribute to the thymic epithelial microenvironment. 
 
1.7. OVERVIEW OF WNT SIGNALING 
  Wnt proteins are a family of secreted signaling molecules. These evolutionarily conserved 
proteins are pleiotropic and play a diverse but crucial role during cell development, differentiation, 
migration, and proliferation in vertebrates and invertebrates (200-202). Gene sequencing has 
revealed ~20 different evolutionary conserved Wnt proteins in various mammalian species, 
divided into 12 subfamilies (203). Wnt genes encode secreted glycoprotein consisting of ~350 
amino acids (201). This protein shows a conserved 23 cysteine residue pattern, and they undergo 
lipid modification (201). Lipid modification (palmitoylation of the conserved Cysteine residues) 
of the Wnt proteins is essential for their function. Wnt proteins also carry N-terminal signal 
peptide, which is essential for Wnt protein secretion. 
       The Wnt signal transduction pathway is known to regulate cell fate, establishing the dorsal 
axis, limb development, asymmetric cell division, progenitor-cell proliferation and survival, and 
long-term memory formation (201, 204). Moreover, Wnt signaling also plays an essential role in 
regulating hematopoietic and epithelial stem cells (205). This signaling pathway is tightly 
regulated, and this pathway's misregulation can lead to cancer (203).   For initiation of the Wnt 
signal transduction pathway, Wnt proteins interact with the Frizzled (Fzd) family's seven-
transmembrane receptors (202, 205, 206). Higher vertebrates have at least ten frizzled proteins. 
The Wnt-Frizzled complex can interact with different co-receptors, including  LDL receptor 
proteins, LRP 5, LRP 6, and the receptor protein tyrosine kinase ROR2 (206).  There are three 
different intracellular wnt signaling pathways present: 1) the canonical Wnt-β- catenin-dependent 
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pathway, 2) the planar cell polarity pathway (PCP), or Wnt-Jun N-terminal kinase pathway, and 
3) the Wnt-Ca2+ pathway. In the past, it was believed that certain types of Wnt proteins and frizzled 
receptor activates specific pathways. Later, it came to light that such a  specificity most probably 
came from a specific combination of Wnt ligands, Fzd receptors, co-receptor,  and even 
intracellular signaling components (206). But recently, redundancy of Wnt proteins in activating 
different pathways or different pathways being activated to regulate each other was observed. This 
new knowledge leads to the new idea about the Wnt signaling network. The canonical Wnt-β-
catenin signaling pathway is the most studied Wnt pathway (205).   
The canonical Wnt signaling cascade exists in two main phases, active and inactive. In the 
inactive phase, the Wnt ligand does not bind to the frizzled receptor, which causes cytoplasmic 
and nuclear β-catenin to be targeted for degradation by the proteasome through the actions of a 
destruction complex (207). The destruction complex is composed of two scaffolding and tumor-
suppressor proteins adenomatous polyposis coli (APC), axis inhibition protein 1 (AXIN1), and 
glycogen synthase kinase 3β (GSK3β). When β-catenin binds to this destruction complex, it is 
phosphorylated by the serine/threonine kinase 1 (CSNK1A1) and glycogen synthase kinase 3β 
(GSK3β). CSNK1A1 phosphorylates β-catenin on Ser45, and then GSK3β phosphorylates β-
catenin on Ser33, Ser37, and Thr41, creating recognition sites for β-transducin repeat-containing 
protein (βTRCP1, and βTRCP2) (208). This βTRCP1 and βTRCP2 recognition site tags the β-
catenin for ubiquitination dependent proteolysis(209). Meanwhile, in the nucleus, TCF assembles 
a transcriptional repressor complex comprised of Groucho/Transducin-like enhancer (GRG/TLE), 
C-terminal binding protein (CTBP), and histone deacetylases (HDACs) to silence Wnt target 
genes(210). In the active phase, when the Wnt ligand bind to the Fzd receptor to initiate the Wnt 
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signaling pathway, that disbands the destruction complex that causes stabilization and 
accumulation of cytoplasmic β-catenin. 
  The initiation of canonical Wnt signaling results in the cytoplasmic stabilization and 
accumulation of β-catenin, which subsequently translocate to the nucleus and coordinates 
transcriptional activity(205). Wnt ligands bind to its Fzd receptor and its co-receptor, low-density 
lipoprotein receptor-related protein 5 (LRP5) or 6 (LRP6), at the cell membrane to activate the 
signaling cascade (211). LRP 5/6 are single-span transmembrane proteins. It is presumed that Wnt 
may induce Fz-LRP 6 complex formation, which in turn activates the Wnt signaling pathway. 
Disheveled (DVL) then binds to Fzd/LRP complex and promotes the phosphorylation of PPPSPxS 
motifs within the LRP5/6 intracellular domain by CSNK1A1 and GSK3β. LRP5/6 then recruits  
AXIN1 to the plasma membrane (212). In the meantime, DVL is also modified through CKIε, 
which increases the affinity of  GSK3β  inhibitor GBP/FRAT and away from the destruction 
complex in the cytoplasm (207, 213). Thus, the inhibition of β-catenin phosphorylation results in 
the accumulation of β-catenin in the cytoplasm, which then translocates into the nucleus and 
associates with the TCF/LEF family of transcription factors to activate β-catenin-dependent 
responsive genes (214). Furthermore, both TCF/LEF and β-catenin interact with additional 
proteins such as BCL9, Pygopus (PYGO), SWI/SNF, Pontin, and CBP/p300, to initiate 
transcription(205). TCF/LEF and β-catenin complex activate gene expression Myc, Jun, Fra, 
Cyclin D1(Figure 1.3). 
The canonical Wnt signaling pathway is tightly regulated at many points to ensure proper 
signaling. The Wnt signaling pathway's antagonists can be divided into two broad groups: the 
secreted Frizzled related protein (Sfrp) group and the Dickkopf group (215).  Sfrp group includes 
the Sfrp family, Wnt inhibitory factor 1 (Wif-1), and Cerberus (215). Inhibitors in Sfrp group 
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inhibitors can bind directly to the Wnt ligands in the extracellular membrane and prevent Wnt 
signaling initiation, and this results in the unspecific inhibition of both canonical and noncanonical 
Wnt signaling (215). On the other hand, Dickkopf group inhibitors specifically inhibit canonical 
Wnt signaling by binding and blocking the LRP5/6 co-receptors (216). Negative regulation also 
occurs in the nucleus by the cell-autonomous inhibitor of β-catenin and TCF (ICAT), which can 
inhibit the nuclear interaction between β-catenin with TCF (217). TCF has at least eight isoforms 
formed by alternative splicing and different promoter usage. All the isoform can bind to the Wnt 
ligands at different extents and thus regulating cells' response to Wnt signaling (205). 
The two non-canonical Wnt signaling pathways are still less understood. One of the two 
noncanonical Wnt signaling pathways generates planar cell polarity (PCP) (218). The PCP 
pathway results in Jun N-terminal kinase (JNK) activation, which mediates cell position and 
shape(205). It is β-catenin-independent and does not include the Fzd co-receptors LRP5/6 or TCF 
molecules. Wnt5a, Wnt11 initiates this pathway using frizzled and DVL (205). DVL associates 
with the Disheveled-associated activator of morphogenesis (DAAM), which activates the RAS 
homologue gene-family member A (RHOA) and Rho-associated coiled-coil-containing protein 
kinase (ROCK) to facilitate cytoskeletal reorganization (205, 219). DVL also activates RAC1, and 
both RAC1 and RHOA activate JNK, which leads to changes in cell adhesion and cell migration 
by regulating cytoskeletal changes (205). It has also shown that non-canonical Wnt signaling can 
inhibit canonical Wnt signaling in lymphocytes (220, 221). 
A more recently recognized non-canonical Wnt pathway, the Wnt-Ca2+ pathway, is 
hypothesized to influence both non-canonical and canonical Wnt signaling. It is presumed that 
Wnt5a and Fzd-2 are the most probable components of the Wnt-Ca2+ pathway. Wnt ligand goes 
through palmitoylation so that they can bond to a cognate Fzd receptor to initiate this signal 
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transduction pathway(222). These lipid-modified proteins are chaperoned by heparin sulfate to 
prevent clustering(223). The extracellular N-terminus of the Fzd receptor binds to the ligand.  The 
PDZ (Psd-95/dics large/ZO1)-binding domain in the intracellular part is responsible for all the 
downstream process. Through a G protein, the Wnt-Fzd complex activates phospholipase C (PLC), 
leading to the cleavage of phosphatidylinositol-4,5-bisphosphate (PtdIns (4,5) P2) to inositol 
triphosphate (IP3) and diacylglycerol (DAG), which then activates protein kinase C (PKC). IP3 
binds to its calcium channel receptor present on the endoplasmic reticulum and releases 
intracellular calcium stores, and increases Ca2+ ion levels in the cytoplasm. Ca2+ ion levels are 
normally kept low, and the increased Ca2+ concentration activates the calmodulin phosphatase 
calcineurin and several calcium-dependent kinases, including calmodulin-dependent protein 
kinase II (CaMKII)(224); whereas DAG activates PKC(225). Increased CaMKII and PKC have a 
wide variety of effects but often triggers the nuclear factor of activated T cells (NFAT)(226). 
Wnt/Fz interaction is also seen to activate phosphodiesterase 6 (PDE6) in a calcium-dependent 
manner to decrease cyclic GMP(cGMP) level(227).  
Wnt signaling is currently assumed to have three individual pathways. Others, however, 
oppose this divisive approach and instead view all three pathways as a single Wnt signaling 
network(206). It has been shown in vivo that different Wnt pathways simultaneously regulated 
each other in the same cell type simultaneously—PCP signaling activation of JNK has been 
reported to inhibit the canonical Wnt signaling pathway in addition to regulating cell movement. 
Redundancy of the same molecule involved in different Wnt signaling pathways has also been 
observed(206, 228). For example, Dejmek et al. 2006, Ma et al. 2006, Yamanaka et al. 2006 and  
He et al. 1997, have shown that Wnt5a is capable of activating not only the noncanonical calcium 
signal pathway and JNK pathway(229-231) but also the canonical β-catenin pathway when in the 
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presence of human Fzd-5 in Xenopus embryos(232). Mikels et al. 2006 demonstrated mouse Fzd-
4 in HEK293 cells can activate the canonical β-catenin pathway via Wnt5a(233). In another study, 
Tu et al. 2007 showed that Wnt3a could simultaneously activate canonical and non-canonical 
pathways in the same cell type(234). Additionally, Boutros et al. 1998 and Sheldahl et. al 2003 
showed the intracellular signaling pathway mediator DVL is involved in β-catenin-dependent 
signaling, as well as PCP and Wnt-Ca2+ signaling(235, 236). Saneyoshi et al. 2002 has shown that 
the Wnt/ Ca2+ pathway stimulated transcription factor NF-AT also involved in wnt mediated 
dorsal-ventral patterning in Xenopus embryos indicating the involvement of Wnt/β catenin 
pathway(237). Kani et al. 2004 has shown that atypical receptor tyrosine kinase ror2 is regulated 
by CKIϵ, which is regulated by canonical wnt signaling(238). From all these experimental facts, it 
is clear that Wnt signaling is extremely context-specific and, stimulation with a certain Wnt ligand 
does not necessarily produce the same results for different cell types in the same species, or the 
same cell type in different species, or even in the same cell type in same species but at different 
time points. Therefore, it is important to view Wnt signaling as a vast, interconnecting network 
rather than individual pathways because making assumptions about specific roles for certain 
proteins can lead to invalid conclusions(206).  
1.7.1. Wnt SIGNALING & TEC DEVELOPMENT 
Several studies have shown that Wnt signaling has an extensive role in hematopoietic stem 
cell self-renewal, maturation of dendritic cells, T-cell development, activation, and peripheral 
migration of T-cells(205, 239-242). Previous studies have demonstrated that in the thymic stroma, 
only thymic epithelial cells express Wnt ligand proteins(204), which regulates proliferation of DN 
T-cell, survival, and positive selection of DP cells(205). Moreover, it has been shown before that 
TCF-1, an effector of canonical Wnt-β-catenin signaling, is important for T-cell development. In 
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addition to demonstrating TECs as the sole source of secreted Wnt ligand in the thymic stroma, it 
has also been shown that TECs even express membrane-bound Fzd receptors. This data created 
speculation that TECs can stimulate Wnt signaling cascades in themselves(204). However, it is 
difficult to separate between Wnt signaling's effect on developing thymocytes and the effect of 
wnt signaling on TEC development because of crosstalk present between developing thymocytes 
and TECs.  
Few studies attempted to reflect upon the direct relationships between individual Wnt 
ligands and their Fzd receptors or the transcriptional targets Wnt signaling simulates in TECs. 
Balciunaite et al. 2002 showed the presence of Wnt1, Wnt3, Wnt4, Wnt5, Wnt10b in thymic tissue. 
They also demonstrated that fetal thymus Wnt expression depends on different developmental 
stages of TECs and the presence of developing thymocytes, whereas, in adult TEC, some Wnt 
ligands are expressed independently of developing thymocytes. Additionally, their study 
highlighted that Wnt proteins play an essential role in fetal thymus development by regulating the 
expression of FOXN1, the key regulatory transcription factor for TEC development(31). Later, 
Kuraguchi et al. (2006) found that the mice with a FoxN1 specific deletion of APC can stabilize 
canonical β-catenin-Wnt signaling. They also demonstrated that these transgenic mice are unable 
to form a proper thymus(243). Later, Brunk et al. 2015, showed transgenic mice with FoxN1 
conditional knockout for GPR177, a Wnt-specific cargo receptor required for secretion of Wnt 
ligands, lose the capability of all Wnt secretion in TECs, including both canonical and non-
canonical Wnt ligands(204). They demonstrated that without GPR177 close to birth, thymus size 
is reduced along with TEC cellularity. Conditional knockout of GPR177 also causes reduction of 
the peripheral T-cell number and The thymus hypotrophy sets in close to birth, and the number of 
T-cells in the periphery reduces(204). These mice showed an increase in the ratio of mature 
43 
 
mTEChi to immature mTEClo cell populations and an increase in the rate of apoptosis in 
TECs(204). Besides that, the mutation does not affect TEC development, chemokine production, 
or the differentiation of Aire+ mTECs. Furthermore, it does not alter the mTEC/cTEC ratio or 
thymocyte development, but only the thymocyte frequency, which was less due to the reduced 
TEC population(204). Other cell populations in the thymus do not compensate for the loss of Wnt 
secretion(204). Together these studies propose a significant role for Wnt signaling in TEC 
proliferation and survival rather than TEC development and differentiation. 
Other studies tried to demonstrate the potential effect of β-catenin TEC development, 
differentiation, and maintenance directly or indirectly. Balciunaite et al. 2002 showed that 
constitutive the canonical β-catenin-Wnt signaling pathway in cTEC1-2, an established cortical 
epithelial cell culture, upregulates FoxN1 expression(22). Later, other in vivo studies showed that 
canonical β-catenin-Wnt signaling in TECs is a complex and tightly regulated process. 
Overexpression or inhibition of β-catenin disrupts normal thymus development(244, 245). Kvell 
et al. 2014 experimented with ICAT, a protein that disrupts the β-catenin/TCF interaction, which 
then inhibits the expression of Wnt signaling pathway target genes. They demonstrated that the 
fetal TECs transfected with ICAT reduces the expressions of FoxN1, MHC-II, and IL-7(245). 
Zuklys et al. 2009 demonstrated that constitutive activation of Wnt-signaling via gain-of-function 
mutation of β-catenin changes the earlier commitments of endodermal epithelial cells to a thymic 
fate. This mutation also disrupts thymic stroma organization as well as thymocyte recruitment by 
TECs (246). Osada et al. 2006 exhibited that Kremen1 (a Wnt antagonist) deficient mice showed 
an increase in canonical β-catenin-Wnt signaling in TEC-derived cell lines. They also 
demonstrated that these transgenic mice could not form properly developed thymic architecture, 
lacking the defined cortex and medulla regions(5). These data altogether suggest that the 
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stabilization of canonical β-catenin-Wnt signaling in TECs disrupts the thymic architecture and 
creates a non-functional thymic microenvironment. Interestingly, Osada et al. 2010, also 
demonstrated that inhibiting canonical β-catenin-Wnt signaling also disrupts the thymus 
architecture(6). In this study, double transgenic (tetO-Dkk1) mice were used, which in the presence 
of doxycycline produce high levels of Dkk1 in both mTECs and cTECs, which leads to the 
inducible inhibition of canonical Wnt signaling. Overexpression of DKK1 causes a decrease in 
TEC proliferation, reduction in all TEC subsets, and subsequently, premature thymic 
degeneration(6). Consequently, because of their role in the creation of developing thymocyte 
niches, Dkk1 inhibition of β-catenin-Wnt signaling also decreases the number of thymocytes(6). 
Taken together, these studies indicate that precise regulation of canonical β-catenin-Wnt signaling 
in TECs is indispensable for proper thymus development, and enhancing or diminishing canonical 
β-catenin-Wnt signaling compromises the integrity of the thymic epithelia.  
The expression of several secreted Wnt proteins has been identified in multiple TEC 
populations, but the results vary (in part due to different experimental techniques as well as the 
age, the sex, and the mice used) and most Wnt proteins detected in the thymus have unknown 
roles. However, some studies were able to reveal the role of a few Wnt ligands in TEC 
development and maintenance. For example, Wnt-4 has been extensively studied for its effect on 
TEC-development. These studies revealed Wnt-4 plays an important role in proper TEC 
development. Several studies have identified Wnt-4 expression in TECs at multiple time points 
during thymus organogenesis, postnatal expansion, and adult homeostasis. Furthermore, 
Balciunaite et al. 2002 and Kvell et al. 2014 both showed that Wnt-4 staining colocalizes with 
EpCAM staining in both human and mouse embryonic TECs suggesting that Wnt-4 expression is 
evolutionarily conserved(22, 245). Balciunaite et al. 2002 also demonstrated an abundant 
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expression of Wnt-4 in the early thymus, highlights the significance of its absence in the aging 
thymus. Balciunaite et al. 2002  and Mathieu 2006 also demonstrated that by E10.5, both the dorsal 
and ventral aspects of the 3rd pp express the Wnt ligands, Wnt4, Wnt5b, but the expression pattern 
was different for Wnt inhibitors Wif-1, Nkd1, Sfrp-2(22, 247). This implies that Wnt signaling is 
spatiotemporally regulated within the 3rd pp and has potential roles in proper patterning and/or 
differentiation of the epithelium in early thymus organogenesis(247). On a similar line, Mulroy et 
al. 2002 and Swann et al. 2017 showed that Wnt-4 transgenic mice play a role in embryonic thymus 
development and migration(17, 248). Mulroy et al. 2002 demonstrated that the TEC-specific Wnt4 
overexpressing transgenic mice disrupts the TEC differentiation and causes abnormal thymus 
migration(17). Interestingly, apart from the suppression of fetal and postnatal thymic expansion, 
the same study also showed that Wnt 4 predominantly affected cTECs and reduced fetal cTEC 
frequency and cell numbers; fetal mTEC numbers were similar to controls (though both cell 
populations were decreased at later time points when compared to controls)(17). This implies that 
Wnt-4 disrupts fetal TEC differentiation primarily through a cTEC dependent mechanism. Later 
Brunk et al. 2015 demonstrated ways Wnt4 can trigger both the canonical-β-catenin-Wnt and non-
canonical-Wnt singling in a context-dependent manner. They also showed it is the highest 
expressed Wnt ligand in the 1-month old mouse thymus and expressed in both cTECs and 
mTECs(204). Furthermore, Heinonen et al. 2011 showed that Wnt-4 stimulates multiple cell 
populations in the thymus (249). They also explained how a PCP-like pathway involving Fzd-6, 
RAC1, and JNK, Wnt-4 expands hematopoietic progenitor cells derived from bone marrow and 
fetal liver(249). In another study, Heinonen et al. 2011 showed that both conventional and 
conditional Wnt-4 KO mice suppress the fetal and postnatal thymic expansion. This mutation 
causes a disproportionate loss of TEPCs an overall decrease in TEC numbers that alters the 
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medullary-to-cortical TEC ratio(4). In the same study, Heinonen et al. 2011 showed that the Wnt-
4 transfected BM cells cultured with thymocytes expand ETPs and DN thymocytes and suggest 
Wnt-4 can regulate thymocytes independent of TECs. Together these data indicate that Wnt-4 
dynamically regulates thymic cellularity and promotes thymopoiesis in multiple cell 
populations(4). 
Additionally, St-Pierre et al. 2015 showed that Wnt-ligand production by wild-type mice 
mTECs is significantly higher than the mTECs from Aire deficient mice(250). Wnt5a, Wnt7b, and 
Wnt8b are all downregulated in the mTEChi cells of AIRE deficient mice compared to WT mTEChi 
cells(250). Even though more conclusive evidence is still needed, this suggests a relationship 
between Aire and Wnt signaling. Furthermore, this represents possible roles for Wnt signaling in 
the differentiation of mature mTECs, the late processes of thymocyte development, and/or the 
emigration of thymocytes from the thymus(250).  
       Previously several papers have shown that potential downstream Wnt target genes impact 
thymus development. Röhrs et al. 2009 and Bredenkamp et al. 2014 have shown that K5 driven 
expression of CCND1/2, a proposed target gene of Wnt signaling and FoxN1, in TEPCs causes 
thymic hyperplasia, expands TEC numbers, and promotes thymus development(251-253). Wnt 
proteins can regulate STAT3 in ESCs(254) and retinal epithelium(255). Subsequently, Lomada et 
al. 2016 have highlighted that STAT3 signaling is known to induce survival and maintenance of 
mTECs and the postnatal development of the thymic medullary regions(256). Hunziker et al. 2011, 
have shown that RAC1 deficient mice increase the expression of c-MYC, another Wnt target gene 
(though other pathways frequently regulate c-MYC), which results in thymic atrophy(257). 
Together, these data highlight that potential downstream genetic targets of Wnt signaling 




1.8. OVERVIEW & SIGNIFICANCE OF THE RESEARCH 
1.8.1 OVERVIEW OF THE RESEARCH 
The primary research project demonstrated the presence of a unique bone marrow 
population that expresses both CD45, a hematopoietic cell marker, and EpCAM, a definitive 
thymic epithelial cell marker. It will also demonstrate how these unique bone marrow derived cells 
can migrate to the thymus and contribute to the thymic epithelial microenvironment under injury 
conditions. Furthermore, it will show that this particular BMC population expresses epithelial stem 
cell markers and that it is derived from the hematopoietic stem cell population of bone marrow. 
The secondary research project will demonstrate that TECs are the primary source of Wnt 
signaling in the fetal thymic stroma. This study characterized active Wnt signaling in different 
thymic epithelial compartments during embryogenesis.  
1.8.2. SIGNIFICANCE OF THE RESEARCH 
Prior work has suggested that the adult thymus may not contain an epithelial progenitor 
cell population, unlike other epithelial organs. In the fetal thymus, the endodermal layer of the 
third pharyngeal pouch gives rise to a bi-potent TEC progenitor population, which subsequently 
differentiates into cTECs and mTECs. More recent studies have identified some distinct non-
hematopoietic self-renewable thymic stromal cell populations that differentiate into different TEC 
lineages. Even though several studies have focused on identifying adult TEPCs, this population's 
characteristics are not fully understood. Previous studies that have tried to identify the TEPC 
population were mainly restricted to CD45 negative (non-hematopoietic) thymic stromal cell 
populations. As explained in the previous section, recently, a large body of research has shown 
that bone-marrow-derived cells can migrate to different organs and contribute to the different 
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organ-specific cell populations. This study explores the newfound plasticity of a bone marrow-
derived cell population and identifies a subpopulation in the bone marrow that can migrate to the 
thymus and contribute to the non-hematopoietic component of the thymic stroma.  
Wnt proteins are a family crucial signaling molecule. This evolutionarily conserved protein 
family plays a diverse and crucial role during the development, differentiation, cell migration, and 
proliferation in both vertebrates and invertebrates (200-202). It is a well-known fact that Wnt 
signaling plays an important role in T-cell development, and the thymic epithelial cells are a 
primary source of wnt signaling, which regulates this process. Few studies have shown the role of 
wnt signaling in TEC development, which is yet not fully understood. In my secondary research 
project, I have characterized changes in active Wnt signaling in TECs during the development of 
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Figure 1.2. This figure is adapted from Grove et al. 2003, Mechanisms of differentiation. The 4 
models shown in the figure above represent the mechanisms of differentiation from BM-derived 
cells into an alternative nonhematopoietic phenotype (green). (A) Consistent with our existing 
paradigm that cells always travel from a less differentiated to a more differentiated state, this model 
predicts that there is a highly pluripotent cell (red) that has not yet committed to the hematopoietic 
lineage and maintains the ability to differentiate into multiple diverse cell types. (B) With indirect 
transdifferentiation, an HSC changes its gene expression pattern to that of an alternative cell type 
through a dedifferentiation/redifferentiation pathway that presumably passes through an as yet 
unidentified intermediate cell type, shown in white. (C) In direct transdifferentiation, an HSC may 
be able to directly change its gene expression pattern from that of a hematopoietic stem cell to an 
alternative cell type. (D) If fusion is the mechanism by which BMSCs acquire a nonhematopoietic 
phenotype, a marrow-derived cell, perhaps a macrophage (blue), fuses with a nonhematopoietic 
cell (yellow), and the nucleus of the marrow-derived cell takes on the gene expression pattern of 
the nonhematopoietic cell type. The 2 nuclei do not have to fuse. Note that these models are not 
mutually exclusive and may all reflect the in vivo mechanisms involved. These models apply 
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equally well to MSCs and MAPCs, which may directly transdifferentiate into multiple cell types, 
dedifferentiate through an intermediate cell type, represent highly pluripotent stem cells with the 




Figure 1.3. Schematic representation of the canonical Wnt/b-catenin signaling pathway. (a) In the 
absence of Wnt signal, β-catenin is recruited into the APC/ Axin/GSK3β complex, and 
phosphorylated by GSK3b at the N-terminal ‘destruction box’. The phosphorylated b-catenin 
binds to β-Trcp of the proteosome machinery and is targeted for degradation. As the result, no free 
β-catenin enters nucleus to form transcriptional complex with LEF/Tcf and to regulate downstream 
gene expression. (b) Wnt binds to its Fz receptor and LRP5/6 co-receptor and activates Dvl, 
leading to the inhibition of APC/Axin/GSK3β mediated β-catenin degradation. Stabilized β-
catenin forms a transcriptional complex with LEF/Tcf and activates downstream targets such as c-
Myc. Negative regulators, such as Dkks, WIF and FRPs, inhibit the interactions between Wnt 
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ligands and their receptors. There is crosstalk between Wnts and other signaling pathways, such 




























2.1. Preparation of  adult Thymic epithelial cells (TEC) 
Thymic lobes were extracted from humanely euthanized mice in ice-cold phosphate-buffered 
saline (PBS). The thymic lobes were cleaned to remove fat and connective tissue and cut into four 
smaller pieces and transferred into a new tube containing PBS. The cut pieces were gently agitated 
using a glass Pasteur pipette to remove thymocytes. The remaining tissue was dissociated using 
Collagenase D (1.8mg/ml) and DNase I (1X) in HBSS solution incubated in a 37oC water bath for 
15 minutes with gentle agitation every 5 minutes using a Pasture pipette. The single-cell 
suspension of digested tissue was washed with PBS and then filtered through a 100 μm strainer to 
remove any clumps of tissue. Hematopoietic cells were removed from the single-cell suspension 
using anti-mouse Thy1.2, CD11b, and CD19 antibodies and magnetic beads to enrich the TEC 
population before sorting flowcytometric analysis. 
2,2. Preparation of fetal thymic epithelial cells. 
Time-pregnant mice were dissected to isolate pups from the embryonic sac. Then the fetuses are 
used to extract thymic lobes from them.  First, the thymic lobes were cleaned to remove fat and 
subsequently was dissociated using Collagenase D (1.8mg/ml) and DNase I (1X) in HBSS solution 
incubated in a 37oC water bath for 15 minutes with gentle agitation every 5 minutes using a Pasture 
pipette. The single-cell suspension of digested tissue was washed with PBS. No depletion of the 
hematopoietic cell was done from E13.5 to E 17.5 and directly used for flow cytometric analysis. 
For E18.5 and E19.5, hematopoietic cells were removed from the single-cell suspension using anti-
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mouse CD45 antibodies and magnetic beads to enrich for the TEC population before sorting or 
flow cytometric analysis. 
2.3. Isolation of Bone Marrow cells 
Bone Marrow cells were isolated from mouse hind limbs, as previously described(259).  The 
resulting single-cell suspension was lineage depleted using biotinylated CD19, CD4, CD8, CD11b, 
CD11c, B220, Ter119 antibody, and biotin-binder magnetic beads. The post-depletion cell 
population was used for flow cytometric analysis 
2.4. Flow cytometry 
Cells were suspended in 106 cells/100 μl concentration in FACS staining buffer (FSB-5% fetal 
bovine serum, 5 mM EDTA in PBS) and incubated with Fc- block (anti-mouse CD16/CD32 
antibody) for 15 minutes in ice. After incubation, cells were washed and resuspended again in106 
cells/100 μl concentration in FSB with appropriately diluted primary antibodies for 20 minutes on 
ice in the dark. After washing, secondary antibodies appropriately diluted in FSB were added, and 
the cells were incubated for an additional 20 minutes on ice in the dark. After washing, the cells 
were resuspended in 500 μl of FSB for data acquisition.  Data acquisition was performed using an 
LSRII analyzer complete with three lasers (BD Bioscience), and cell sorts were performed using 
a FACS Aria (BD Bioscience). FACS data were analyzed using Flow Jo software (Tree Star) or 
FACS Diva software (BD Bioscience). For FACS analysis, we have routinely used the forward 
Scatter (FSC) area versus Side Scatter (SSC) area analysis to discriminate the appropriate live cell 
populations together with 7AAD staining. Doublet discrimination was performed by using SSC W 
vs. SSC H followed by FSC W vs. FSC H. The single cells are then negatively selected for CD11b, 
CD11c, CD19 staining to exclude thymic DCs, Macrophages, and B-cells from our population of 
interest. To control for non-specific binding by the antibodies, gates for positive staining were set 
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using isotype controls and/or one minus controls. To accurately set gates for GFP expression, 
C56BL6 mice analysis controls stained with the same antibody cocktail were used. We 
additionally used 7AAD staining for live-dead discrimination when we used irradiated C57BL6 
mouse for our experiment to exclude the high proportion of radiation-induced dead cells. 
2.5. RNA extraction and q-RT PCR from sorted cells 
Cells were sorted as described above, and RNA was isolated using the Trizol method as directed 
by the Qiagen RNA isolation mini-prep kit. Isolated RNA was used for cDNA synthesis using 
Reverse transcriptase and random hexamers.  The resulting cDNAs were used for q-RT PCR 
analysis using Taqman probes for CD45 and EpCAM. The 18s RNA housekeeping gene was used 
as a positive control to normalize the qPCR results. 
2.6. Reaggregate Thymic Organ Cultures (RTOC) 
EpCAM+CD45+ cells were isolated and sorted to greater than 95% purity from the bone marrow 
and thymus-derived from Actin H2BGFP mice and placed in single-cell suspensions as described 
above. The resulting highly purified EpCAM+ CD45+ GFP+ cells were mixed with dissociated 
fetal thymic stromal cells from an E14.5 C57BL6 fetal thymus at a ratio of 1:10 to form a 
reaggregate on a polycarbonate filter suspended over a trans-well plate.  After 48 hours of culture, 
these reaggregates were then surgically transplanted under Athymic Nude mice's kidney capsule 
and grown for three weeks in vivo. After three weeks, the reaggregates were harvested and 
sectioned for further IHC analysis. 
2.7. Fetal Thymus Transfer Under Mouse Kidney Capsule 
Fetal thymi were isolated from E14.5 C57BL6 or Actin H2BGFP mice, as stated, and 5-6 fetal 
lobes were placed under the kidney capsule of either Actin H2BGFP mice or Rosa26 mRFP mice, 
respectively. Following a time course of 3, 6, 9, or 12 weeks the kidneys were isolated, and most 
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of the exogenous thymi were used for flow cytometric analysis, while the remaining lobes were 
used for immunohistochemistry. 
2.8. Hematopoietic stem cell transplant 
For hematopoietic stem cell transplant, C57BL6 mice were subjected to total body irradiation with 
1300 cGy using an X-ray irradiator. Total body sublethal irradiation cause hematopoietic cell 
ablation. Simultaneously, linage-ve  c-kit+Sca1+ positive hematopoietic stem cells are sorted from 
ActinH2B GFP transgenic mice bone marrow. This Lineage-ve c-kit+Sca1+GFP+ sorted 
cells(~200,000 cells) are then resuspended in 300µl PBS intravenously injected into sublethally 
irradiated mice. Following a time course of 4, 5, 6, or 20 weeks these injected mice are sacrificed, 
and their bone marrow and thymus were isolated for subsequent FACS analysis. 
2.9. Systemic delivery of Bone marrow-derived cell  
To induce partial injury to the mouse thymus, C57BL6 mice were subjected to total body 
irradiation with 650 cGy using an X-ray irradiator. Simultaneously, linage-veCD45+EpCAM+ 
cells were sorted from ActinH2B GFP transgenic mice bone marrow. These linage-
veCD45+EpCAM+ GFP+ sorted cells(~50,000 cells) were then resuspended in 300µl PBS 
intravenously injected into sublethally irradiated mice. Following a time course of 6 weeks, these 
injected mice are sacrificed and their bone marrow and thymus were isolated for subsequent FACS 
analysis. 
2.10. Immunohistochemistry of Thymic Sections 
Thymi were embedded in OCT compound from Tissue-Tek and snap-frozen using Liquid-N2. 8 
µm sections were cut using a cryostat and mounted on coated slides. The slides were then air-dried 
and fixed in 4% paraformaldehyde for 10 minutes, washed with PBS three times, then 
permeabilized using acetone for 10 minutes, washed and blocked with complete normal donkey 
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serum (1% Normal donkey serum in Bovine serum albumin). Appropriately diluted antibodies 
specific to stromal subsets were added to the slides and then placed into a humid chamber at 4oC 
overnight. Secondary antibodies were applied, if needed, and incubated in a humid chamber for 
one hour at 37oC. After incubation, the slides were washed in PBS three times, mounted, then they 
were sealed following the application of Prolong Gold antifade +DAPI reagent. Images were 
acquired using a Zeiss LSM800 confocal microscope and LSM710 confocal microscope. Confocal 
images were analyzed using LSM software (Zeiss). 
2.11. Statistical Analysis 
Data comparisons were performed using a non-parametric, unpaired, one-tailed T-test.  All graphs 
and statistical results were generated using Graph-pad Prism software. A P-value of <0.03 was 
considered significant.  
Table 1: A list of antibodies used in this study is given below. 
Name  Specificity 
CD45 Pan-hematopoietic marker 
EpCAM Thymic epithleial cell mamker 
Pan-Keratin Epithelial cell marker 
FoxN1 Thymic epithelial cell marker 
Dec205 Cortical thymic epithelial cell maker 
BP1 Cortical thymic epithelial cell maker 
UEA1 Medullary thymic epithelial cell maker 
CD11b Macrophage marker 
CD11c Dendritic cell marker 






Sca-1 Stem cell marker 
CD49f α6 integrin, epithelial stem cell marker 
CD29 β1 integrin 
FSP1 Fibroblast specific marker 
























Bone Marrow-Derived Cells Contribute to the Maintenance of Thymic Stroma, including 
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In paradox to critical functions for T-cell selection and self-tolerance, the thymus undergoes 
profound age-associated atrophy and loss of T-cell function, which are further enhanced by cancer 
therapies. Identification of thymic epithelial progenitor populations capable of forming functional 
thymic tissue will be critical in understanding thymic epithelial cell (TEC) ontogeny and designing 
strategies to reverse involution. We identified a new population of progenitor cells, present in both 
the thymus and bone marrow (BM) of mice, that co-express the hematopoietic marker CD45 and 
the definitive thymic epithelial marker EpCAM and maintains the capacity to form functional 
thymic tissue. Confocal analysis and qRT-PCR of sorted cells from both BM and thymus 
confirmed co-expression of CD45 and EpCAM.  Grafting of C57BL/6 fetal thymi under the kidney 
capsule of H2BGFP transgenic mice revealed that peripheral CD45+ EpCAM+ GFP-expressing 
cells migrate into the developing thymus and contribute to both TECs and FSP1-expressing 
stroma.   Sorted BM-derived CD45+EpCAM+ cells contribute to reaggregate thymic organ 
cultures (RTOCs) and differentiate into keratin and FoxN1 expressing TECs, demonstrating that 
BM cells can contribute to the maintenance of TEC microenvironments previously thought to be 
derived solely from endoderm. BM-derived CD45+EpCAM+ cells represent a new source of 
progenitor cells that contribute to thymic homeostasis.  Future studies will characterize the 
contribution of BM-derived CD45+EpCAM+ TEC progenitors to distinct functional TEC 
microenvironments in both the steady-state thymus and under conditions of demand. Cell therapies 
utilizing this population may prove useful for counteracting thymic involution in cancer patients. 
Key points 
CD45+ EpCAM+ TEC progenitor cells are found in mouse bone marrow and thymus.   
Peripheral cells contribute to the thymic stroma, including TECs. 
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Bone marrow-derived CD45+EpCAM+ cells contribute to TECs in RTOCs. 
3.1. INTRODUCTION 
The thymus serves as the primary lymphoid organ responsible for the development and 
selection of a self-tolerant T-cell repertoire(33, 260). Thymic epithelial cells (TECs) are the most 
significant component of the thymic microenvironment responsible for regulating T cell 
development and selection(114, 260, 261). Thus, proper organization and maintenance of TECs 
are critical for a properly functioning adaptive immune system(260-262). Despite the fundamental 
importance of the thymus in the development of T cells, the thymus undergoes profound atrophy 
relatively early in life(144, 263, 264). Thymus degeneration is physically evident in humans 
starting at puberty, where the loss of functional thymic microenvironments contributes to a 
progressively restricted naïve T cell repertoire, resulting in an immune system that is less capable 
of responding to new immune challenges(144, 147).  Thymic involution also severely restricts the 
ability to generate long term, low morbidity tolerance to foreign transplants, including those of 
stem cell origin(265). Understanding the signals and cell-to-cell interactions that control both the 
development and postnatal maintenance of thymic epithelial cells is critical to design clinical 
strategies to counteract age-associated involution while enhancing thymic recovery following 
HSCT.   
Structurally, the thymic stroma contains three compartments: 1) Cortex, 2) Medulla, and 
3) Cortico-medullary junction(12). The cortex is composed of cortical thymic epithelial cells 
(cTEC), defined by primarily keratin 8 expression as well as the surface expression of BP1 and 
CD205,  together with immature thymocyte subsets, and it is involved in positive selection and 
MHC restriction during T-cell development(142).  The thymic medulla is composed of medullary 
thymic epithelial cells (mTEC), defined by primarily Keratin 5/Keratin 14 expression together 
with UEA1 binding, and is involved in negative selection of mature single-positive (SP) 
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thymocytes expressing autoreactive T-cell antigen receptors and development of FoxP3+Tregs(130, 
142). The cortico-medullary junction is the perivascular space between the cortex and medulla, 
which serves as the entry point of CD4-CD8-(DN) thymocytes to the thymus(266) as well as the 
location where fully mature SP naïve T-cells exit to the peripheral blood vessels(142, 260, 262).  
Most epithelial tissues are known to maintain tissue homeostasis throughout their adult life 
through the action of progenitor or stem cell populations(267). Previous work has shown that TECs 
of both the cortex and medulla develops from common progenitors during thymic organogenesis 
(53, 92, 100, 106).   The presence of progenitors restricted to each lineage has also been 
demonstrated(88, 100, 103, 104, 268, 269). Previous studies identified embryonic TEC 
progenitors, expressing high levels of claudin-3 and claudin-4, that exclusively give rise to mature 
mTECs(268).  Progenitors initially expressing cTEC lineage markers(270), including the 
thymoproteosome subunit β5t(105, 108) and CD205(106), were shown to give rise to mTECS 
during thymic organogenesis. However, the mechanisms responsible for the maintenance of 
functional thymic microenvironments in the postnatal thymus remain unclear. Tissue maintenance 
might be mediated through stem-cell-based regeneration similar to tissues with high turnover rates, 
including hematopoietic, skin, and intestinal tissues(271).  Alternatively, the thymus might be 
maintained by replication of more differentiated cells, similar to tissues with lower turnover rates, 
including the liver and pancreas(15). Previous studies revealed that TECs, particularly mTECs, 
have much higher turnover rates than previously thought and are comparable with 
keratinocytes(272), implying a stem-cell-based regeneration of at least mTECs.  Embryonic 
SSEA-1+ Cld3,4hi mTEC stem cells were shown to be capable of maintaining functional mTEC 
regeneration, including mature mTECs and central T cell tolerance(1). The clonogenic activity of 
these SSEA-1+ Cld3,4hi TECs was rapidly decreased after birth in wild-type (WT) mice but was 
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maintaining in postnatal Rag2 deficient mice, suggesting that crosstalk previously thought to be 
important in maintaining an appropriately organized thymus might inhibit maintenance of mTEC 
stem cell activity(1).  
The existence of bipotent TEPC in the postnatal thymus has also been demonstrated(100, 
102, 104, 109), and they appear to be found within the cTEC population(273). The stem cell 
characteristics of label retention and increased colony-forming capacity were identified within the 
Sca-1hi MHCIIlo TEC subset(102, 109). In contrast, other studies demonstrated bipotent TEPC 
potential within the PLET1+ MHCIIhi subset(104). These competing results suggest that more 
work is needed to identify the bipotent epithelial progenitor phenotype and the mechanisms 
responsible for postnatal TEC maintenance.  
Hematopoietic stem cells (HSCs) give rise to a variety of hematopoietic cells found in the 
thymus, including thymocytes, B cells, dendritic cells, and macrophages. Several recent studies 
identified unexpected plasticity of bone marrow-derived hematopoietic stem cell populations(154, 
183, 192, 274-276). These studies suggested that bone marrow-derived HSC can give rise to a 
variety of different adult cell types. Previous work showed that BM-derived HSC, when 
transplanted to irradiated hosts, home to and repopulate the bone marrow(154). Interestingly, it 
was also shown that this cell population could migrate and differentiate into epithelial cells in the 
lung, GI tract, and skin(154). BM-derived HSC can give rise to hepatocytes in both rodents and 
humans was also demonstrated previously (156, 157).  However, these studies were refuted by 
showing that BM-derived populations begin expressing characteristics of non-hematopoietic 
populations as a result of cell fusion rather than by trans-differentiation in the hepatocyte 
system(197, 199). Later, by using a Cre-lox system to demonstrate that even though a small subset 
of stem cells in the presence of somatic cells undergoes spontaneous fusion, there is a part of the 
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HSC population that can undergo trans-differentiation to contribute to the keratinocyte expressing 
epithelial cells in the skin during the process of wound healing(277). This study also showed that 
BM-derived epithelial cells at the wound edges express Ki67, proving that these trans-
differentiated cells are actively cycling(277). Bone-marrow-derived HSC was also shown to give 
rise to lung epithelial cells under conditions of naphthalene-induced lung injury(276). Together, 
these studies showed unexpected plasticity, with BM-derived HSC giving rise to epithelial cells in 
different organs, but none of these studies suggested a contribution of BM-derived HSC to the 
maintenance of thymic epithelial or other thymic stromal components.  
In this study, we describe a unique population of CD45+EpCAM+ cells in both adult BM 
and thymus that expresses both the definitive hematopoietic marker CD45 and the definitive 
thymic epithelial marker EpCAM.  Using both organ transplant and reconstitution thymus organ 
culture, we show that this unique population of cells can contribute to the maintenance of non-




3.2. MATERIALS & METHODS 
Mice  
C57BL6 control, Actin H2BGFP transgenic, mRFP Rosa26 transgenic mice, and athymic 
nude mice purchased from Jackson Laboratory were used for this study. The ages of the mice 
ranged from 7-9 weeks. All mice were bred and maintained at the City College of New York 
animal facility, and all experiments were performed with approval from the City College of New 
York institutional animal care and use committee. 
Antibodies 
The following primary antibodies were used for experiments: CD45-PE Cy7, CD45-APC 
Cy7, CD45 APC (clone 30-F11, BD Bioscience,Biolegend), Pan-keratin ( Polyclonal, Dako), 
EpCAM-PE (clone G8.8, eBioscience),FoxN1(clone G-20, Santa Cruz Biotechnology) 
FSP1(CloneS100A4 , Biolegend),Thy1.2(clone 30-H12, BD Bioscience), CD11b ( clone, 
BioLegend), CD11b PerCpcy5.5 (clone M1/70, Biolegend) CD4- biotinylated(clone RM4-5 , 
BioLegend), CD8 -biotinylated (clone53-6.7, BioLegend), CD19 (clone1D3, Biolegend), Rabbit 
anti-GFP (Life), , and CD205 (LY75/DEC-205)( clone HD30 (Millipore).We also used lineage 
depletion panel containing B220. As control for EpCAM staining we used Rat IgG2a,κ Isotype 
control(eBioscience). As control for CD45 staining we used Rat IgG2b,κ Isotype 
control(Biolegend). 
The following secondary reagents were used for experiments: donkey anti-rabbit IgG-
TRITC, donkey anti-rabbit IgG-Cy5, donkey anti-rabbit IgG-FITC, donkey anti-rat IgG-TRITC, 
donkey anti-goat IgG-FITC, goat anti-rat IgM-TRITC (Jackson ImmunoResearch), anti-rat IgG2a-
FITC, anti-rat IgM-FITC, streptavidin-APC, streptavidin-APC Cy7, streptavidin-PerCP Cy5.5 




All Taqman probes were purchased from Thermo-fisher Scientific, including CD45 
(PTPRC), CD11c, EpCAM, and 18S rRNA. 
Preparation of Thymic epithelial cells (TEC) 
Thymic lobes were extracted from humanely euthanized mice in ice-cold phosphate-
buffered saline (PBS). The thymic lobes were cleaned to remove fat and connective tissue and cut 
into four smaller pieces, and transferred into a new tube containing PBS. The cut pieces were 
gently agitated using a glass Pasteur pipette to remove thymocytes. The remaining tissue was 
dissociated using Collagenase D (1.8mg/ml) and DNase I (1X) in HBSS solution incubated in a 
37oC water bath for 15 minutes with gentle agitation every 5 minutes using a Pasture pipette. The 
single-cell suspension of digested tissue was washed with PBS and then filtered through a 100 μm 
strainer to remove any clumps of tissue. Hematopoietic cells were removed from the single-cell 
suspension using anti-mouse Thy1.2, CD11b, and CD19 antibodies and magnetic beads to enrich 
for the TEC population before sorting or flowcytometric analysis. 
Isolation of Bone Marrow cells 
Bone Marrow cells were isolated from mouse hind limbs, as previously described(259).  
The resulting single-cell suspension was lineage depleted using biotinylated CD19, CD4, CD8, 
CD11b, CD11c, B220, Ter119 antibody, and biotin-binder magnetic beads. The post-depletion 
cell population was used for flow cytometric analysis. 
Flow cytometry 
 Cells were suspended in 106 cells/100 μl concentration in FACS staining buffer (FSB-
5% fetal bovine serum, 5 mM EDTA in PBS) and incubated with Fc- block (anti-mouse 
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CD16/CD32 antibody) for 15 minutes in ice. After incubation, cells are washed and resuspended 
again in 106 cells/100 μl concentration in FSB with appropriately diluted primary antibodies for 
20 minutes on ice in the dark. After washing, secondary antibodies appropriately diluted in FSB 
were added, and the cells were incubated for an additional 20 minutes on ice in the dark. After 
washing, the cells were resuspended in 500 μl of FSB for data acquisition.  Data acquisition was 
performed using an LSRII analyzer complete with three lasers (BD Bioscience), and cell sorts 
were performed using a FACS Aria (BD Bioscience). FACS data were analyzed using Flow Jo 
software (Tree Star) or FACS Diva software (BD Bioscience). For FACS analysis, we have 
routinely used the forward Scatter (FSC) area versus Side Scatter (SSC) area analysis to 
discriminate the appropriate live cell populations together with 7AAD or DAPI staining. Doublet 
discrimination was performed by using SSC W vs. SSC H, followed by FSC W vs. FSC H. The 
single cells are then negatively selected for CD11b, CD11c, CD19 staining to exclude thymic DCs, 
Macrophages, and B-cells from our population of interest. Gates for positive staining were set 
using isotype controls and/or one minus controls to eliminate false-positive results by non-specific 
binding of the antibodies. To accurately set gates for GFP expression, C56BL6 mice analysis 
controls stained with the same antibody cocktail were used. We additionally used 7AAD staining 
for live-dead discrimination when we used irradiated C57BL6 mouse for our experiment to 
exclude the high proportion of radiation-induced dead cells, 
RNA extraction and q-RT PCR from sorted cells 
Cells were sorted as described above, and RNA was isolated using the Trizol method as 
directed by the Qiagen RNA isolation mini-prep kit. Isolated RNA was used for cDNA synthesis 
using Reverse transcriptase and random hexamers.  The resulting cDNAs were used for q-RT PCR 
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analysis using Taqman probes for CD45 and EpCAM. The 18s RNA housekeeping gene was used 
as a positive control to normalize the qPCR results. 
Reaggregate Thymic Organ Cultures (RTOC) 
EpCAM+CD45+ cells were isolated and sorted to greater than 95% purity from the bone 
marrow and thymus-derived from Actin H2BGFP mice and placed in single-cell suspensions as 
described above. The resulting highly purified EpCAM+ CD45+ GFP+ cells were mixed with 
dissociated fetal thymic stromal cells from an E14.5 C57BL6 fetal thymus at a ratio of 1:10 to 
form a reaggregate on a polycarbonate filter suspended over a trans-well plate.  After 48 hours of 
culture, these reaggregates were then surgically transplanted under the kidney capsule of athymic 
Nude mice and grown for three weeks in vivo. After three weeks, the reaggregates were harvested 
and sectioned for further IHC analysis. 
Organ Transfer Experiments 
Fetal thymi were isolated from E14.5 C57BL6 or Actin H2BGFP mice, as stated, and 5-6 
fetal lobes were placed under the kidney capsule of either Actin H2BGFP mice or Rosa26 mRFP 
mice, respectively. Following a time course of 3, 6, 9, or 12 weeks the kidneys were isolated, and 
most of the exogenous thymi were used for flow cytometric analysis, while the remaining lobes 
were used for immunohistochemistry. 
Immunohistochemistry of Thymic Sections 
Thymi were embedded in OCT compound from Tissue-Tek and snap-frozen using Liquid-
N2. 8 µm sections were cut using a cryostat and mounted on coated slides. The slides were then 
air-dried and fixed in 4% paraformaldehyde for 10 minutes, washed with PBS three times, then 
permeabilized using acetone for 10 minutes, washed and blocked with complete normal donkey 
serum (1% Normal donkey serum in Bovine serum albumin). Appropriately diluted antibodies 
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specific to stromal subsets were added to the slides and then placed into a humid chamber at 4oC 
overnight. Secondary antibodies were applied, if needed, and incubated in a humid chamber for 
one hour at 37oC. After incubation, the slides were washed in PBS three times, mounted, then they 
were sealed following the application of Prolong Gold antifade +DAPI reagent. Images were 
acquired using a Zeiss LSM800 confocal microscope and LSM710 confocal microscope. Confocal 
images were analyzed using LSM software (Zeiss). 
Statistical Analysis 
Data comparisons were performed using a non-parametric, unpaired, one-tailed T-test.  All 
graphs and statistical results were generated using Graph-pad Prism software. A P-value of <0.01 





Cells co-expressing both the definitive thymic epithelial marker EpCAM and the hematopoietic 
marker CD45 are present in both the bone marrow and the thymus. 
Presence of CD45+EpCAM+ cells in the thymus. 
Using standard enzymatic digestion of thymic tissue in conjunction with CD45 magnetic 
bead depletion to reduce the frequency of hematopoietic cells, we observed a persistent but rare 
population of cells that co-expressed both CD45+ and EpCAM+ (DP), shown in Figure 3.1A. This 
population has been described in several publications; however, they were identified as thymic 
nurse cells, which are complexes of cTECs with internalized CD45+ thymocytes(50).  Due to the 
consistent presence of this DP population, even after very conservative doublet discrimination, we 
set out to determine if this unusual population truly represented thymic nurse cells or was a unique 
previously undescribed cell population expressing both CD45 and EpCAM.  We enhanced the 
isolation of this population by depleting hematopoietic cells in our enzymatically dissociated 
thymic tissue using a cocktail of antibodies, including anti-Thy1.2, CD11b, CD11c, and CD19 
together, rather than the usual anti-CD45 antibody. Figure 3.1 shows a representative FACS profile 
demonstrating the increase in the frequency of the CD45+EpCAM+ population when anti-CD45 
depletion was not utilized to deplete hematopoietic cells.  Panel A shows that when anti-CD45 
depletion was used to analyze the frequency of DP cells present in 8-month old C57BL/6 mice, 
the CD45+EpCAM+ population represents only an average of 0.23% (+/-0.2%) of the total cells 
present, whereas in panel B, when a cocktail of anti- Thy1.2, CD11b, CD11c, and CD19 was used 
for depletion, the frequency of the CD45+EpCAM+ population in the total dissociated thymic cells 
increased to an average of 1.14%. (+/-0.3%). Every set of experiments had four replicates. Our 
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gating strategy, including stringent doublet discrimination, lineage-negative selection, along with 
the isotype control for the EpCAM antibody, is shown in  figure 3.11(H-M).   
Thymic CD45+EpCAM+ cells co-express both CD45 and EpCAM at both the protein and 
mRNA levels. 
 We reasoned that the apparent co-expression of CD45 and EpCAM, observed using flow 
cytometry of dissociated thymic tissue, could be the result of epitope sharing caused by the close 
association of thymocytes with thymic epithelial cells due to penetration of CD45 antibodies into 
partially damaged TNC complexes or because of EpCAM expressing thymic dendritic 
cells(DCs)(278).  To confirm the presence of single cells co-expressing both CD45 and EpCAM, 
CD45+EpCAM+ cells were sorted to high purity (~98% purity) using a FACS sorter from 
dissociated thymic tissue using conservative doublet discrimination. Cells were also gated to 
exclude hematopoietic cells using a cocktail of anti-Thy1.2, CD11b, CD11c, and CD19.  To 
confirm that the DP population expressed both the CD45 and EpCAM genes at the RNA level, 
RNA was isolated from CD45+EpCAM+; CD45+; EpCAM+ cell populations sorted from thymic 
tissue with high purity for and used for RNA isolation. For the CD45+EpCAM+ population, we 
were able to achieve greater than 99% purity with the aid of back gating. For the CD45+EpCAM- 
and CD45-EpCAM+ control populations, we achieved greater than ~96% purity. The sort purity 
results are shown in Figure 3.12(A-E). We also sorted the lineage positive population to determine 
the relative expression of CD11c to ensure that the DP population was not CD11C-expressing 
thymic dendritic cells, which have been reported to express EpCAM(130). All RNA samples were 
normalized to 5 ng/µl before performing qPCR. 18s rRNA was used as a housekeeping gene to 
compare relative amounts of RNA expression (Fig. 3.2B-D).  Isolated and normalized RNA was 
analyzed using qRT-PCR with Taqman primers specific to EpCAM and CD45. Relative levels of 
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RNA expression of both CD45 and EpCAM were normalized in each sorted population to the 
levels of 18s rRNA to thoroughly rule out epitope sharing as the cause of this unique population. 
Figure 3.2 shows the fold change in the expression level for both CD45 and EpCAM between the 
two control populations (CD45+EpCAM-and CD45-EpCAM+) and the CD45+EpCAM+ 
population. Panel A shows the FACS representation of the sorted populations. Panel B shows the 
relative CD45 expression in all three populations, where the CD45+EpCAM- population serves as 
the positive control. As expected, the CD45+ control population has a high level of CD45 
expression, whereas the EpCAM+ population has negligible (~98-fold lower) CD45 expression 
compared to the CD45 only population. The DP population expressed ~80 fold more CD45 than 
the CD45-EpCAM+ TEC population but only had a ~10-fold lower expression of CD45 than the 
CD45+ EpCAM- population. Panel C shows the relative EpCAM expression in all three 
populations, where the CD45-EpCAM+ population was used as a positive control. DP cells 
exhibited ~37-fold higher EpCAM expression than the CD45+ population, while expression of 
EpCAM was ~60- fold lower than that observed in the EpCAM only TEC positive control. As 
expected, the CD45 only population has negligible EpCAM expression (~97 fold lower). The qRT-
PCR confirmed that the DP population co-expressed both CD45 and EpCAM mRNA. Analysis of 
CD11c expression demonstrated a high level of CD11c expression in the lineage positive 
population; however negligible CD11c expression (~96 fold lower) was observed in the lineage 
depleted EpCAM-CD45+, CD45-EpCAM+, and CD45+EpCAM+ populations (Figure 3.2D). The 
absence of CD11c mRNA expression in the CD45+EpCAM+ population showed that this new 
population is not CD11C+EpCAM+ thymic DC and represents a previously undescribed subset.  
Expression of both the CD45 and EpCAM surface proteins by sorted CD45+EpCAM+ cells was 
verified using immunohistochemistry. CD45+ EpCAM- or CD45-EpCAM+ subsets were also 
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sorted as controls and immediately imaged under a fluorescence microscope without further 
staining to ensure that the antibodies were specific and that the CD45+EpCAM+ cells observed 
using flow cytometry were indeed single cells co-expressing both CD45 and EpCAM surface 
proteins. Figure 3.2 (E-S) shows the fluorescent microscopy imaging results obtained using the 
sorted CD45+EpCAM+ population and the control CD45+ EpCAM- or CD45-EpCAM+ 
populations from C57BL6 thymus following Anti-CD45 antibody and anti-EpCAM antibody 
staining. Combined CD11b, CD11c, and CD19 staining were performed on all sorted populations 
to rule out Langerhans cells and thymic DCs that are known to co-express EpCAM(48-50) as well 
as to rule out non-specific binding of the anti-CD45 and anti-EpCAM antibodies to FC receptors 
on hematopoietic cells, leading to a false-positive result. The CD45+EpCAM- control cells showed 
staining with only the anti-CD45 antibody (Fig. 3.2 E-I). The CD45-EpCAM+ control cells only 
exhibited anti-EpCAM staining (Fig. 3.2 J-N). However, the CD45+EpCAM+ cells stained 
strongly with both the anti-CD45 and anti-EpCAM antibodies while no staining with a cocktail of 
anti- CD11b, CD11c, CD19 antibodies was observed (Fig. 3.2 O-S) and confirming that the 
staining observed was not the result of non-specific FC-receptor binding. The inset of the merged 
image of the sorted CD45+EpCAM+ population shows a single representative cell expressing both 
CD45 and EpCAM. IHC results of the sorted cells confirmed protein co-expression of both CD45 
and EpCAM on the CD45+EpCAM+ population. 
To provide further evidence for this unique population's presence and to localize the cells 
within the thymus, we sought to determine if the DP population could be seen within sections of 
an intact adult mouse thymus. Within adult mouse thymus, CD45+ cells far outnumber and are 
close to TECs.  To better visualize the rare DP cells within the background of abundant CD45+ 
thymocytes, we performed intraperitoneal injections of dexamethasone on 6-week-old C57BL/6 
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mice to specifically reduce the number of double-positive thymocytes, the most abundant CD45+ 
cells in the thymus. Three days following the dexamethasone injections, when the number of 
thymocytes is most reduced, the mice were sacrificed, and their thymi were harvested, sectioned, 
and stained with antibodies specific to CD45 (hematopoietic) and Pan-Keratin (epithelial) to 
enable identification of thymic stromal cells co-expressing CD45 and EpCAM. Confocal imaging 
of the stained sections revealed rare cells that share both hematopoietic (CD45+) and epithelial 
(Pan Cytokeratin) characteristics in the intact thymus ( Figure 3.13). Together the IHC and qRT-
PCR results obtained with highly purified sorted cells from mouse thymus and IHC of sections of 
intact thymus confirmed that the CD45+EpCAM+ cell population was observed in dissociated 
thymic preparations truly co-express CD45 and EpCAM at both the protein and mRNA levels. 
Further, these results suggest that we and others in the field may be losing a large percentage of 
EpCAM+ cells by ignoring this CD45+ EpCAM+ population, including potential TEC 
progenitors. 
Rare CD45+ EpCAM+ Cells are present in the bone marrow. 
 Bone marrow-derived cells, including hematopoietic stem cells (HSCs), were previously 
reported as contributors of epithelial cells for epithelial organs, including lung(276), gut, and 
uterus through the process of trans-differentiation(154). Wong et al. showed that the BM-derived 
CD45+CCSP+ cell population contributes to the alveolar epithelial cell population (CCSP is a 
unique alveolar epithelial cell marker)(183, 276). As the DP population is expressing the 
hematopoietic marker CD45, we wanted to determine if the CD45+EpCAM+ cells observed in the 
thymus might be derived from a population in the BM.  Bone marrow preparations were analyzed 
for the presence of CD45+ EpCAM+ cells using flow cytometry.  Multiple experiments with 
C57BL6 bone marrow showed that bone marrow contains a low frequency (~0.1%-0.2%) of 
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CD45+EpCAM+ cells (Figure 3.3A).  Our gating strategy, including doublet discrimination, 
lineage negative cell population selection along with isotype control staining for the EpCAM 
antibody, is shown in figure 3.11(A-F). We have also shown the presence of the CD45+EpCAM+ 
cell population in athymic nude mice in figure 3.11 G. The presence of the CD45+EpCAM+ cell 
population in nude mouse bone marrow confirms this population originates in the bone marrow 
and does not migrate from the thymus to the bone-marrow. CD45+EpCAM+ cells could not be 
identified in dissociated nude mouse thymus (data not shown). 
 To confirm that the population of CD45+EpCAM+ cells detected in flow cytometry 
analysis represented a new population co-expressing both the CD45 and EpCAM proteins on their 
surface and expressed at the mRNA level, we performed the same set of experiments shown above 
for the thymic derived CD45+EpCAM+ population using sorted BM-derived cells. 
CD45+EpCAM+ cells and CD45+EpCAM-cells (control) were sorted to high purity (~99%) from 
a bone marrow preparation depleted of lineage-committed cells and stained with CD45 and 
EpCAM antibodies. Bone marrow sort purity results are shown in figure 3.12 (F-I). The sorted 
populations were subsequently analyzed using immunohistochemistry and qRT-PCR for 
expression of CD45 and EpCAM for each of the sorted cell population.  
 To rule out epitope sharing as the cause of the bone marrow-derived DP population, we 
determined the relative level of mRNA expression of both CD45 and EpCAM compared to the 
housekeeping gene, 18s rRNA. All RNA samples isolated for these experiments were diluted to 5 
ng/µL, to exclude differences in RNA amounts and normalized to 18s rRNA. The 
CD45+EpCAM+ population was shown to express both CD45 and EpCAM mRNA using qRT-
PCR (Figure 3.3 B-C). Figure 3.3 panel B shows the relative CD45 expression in the 
CD45+EpCAM+ population when compared with the CD45+EpCAM- positive control 
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population. As expected, the CD45+ population has a high level of CD45 mRNA expression. The 
DP population clearly expresses CD45 mRNA. However, it has a ~51-fold lower expression level 
than the CD45+ EpCAM- control population. Panel C shows the relative EpCAM expression in 
comparison to the CD45+EpCAM-, negative control population. The CD45+EpCAM+population 
has a ~93- fold higher EpCAM mRNA than the CD45+EpCAM-control population. 
The sorted DP and CD45 only populations in the BM were also analyzed using 
immunohistochemistry for surface protein expression of CD45, EpCAM, and a mixture of CD11b, 
CD11c, CD19 for each of the populations (Figure 3.3D-M). CD11b, CD11c, and CD19 combined 
staining were done to rule out FC receptor binding to the CD45 and EpCAM antibodies leading to 
a false-positive result as well as ensuring that the CD45+EpCAM+ cells observed were not CD11c-
expressing DCs. The control CD45+EpCAM- cells only exhibited staining with the anti-CD45 
antibody (3D-H). In contrast, the CD45+EpCAM+ cells were stained with both the anti-CD45 (3J) 
and anti-EpCAM antibodies (3L) while no staining with the CD11b, CD11c, CD19 cocktail (3K) 
was observed.  The inset shows a higher magnification image of the DP cells (outlined by the box) 
for every staining panel and demonstrates that the DP cells represent single cells expressing both 
CD45 and EpCAM. Together these IHC results of sorted cells confirmed that single 
CD45+EpCAM+ cells co-express both the CD45 and EpCAM proteins on their cell surface. 
Isotype control staining was used to verify the specificity of the EpCAM and CD45 antibodies 
(data not shown). 
Collectively, these data show that there is a rare population of previously undescribed cells 
in both the adult thymus and the bone marrow that co-express the hematopoietic marker CD45 and 
the definitive thymic epithelial marker EpCAM. Further, we have demonstrated that in both adult 
bone marrow and thymus, single cells express both the CD45 and EpCAM surface proteins and 
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that highly purified sorted populations express mRNA for both genes confirming that this rare and 
unique population exists.  The absence of TNC complexes ensures that contrary to previous reports 
when careful double discrimination is used, the DP cells are not TNCs, while the lack of CD11c, 
CD11b, and CD19 surface protein expression allows exclusion of FC receptor binding to antibodies 
or identification of Langerhans cells and thymic DCs which are known to express both CD11c and 
EpCAM(278, 279). 
CD45+EpCAM+ cells are recruited to thymic stroma from the periphery and contribute to 
EpCAM+CD45- TECs. 
E14.5 C57BL/6 fetal thymic lobes were transplanted under the kidney capsule of Actin 
H2BGFP transgenic mice to understand if peripheral CD45+EpCAM+ cells can contribute to the 
non-hematopoietic populations of the thymic stroma. The engrafted thymic lobes were then 
harvested at different time points from 3 to 12 weeks following transplant and analyzed for the 
presence of H2B-GFP-expressing cells that have migrated into and contributed to the growing fetal 
thymi using both flow cytometry and immunohistochemistry. As a control, E14.5 C57BL/6 fetal 
thymic lobes were transplanted under the kidney capsule of C57Bl6 mice and harvested after three 
weeks for flow cytometric analysis to set up negative gating for GFP expression. 
Figure 3.4A shows representative FACS analysis of dissociated transplanted thymic lobes 
analyzed at different time points after transplant, Figure 3.4B shows the percentage of 
CD45+EpCAM+GFP+ cells migrating into the C57BL/6 GFP-negative thymus, and 4C shows the 
frequency of CD45-EpCAM+GFP+ TECs that are derived from peripheral sources. Bar graphs of 
the mean percentages of peripheral CD45+EpCAM+GFP+ and CD45-EpCAM+GFP+ populations 
found in the transplanted thymi are shown in Figure 3.4D-E. 
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The flow-cytometric analysis revealed an influx of GFP+CD45+EpCAM+ cells into the engrafted 
fetal thymic lobes. The presence of CD45-EpCAM+GFP+ TECs was detected at a later timepoint 
in the C57BL/6 grafts (Figure 3.4). An influx of the peripherally derived CD45+EpCAM+GFP+ 
population was observed at every timepoint. The average frequency of the CD45+EpCAM+GFP+ 
population remained almost constant at week three, 17.88% (+/-7.3%), and week six, 18% 
(+/7.9%). At week nine and week twelve, the average frequency of the CD45+EpCAM+GFP+ 
population increased to 26.53% (+/-19%) and 27.3%(+/-13%), respectively.  An unpaired, non-
parametric one-tailed T-test demonstrated that there was a significant increase in the frequency of 
peripherally derived GFP+CD45+EpCAM+ cells within the C57BL6 fetal thymi that were 
transplanted under C57BL6 kidney capsules when compared with C57BL/6 control thymi 
transplanted under the kidney capsules of non-GFP expressing mice.  
We compared each time point with the control. All the time points analyzed, when 
C57BL/6 fetal lobes were transplanted under the kidney capsule of ActinH2BGFP mice, showed 
a statistically significant number of CD45+EpCAM+GFP+ cells had migrated to the transplanted 
thymi. Interestingly, a small but progressive increase in the frequency of CD45-EpCAM+GFP+ 
TECs was also observed, suggesting that true EpCAM-expressing TECs were also derived from 
peripheral sources.   The average frequency of GFP expressing TECs increased from 2.6% (+/- 
2%) at week three to 4.4% (+/- 2%) at week six. At week nine, the average frequency of GFP 
expressing TECs was 6.34% (+/- 4%) and increased to 7.4% (+/- 4%) at week twelve. C57BL/6 
fetal thymi transplanted under the C57BL/6 kidney capsule were used as a control to allow gating 
on true GFP-expressing cells in the engrafted thymus. When the frequency of EpCAM+GFP+ cells 
in the engrafted thymi at each time points was compared to the control (using a non-parametric, 
unpaired, one-tailed T-test), it showed significant numbers of EpCAM+GFP+ true TECs appearing 
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in the transplanted thymic lobes. These results confirm that peripheral GFP+ CD45+EpCAM+ 
cells migrate into the thymus and that these peripheral cells then give rise to GFP-expressing 
CD45-EpCAM+ thymic epithelial cells.  This result is unprecedented, as it suggests that contrary 
to previous models of thymic organogenesis, which suggested that all EpCAM expressing TECs 
were derived from the third pharyngeal pouch endoderm and its derivatives, that in fact, up to 7% 
of EpCAM only TECs may be derived from peripheral sources that migrate into the thymus. 
Peripheral cells contribute to the pan-keratin and FoxN1 expressing epithelial cells in the 
thymic stroma. 
The engrafted thymi were also analyzed histologically in parallel experiments at the 
previously indicated time points. Figure 3.5 shows the staining pattern of PanK (an epithelial cell 
marker) and FoxN1 (a definitive thymic epithelial cell marker) in the transplanted thymic tissues 
at different time points following transplant. These histological results showed the presence of a 
PanK+ FoxN1+ H2B-GFP+ and PanK+FoxN1- H2BGFP populations in the engrafted fetal 
thymus at week three and week six, and PanK+FoxN1+H2B-GFP+ cells appeared in higher 
number at later time points (week nine and week twelve) shown in figure 3.5. Expression of PanK 
on a GFP+ cell in the transplanted thymi indicates that peripheral cells can migrate into the thymus 
and contribute to true TECs. At earlier time points, only PanK+FoxN1-GFP+ cells were observed, 
while at later time points, PanK+FoxN1+GFP+ cells were observed. This sequential emergence of 
two different populations of PanK+GFP+ cells that were initially FoxN1- followed by FoxN1+ 
cells with progressive age, indicates that first peripheral cells are recruited to the thymus and 
differentiate into only PanK expressing TEC, and at a later time point more mature PanK+FoxN1-
expressing cells emerge. Images of 12th week transplanted fetal thymus staining for Pan-keratin 
and DAPI at lower magnification (200x) is shown in figure 3.14 as a representative figure to show 
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the morphology of fetal transplanted thymus. Figure 3.14 A-C shows week 12 images of the 
transplanted fetal thymus. In this figure, the kidney is visible in the lower part of each image. This 
figure clearly shows a properly developed transplanted thymus at week 12. 
CD45+EpCAM+ cells can contribute to the thymic stroma in vivo. 
To understand the differentiation potential of the CD45+EpCAM+ population in vivo, we 
used reaggregate thymic organ culture (RTOC). GFP+CD45+EpCAM+cells were sorted to high 
purity (greater than 96%) from Actin H2BGFP mouse bone marrow or thymus and reaggregated 
with dissociated fetal thymic cells (E14.5) derived from GFP- C57BL6 mice. Reaggregates were 
cultured for 48hrs on polycarbonate filters supported by trans-well plates and then engrafted under 
the kidney capsule of athymic nude mice. The resulting ectopic thymic graft incorporated the 
GFP+CD45+EpCAM+ population into the thymic stroma. At week three, we observed PanK and 
FOXN1 expressing GFP+ cells in thymic stroma (Figure 3.6). RTOCs derived from bone marrow 
had more GFP+ TECs, shown in figure 3.6 A-D, whereas thymus-derived RTOCs had a limited 
GFP+ TEC population (figure 3.6 E-H). These results together showed that bone marrow and 
thymus-derived CD45+ EpCAM+ cells could give rise to the thymic epithelium and prove that 
peripheral cells contribute to the TEC component of the thymic stroma. Images of sections of 
transplanted RTOCs stained for Pan-keratin and DAPI at lower magnification (200x) are shown 
in figure 3.14.  Figure 3.14 D-F shows BM RTOC, whereas panel G-I shows sections of thymic 
derived RTOCs. In this figure, the kidney is visible in the lower part of each image. The figure 
shows extensive Pan-keratin staining in both bone-marrow-derived and thymus-derived RTOCs, 





FSP1 expressing fibroblast cells in the thymus are derived from peripheral cells. 
During our FACS and IHC analysis, we observed that apart from the CD45+GFP+, 
CD45+EpCAM+GFP+, and CD45-EpCAM+GFP+ populations, there were a significant number 
of GFP+ cells that did not express either CD45 or EpCAM. In addition to TECs, another non-
hematopoietic contributor of the thymic stroma is fibroblasts.  Recently, Fibroblast Specific 
Protein-1 (FSP-1) expressing cells were shown to help to maintain medullary thymic epithelial 
cells(280).  Engrafted thymi were analyzed for FSP1 expression using IHC (Figure 3.7). Figure 
3.7A-L shows a representative figure of FSP1 staining in the transplanted thymi at different 
timepoints.  The frequency of peripherally derived GFP+ cells found in the transplanted fetal lobes 
that express FSP1 was calculated at the different time points post-transplant.  At week three, the 
percentage of GFP+ cells expressing FSP1 was 35% (+/- 8%), while at week six, it increased to 
53 (+/-13). At week nine and week twelve, the percentage increased to 71.2% (+/-8%) and 71.4% 
(+/-10%), respectively (figure 3.7 M).  These results suggest that FSP1-expressing cells in the 
thymic stroma are continuously derived from cells migrating into the thymus from peripheral 
sources rather than through the expansion of stromal cells derived during embryonic development 
of the thymus.  
CD45+EpCAM+ cells can contribute to the FSP1 expressing fibroblasts in the thymic stroma 
in vivo. 
We next wanted to investigate whether the BM and thymic derived CD45+EpCAM+ cells 
that contribute to TECs might also contribute to the peripheral populations giving rise to FSP1-
expressing stromal components of the thymus. RTOCS composed of sorted 
CD45+EpCAM+H2BGFP+ BM or thymic cells mixed with non-GFP expressing fetal thymic cells 
were sectioned and stained with FSP1 to investigate if CD45+EpCAM+ cells can contribute to the 
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FSP1+ fibroblast population of the thymic stroma (Figure 3.8). We observed FSP1 expressing 
H2B-GFP+ cells in the thymic stroma of RTOCs derived from both bone marrow and thymic-
derived CD45+EpCAM+ cells showing that CD45+EpCAM+ cells can also give rise to FSP1 
expressing fibroblasts. 
Peripheral derived CD45+EpCAM+H2BGFP+ and CD45-EpCAM+H2BGFP+ result from 
trans-differentiation and not cell fusion. 
Previous studies reported that HSC cells could give rise to epithelial cells in different 
organs, including the liver, lung, GI tract, and skin, through trans-differentiation(154, 276). 
However, these results were later disputed by Terada et al. and Wang et al., which suggested that 
BM-derived cells do not transdifferentiate, but they spontaneously fuse with other cells and adopt 
their characteristics(197, 199). The relatively high frequency of CD45+EpCAM+ cells observed 
in both the thymus and BM suggested that they were not derived from fusion.  To determine if the 
H2BGFP-expressing TECs we observed in transplant experiments were the result of cell fusion 
events or true trans-differentiation, we transplanted E14.5 fetal thymuses derived from Actin 
H2BGFP time-pregnant mice under the kidney capsule of Rosa26 mRFP mice. If actin-H2BGFP+ 
EpCAM expressing CD45+EpCAM+ cells and the CD45-EpCAM+ true TECs shown in Figure 
3.4 are the result of cell fusion, then in this double transgenic model, both GFP and RFP should be 
expressed together on both the CD45+EpCAM+ cells and their resulting TEC progeny. However, 
if the cells are genuinely derived from peripheral sources, then co-expression of both RFP and 
GFP in the CD45+ EpCAM+ and EpCAM+ populations should not be observed. We analyzed the 
transplanted thymi at two different time points 6 and 9 weeks after transplant. Analysis of 
dissociated GFP-expressing fetal lobes using flow cytometry to identify RFP and GFP 6 and 9 
weeks after transplant under the kidney capsule of Rosa26 mRFP mice revealed no co-expression 
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of GFP and mRFP in either the CD45- EpCAM+, CD45+ EpCAM+ populations (Figure 3.9). 
mRFP+ peripheral cells were observed in all the populations, including CD45-EpCAM+ TECs. 
The CD45+EpCAM+ cell population had similar frequencies of peripheral mRFP+ cells at both 
time points, 68% (+/-15%) and 66% (+/-15), respectively. The CD45-EpCAM+ population also 
contained ~1% RFP + cells that were derived from peripheral mRFP cells migrating into the lobes.  
This set of results showed that peripheral CD45+EpCAM+ cells that migrate to the thymus and 
contribute to the thymic stroma are not the result of cell fusion and any H2BGFP+CD45+EpCAM+ 
cells observed as well as their H2BGFP+ CD45-EpCAM+ TEC progeny represent peripheral cells 
migrating into the thymus and contributing to stromal components. There remains a slight 
possibility that the CD45+ EpCAM+ cells observed in this experiment could be derived from an 
earlier fusion event that occurred prior to the surgical transplant of the fetal lobes; however, we 
argue that the complete absence of DP cells co-expressing RFP and GFP strongly supports that 
they are not likely to be derived from cell fusion.  
BM-derived CD45+EpCAM+ cells can migrate to the thymus and contribute to the thymus-
derived CD45+EpCAM+ and CD45-EpCAM+populations under the condition of the 
radiation-induced injury. 
 Previously it was shown that the CD45+CCSP+ population in the bone marrow migrates 
to the lungs and contributes to the alveolar epithelial population following naphthalene induced 
lung injury(276). To understand if the CD45+EpCAM+ population found in the bone marrow can 
contribute to the thymus under flowing radiation-induced injury, we partially irradiated (650cGy) 
four-month-old C57BL6 mice and intravenous injected ~30,000 CD45+EpCAM+ cells sorted to 
high purity (>95%) from Actin H2BGFP transgenic mice.  Six weeks after injection, the mice were 
sacrificed for further analysis. The presence of H2BGFP+ cells in the dissociated thymus of 
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injected mice would indicate that the GFP labeled CD45+EpCAM+ population can migrate from 
the bone marrow to the thymus.  As a control, C57BL6 mice were irradiated with the same dose 
X-rays and sacrificed within 48 hours, followed by thymic dissociation for FACS analysis. This 
was done to enable accurate gating of the GFP+ cells migrating into the thymus from the 
bloodstream or bone marrow.  7AAD staining was used to excluded radiation-induced dead cells 
from the FACS analysis. Figure 3.10 shows representative FACS analysis of dissociated thymic 
lobes. The lower panel of the figure shows the analysis of C57BL/6 control mice.  Since the 
irradiated C57BL/6 control mice were sacrificed within 48 hours, they show a higher frequency of 
EpCAM only TECs than our experimental mice (due to less radiation-induced death), which were 
analyzed 6-weeks after irradiation and CD45+EpCAM+cell injection.  The upper panel of the 
figure shows a representative image of irradiated C57BL/6 mice injected with H2B-GFP-
expressing CD45+EpCAM+ BM-derived cells. The injected CD45+EpCAM+ H2BGFP-
expressing cells were present in the thymus of the irradiated mice, where the frequency of 
GFP+CD45+EpCAM+ cells averaged 15% (+/-10%).  Interestingly we also observed a small but 
consistent presence of GFP+CD45-EpCAM+ true TECS (2%), which could only have been 
derived from the injected GFP-expressing CD45+EpCAM+ cells. These data show that the bone-
marrow-derived CD45+EpCAM+ population can migrate to the thymus and contribute to non-






In this study, we describe a unique, rare population in the postnatal bone marrow, which 
can migrate to the thymus and contribute to the thymic epithelial cell pool. This bone marrow-
derived population expresses both the definitive thymic epithelial cell marker EpCAM and pan-
hematopoietic cell marker CD45. This unique population was identified in dissociated thymic 
tissue as well, supporting the idea that it migrates from the bone marrow to the thymus. 
Immunohistochemistry and qRT-PCR results performed with highly purified sorted populations 
of these CD45+EpCAM+ cells derived from both the bone marrow and thymus showed that these 
cells express both CD45, EpCAM and no expression of CD11c at both the mRNA and protein 
levels, confirming that they are not thymic nurse cells, or thymic DCs as previously reported(50)  
or an artifact derived from enzymatic dissociation of closely associated TECs and thymocytes 
(Figure 3.2 and Figure 3.3).   
Several previous studies suggested that bone marrow-derived populations could contribute 
to the epithelial cell populations of different organs, including lung, stomach, intestine, uterus(154, 
156, 275, 276); however, these studies never identified a contribution to the thymus. In this study, 
for the very first time, we are showing the presence of a potential thymic epithelial progenitor cell 
population within the bone marrow. Analysis of C57BL6 fetal thymi, transplanted under the 
kidney capsule of Actin H2BGFP mice, revealed that the CD45+EpCAM+ population can migrate 
from the periphery to a growing fetal thymus and can contribute to non-hematopoietic components 
of the thymic stroma (Figure 3.4).  With progressive time after transplant, the frequency of the 
CD45+EpCAM+GFP+ cell population increased and was followed by the subsequent emergence 
of EpCAM+GFP+ TECs in the transplanted thymus.  
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IHC analysis of the same tissue showed the presence of Pan-keratin and GFP expressing 
cells in the transplanted tissues at all time points (Figure 3.5). Interestingly, Pan-
keratin+FoxN1+GFP+ cells also appear to emerge at later time points. Foxn1 is a crucial 
transcription factor in TEC development and thymic function, and it is a well-established marker 
for thymic epithelial cells. The sequential expression of FoxN1 leads us to believe that peripheral 
cells can migrate to the growing thymus and can contribute to thymic stroma as PanK expressing 
thymic epithelial cells, which later differentiate into more mature FoxN1 expressing TEC at later 
time points(96, 97). The presence of relatively abundant GFP+ cells in grafted fetal thymic lobes 
that did not bind the pan-keratin antibody, CD45, or Foxn1 led us to analyze the engrafted lobes 
for the presence of other non-hematopoietic stromal components, including fibroblasts using FSP1 
(a fibroblast marker). Recently it has been shown that FSP1 expressing cells are essential for the 
maintenance of medullary thymic epithelial cells(280). FSP1 staining of the transplanted tissue 
revealed the presence of a GFP expressing peripherally derived FSP1+ cell population (Figure 
3.7). We also observed with the progressive time that the number of peripherally derived 
GFP+FSP1+ cells increased (Figure 3.7M).   
These results together showed that a peripheral CD45+EpCAM+ cell population could 
migrate to the thymus and contribute to the non-hematopoietic components of the thymic stroma. 
The CD45+EpCAM+ population appears to contribute to thymic stroma in two different ways: 1) 
by directly giving rise to EpCAM and keratin expressing epithelial cells and 2) by giving rise to 
an FSP1 expressing cell population, known to support the maintenance of the medullary thymic 
epithelial cell population. Limitations in the availability of antibodies to sort FSP1-expressing cells 
or co-localize both Keratin and FSP1 on the same populations post-RTOC precluded determining 
whether they represented the same population or unique lineages derived from the 
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CD45+EpCAM+ population.  Future experiments will need to be performed to determine the 
lineage relationship between FSP1+ GFP + peripheral cells and PanK+GFP+ peripherally derived 
TECs.  
Although several previous studies showed that bone-marrow-derived populations 
including HSCs could contribute to tissue regeneration in epithelial organs, some of this work had 
been refuted by subsequent studies which demonstrated that bone marrow-derived cells undergo 
fusion, allowing them to take on characteristics of the recipient organs cell phenotype, instead of 
genuinely transdifferentiating(197). Our results obtained when ActinH2BGFP fetal thymus was 
transplanted under the kidney capsule of mRFPRosa26 mice clearly showed that the 
CD45+EpCAM+ RFP+ cell population observed in the ActinH2BGFP thymus after transplant is 
not the result of fusion (Figure 3.9) since no cells co-expressing RFP and GFP were observed. The 
RFP+ CD45-EpCAM+ TECs observed in the transplanted thymi are derived from peripheral RFP+ 
cells migrating into the GFP-expressing fetal lobe. 
When highly purified CD45+EpCAM+ GFP+ cells from the bone-marrow were 
reaggregated with non-GFP fetal thymic stroma, the GFP+ bone-marrow-derived cells gave rise 
to pan-keratin and FoxN1-expressing true thymic epithelial cells (Figure 3.6A-D), as well as FSP1 
expressing fibroblast cells (Figure 3.8A-C). Similar results were obtained with reaggregates made 
using the thymus-derived CD45+EpCAM+ population (Figure 3.6 E-H and Figure 3.8 D-F). 
Together these results confirm that the CD45+EpCAM+ cell population from both bone marrow 
and thymus can differentiate to Pan-Keratin expressing epithelial cells as well as FSP1 expressing 
fibroblasts. Our results suggest that the thymus-derived CD45+EpCAM+ cells in RTOCs exhibit 
less potential to differentiate into Pan-keratin expressing TECs than BM-derived CD45+EpCAM+ 
cells supported by the lower frequency of Pan-Keratin+ true TECs.  This result leads us to 
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hypothesize that the BM-derived cells have more potential to differentiate in Pan-Keratin 
expressing TECs, whereas the thymus-derived CD45+EpCAM+ population might have lost some 
of its potentials to differentiate into TECS, or some of the cells may be committed to a different 
fate other than Pan-Keratin expressing epithelial cells.  
Further, when highly purified CD45+EpCAM+GFP+ cells sorted from the BM of Actin 
H2BGFP mice were intravenously injected into partially irradiated C57BL6 mice, 
CD45+EpCAM+GFP+ cells were shown to migrate to the thymus under the condition of demand 
induced due to injury and contribute to the CD45+EpCAM+ population in the recovering thymic 
stroma (Figure 3.10). The frequency CD45+EpCAM+GFP+cells in the recovering thymus is 
significant; however, the frequency of EpCAM+GFP+ cells remained low. Later timepoint 
analysis is needed to understand if a longer time is needed to observe an increase in the 
CD45+EpCAM+GFP+ population's contribution to the EpCAM expressing TEC population or if 
the migration of this population decreases with the further recovery of the thymus. 
In summary, this study demonstrates that a bone-marrow-derived population expressing 
both CD45 and EpCAM can migrate and contribute to the thymic stroma and can give rise to two 
different non-hematopoietic cell populations in the thymic stroma, including both FSP1-
expressing fibroblasts and keratin/FoxN1- expressing TECs under the condition of demand.  It is 
not clear whether the CD45+EpCAM+ cells are derived from HSCs or represent a distinct lineage 
of BM cells.  Future studies will also need to be performed to determine the lineage relationships 
between the FSP1+ cells and the true keratin expressing TECs derived from the CD45+EpCAM+ 
population.  They could represent distinct fates of the same population or steps in an undefined 
ontogeny.   It is also unclear how significant the CD45+EpCAM+ population and its progeny are 
to TEC homeostasis or how they might contribute to self-tolerance or T cell selection.  Previous 
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work has suggested that the MHC background of the thymic microenvironment determines the 
MHC restriction of developing T cells after BMTs(281).  If BM-derived cells are migrating into 
the thymus and contributing to the maintenance of TEC subsets, then it is surprising that they do 
not influence the MHC restriction of developing thymocytes.   Further studies needed to be done 
to understand the ontogeny of this population and its contribution to distinct TEC subsets. If 
migrating CD45+EpCAM+ cells only contribute to mTECs, then it is possible that they do not 
influence MHC restriction but might contribute to self-tolerance through negative selection or the 
development of Regulatory T-Cell (Tregs).  
Despite the presence of a progenitor cell population in BM that can contribute to TECs, the 
thymus still undergoes age-related involution. Understanding the lineage of the CD45+EpCAM+ 
BM population as well as the mechanisms responsible for the migration of this population to the 
thymus and how they contribute to the maintenance of TEC number and organization will be 
critical in counteracting age-associated involution, particularly in cancer patients, due to enhanced 
degeneration in response to therapy.  This study addresses a significant unmet clinical need for 
thymus reconstitution by defining the contribution of bone-marrow-derived thymic epithelial 
progenitor cells (TEPC) to the maintenance of TEC microenvironments in the postnatal thymus. 
It should provide an additional target for overcoming thymic atrophy and hence, the development 








Figures and Figure Legends: 
Figure 3.1 
 
Figure 3.1. An alternative hematopoietic cell depletion method reveals a previously unidentified 
CD45+ EpCAM+ population in the thymus. FACS profiles show viable single cells gated on 
CD11c-, CD11b-and CD19- cells.   A- Shows the presence of only 0.091% of CD45+EpCAM+ 
cells present in dissociated thymic tissue when using the sheep-anti-CD45 antibody followed by 
anti-sheep magnetic beads for the depletion of hematopoietic cells. B- Shows enrichment of the 
CD45+EpCAM+ population to 1.5% derived from dissociated thymic tissue when a cocktail of 
sheep anti-Thy1.2, anti-CD11b, and anti-CD19 antibodies followed by anti-sheep magnetic beads 











Figure 3.2. Single sorted thymic CD45+ EpCAM+ cells express both CD45 and EpCAM surface 
proteins and their mRNA. CD45+ EpCAM+ cells were sorted to high purity and analyzed for 
CD45 and EpCAM expression using immunofluorescence microscopy and qRT-PCR. 
CD45+EpCAM-; and CD45-EpCAM+ cells were sorted as controls. A: FACS analysis 
representation of the gating strategy used for cell sort. B: Shows relative CD45 expression level in 
the thymus-derived CD45+EpCAM+ cells compared to the CD45+EpCAM- and CD45-EpCAM+ 
control populations; C: Shows the relative EpCAM expression level in the thymus-derived 
CD45+EpCAM+ cells compared to the CD45+EpCAM- and CD45-EpCAM+ control populations. 
D: Shows the relative CD11c expression level in the thymus-derived CD45+EpCAM+ cells 
compared to the Lineage positive (CD11c+), CD45+EpCAM- and CD45-EpCAM+ control 
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populations.  E -I: DIC image, CD45 staining (blue), CD11b,CD11c,CD19 staining (green); 
EpCAM staining (red) and Merged image respectively for CD45+EpCAM- control population ; J-
N: DIC image, CD45 staining(blue),  CD11b,CD11c,CD19 staining (green);  EpCAM staining 
(red)  and Merged image respectively for CD45-EpCAM+ control population; O-S: DIC image, 
CD45 staining (blue),  CD11b,CD11c,CD19 staining (green);   EpCAM staining (red) and Merged 
image respectively for the CD45+EpCAM+ experimental population. CD45+EpCAM+ cells of 
interest are enlarged in the insets to show both proteins' colocalization and represent the cells 
shown in the white boxes. The experiments were done in three replicates. 
Figure 3.3 
 
Figure 3.3. Single sorted bone marrow-derived CD45+ EpCAM+ cells express both the CD45 and 
EpCAM genes and surface proteins. CD45+ EpCAM+ cells were sorted to high purity and 
analyzed for CD45 and EpCAM expression using immunofluorescence microscopy as well as 
qRT-PCR. CD45+EpCAM- cells were also sorted as a control. A: FACS profile of the gating 
strategy used for sorting. B: Shows the relative CD45 expression level in the sorted BM-derived 
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CD45+EpCAM+ cells compared to the CD45+EpCAM- control population; C: Shows relative 
EpCAM expression level in the sorted BM-derived CD45+EpCAM+ cells compared to the 
CD45+EpCAM- control population. D-H sorted CD45+EpCAM- controls (D) DIC image; (E) 
CD45 staining (blue); (F) CD11b, CD11c, CD19 staining (green); (G) EpCAM staining (red);  (H) 
Merged. I-M shows immunohistochemistry results obtained with sorted CD45+EpCAM+ cells (I) 
DIC image; (J) CD45 staining (blue); (K) CD11b, CD11c, CD19 staining (green); (L) EpCAM 
staining (red) and (M) Merged image. CD45+EpCAM+ cells of interest are enlarged in the insets 
to show the colocalization of both proteins and represent the cells shown in the white boxes. All 





Figure 3.4. A peripheral population can contribute both CD45+ EpCAM+ cells as well as CD45-
EpCAM+ TECs in the thymus. C57BL6 fetal thymi were transplanted under the kidney capsule of 
Actin H2BGFP mice and analyzed for the presence of GFP-expressing cells at four timepoints 3 
to 12 weeks after transplant using FACS. A: The FACS representation of the lineage depleted cells 
derived from dissociated engrafted thymi gated for CD45 and EpCAM. (B) The FACS 
representation of the percentage GFP+ cells within the CD45+EpCAM+subset found in the grafted 
thymus and (C) The FACS representation of the percentage GFP+ cells within the CD45-EpCAM+ 
population at the different time points after transplant under the kidney capsule. D. Bar graph 
showing the mean percentage of the GFP-expressing cells found within the CD45+EpCAM+ cell 
population at different timepoint (error bars represent SEM). E: Bar graph showing the mean 
percentage of the GFP-expressing cells found within the CD45-EpCAM+ TEC population at 
different time points (error bars represent SEM). "*" indicates a statistically significant difference 
between control and any time point. P-values for each t-test analysis are given with the bar graph. 













Figure 3.5. A peripheral population can migrate into the thymus and contribute to PanK and FoxN1 
expressing thymic epithelial cells. C57BL6 fetal thymi were transplanted under the kidney capsule 
of Actin H2BGFP mice and analyzed for the presence of GFP-expressing peripheral cells 3-12 
weeks after transplant using IHC. A-D: Week 3 transplanted thymic tissue sections showing 
expression of PanK (A), GFP+ peripheral cells (B), FoxN1 (C), and Merged image (D). E-H: Week 
6 transplanted thymic tissue section showing expression of PanK (E), GFP+ peripheral cells (F), 
FoxN1 (G), and Merged image (H). I-L: Week 9 transplanted thymic tissue section showing 
expression of PanK (I), GFP+ peripheral cells (J), FoxN1 (K), and Merged image (L). M-P: Week 
12 transplanted thymic tissue section showing expression of PanK (M), GFP+ peripheral cells (N), 
FoxN1 (O), and Merged image (P). GFP, Pank, and FoxN1 expressing cells of interest are enlarged 
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in the insets to show colocalization of both proteins and represent the cells shown in the white 
boxes. PanK+ FoxN1+ GFP+ cells and PanK+ FoxN1- GFP+ cells at all time points are indicated 
by white and red arrows, respectively. All the experiments were done in three-five replicates. 
Figure 3.6 
 
Figure 3.6. Reaggregate thymic organ cultures show that both bone marrow and thymus-derived 
CD45+ EpCAM+ cells can give rise to PanK+ FoxN1+ thymic epithelial cells. (A-D) Sections of 
RTOC consisting of C57BL/6 fetal thymus mixed with sorted actin-H2BGFP-expressing bone 
marrow-derived CD45+EpCAM+ cells. A representative RTOC section showing PanK expression 
(A); FoxN1 expression (B) with GFP expressing cells derived from the CD45+EpCAM+ cells 
sorted from adult GFP-expressing bone-marrow (C), (D) Merged image of PanK, FoxN1 and GFP. 
(E-H) Sections of RTOC consisting of C57BL/6 fetal thymus mixed with sorted actin-H2BGFP-
expressing thymic derived CD45+EpCAM+ cells. A representative RTOC section showing PanK 
expression (E); FoxN1 expression (F) and; GFP expressing cells derived from actin H2B-GFP-
expressing CD45+EpCAM+ cells sorted from the adult thymus (G); the Merged image of PanK, 
FoxN1 and GFP (H). GFP, Pank, and FoxN1 expressing cells of interest are enlarged in the insets 
to show co-expression of both proteins and represent the cells shown in the white boxes. All the 





Figure 3.7. Peripheral cells migrating into the thymus contribute to FSP1-expressing fibroblasts. 
C57BL6 fetal thymi were transplanted under the kidney capsule of Actin H2BGFP mice and 
analyzed 3-12 weeks after transplant using IHC. A-C: Week 3 transplanted thymic tissue section 
showing the presence of GFP expressing peripheral cells (A), FSP1-expressing cells (B), and 
Merged image for FSP1 and GFP expression (C). D-F: Week 6 transplanted thymic tissue section 
shows the presence of GFP-expressing peripheral cells (D), staining pattern for FSP1 (E), and 
Merged image for FSP1 and GFP expression (F). G-I: Week 9 transplanted thymic tissue section 
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shows the presence of GFP expressing peripheral cell (G), staining pattern for FSP1 (H), and 
Merged image for FSP1 and GFP expression (I). J-L: Week 12 transplanted thymic tissue section 
shows the presence of GFP-expressing peripheral cells (J), staining pattern for FSP1(K), and 
Merged image for FSP1 and GFP expression (L). GFP, FSP1 expressing cells of interest are 
enlarged in the insets to show co-expression of both proteins and represent the cells shown in the 
white boxes. Bar-Graph showing the mean of frequency of GFP expressing peripheral cells also 
expressing FSP1 at different timepoints following transplant (error bars represent SEM). All the 
experiments were done in three-five replicates. 
Figure 3.8 
 
Figure 3.8. Reaggregate thymic organ cultures show that both bone marrow and thymus-derived 
CD45+ EpCAM+ cells can give rise to FSP1+ thymic stromal cells. (A-C) RTOC consisted of 
C57BL/6 fetal thymus mixed with bone marrow-derived actin H2B-GFP-expressing 
CD45+EpCAM+ cells. A representative RTOC section showing FSP1 expression (A), with GFP 
expressing cells derived from actin H2BGFP expressing CD45+EpCAM+ cells sorted from adult 
bone-marrow (B); the Merged image of FSP1 and GFP (C). (D-F) RTOC consisting of C57BL/6 
fetal thymus mixed with thymus-derived actin H2B-GFP-expressing CD45+EpCAM+ cells. A 
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representative RTOC section showing FSP1 expression (D); with GFP expressing cells derived 
from CD45+EpCAM+ cells sorted from adult bone-marrow (E); the Merged image of FSP1 and 
GFP (F). GFP and FSP1 expressing cells of interest are enlarged in the insets to show co-
expression of both proteins and represent the cells shown in the white boxes. All the experiments 
were done in three replicates. 
Figure 3.9 
 
Figure 3.9. The CD45+EpCAM+ and CD45-EpCAM+ TEC populations derived from peripheral 
cells are not a result of cell fusion. Actin H2B-GFP fetal thymuses were transplanted under the 
kidney capsule of mRFP ROSA26 mice and analyzed 6 and 9 weeks after transplant using FACS. 
All the experiments were done in triplicate. A: The FACS representation of the lineage depleted 
cells derived from dissociated engrafted thymi gated for CD45 and EpCAM B: The FACS 
representation of the percentage of GFP+; GFP+RFP+; and RFP+ expressing cells within the 
CD45+EpCAM- population at different time points; C: The FACS representation of the 
percentage of GFP+; GFP+RFP+; and RFP+ expressing cells within the CD45+EpCAM+ 
population at different time points; D: The FACS representation of the percentage of GFP+; 
GFP+RFP+; and RFP+ expressing cells within the CD45-EpCAM+ population at different time 
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points. E. Bar graph showing the mean percentage of the CD45+GFP+RFP+ (potential cell 
fusions) and CD45+RFP+ (peripheral cells) populations at different time points (error bars 
represent SEM). F: Bar graph showing the mean percentages of the CD45+EpCAM+GFP+RFP+ 
(potential cell fusions); CD45+EpCAM+RFP+ (peripheral cells) populations at different 
timepoint (error bars represent SEM). G: Bar graph showing the percentages of the 
EpCAM+GFP+RFP+ (potential cell fusions); EpCAM+RFP+ (peripheral cells) cell populations 
at different time points (error bars represent SEM). This experiment was done in three replicates. 
Figure 3.10 
 
Figure 3.10. Bone-marrow derived CD45+ EpCAM+ cells can migrate to the thymus and 
contribute to the thymic CD45+EpCAM+ population, as well as CD45-EpCAM+ TECs under the 
condition of the radiation-induced injury. CD45+EpCAM+ GFP+ cells were sorted to greater than 
99% purity from Actin H2BGFP mouse bone-marrow and intravenously injected into partially 
irradiated C57BL6 mice. The thymus was then dissociated and analyzed for the presence of GFP-
expressing cells 6-weeks after transplant using FACS. (A) Representative FACS profile of the 
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lineage depleted cells derived from dissociated irradiated and injected thymus showing the gating 
strategy used analysis of live, lineage negative cells. (B) (A) The FACS representation of the 
lineage depleted cells derived from dissociated irradiated and injected thymi gated for live and 
lineage negative cells. (B) Representative FACS profile showing CD45 and EpCAM expression 
within the viable lineage negative cells from A and the gating strategy used for the analysis of the 
CD45+EpCAM+  and CD45-EpCAM+ subsets subsequently analyzed for GFP expression in 
panels C and D. (C) Representative FACS profile showing the percentage of EpCAM+GFP+ cells 
within the CD45+EpCAM+subset found in the thymus post-irradiation and injection of DP cells 
and (D) Representative FACS profile showing the percentage of EpCAM+GFP+ cells within the 
CD45-EpCAM+subset found in the thymus post-irradiation and injection of DP cells (E-F). 
Identical analysis to that A-D above using dissociated thymus from irradiated control non-GFP 
expressing C57BL/6 mice to allow proper gating on H2BGFP+ cells. E) Gating used for viable 
lineage negative dissociated thymic cells. (F) Representative FACS profile showing CD45 and 
EpCAM expression within the viable lineage negative cells from E and the gating strategy used 
for the analysis of the CD45+EpCAM+  and CD45-EpCAM+ subsets subsequently analyzed to 
allow proper gating for GFP expression in G and H. (G) The FACS representation of the control 
gate for  GFP expressing cells within the CD45+EpCAM+subset found in the irradiated thymus 
and (H) The FACS representation of the control gate for  GFP expressing cells within the CD45-









Figure 3.11. Gating strategy for FACs analysis of the lineage depleted bone-marrow and thymus-
derived CD45+EpCAM+ cell populations. A) Gating strategy for live cells in bone marrow 
analysis: SSC A vs. FSC A. B) Gating for doublet discrimination of live cells: SSC W vs. SSC H; 
C) Gating strategy for doublet discrimination of live cells: FSC W vs. FSC H; D) Gating for lineage 
negative single cells using a cocktail of lineage antibodies including CD11b, CD11c, CD19; E) 
The FACS representation of the lineage depleted cells derived from bone-marrow gated for CD45 
and EpCAM. F) The FACS representation of the lineage depleted cells derived from bone-marrow 
gated stained with CD45 together with the EpCAM using isotype control used to set the gate for 
EpCAM staining. G) The FACS representation of the lineage depleted cells derived from the bone-
marrow of nude mice gated for CD45 and EpCAM. H) Gating strategy for live cells in the analysis 
of dissociated thymus: SSC A vs. FSC A. I) Gating for doublet discrimination of live cell: SSC W 
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vs SSC H; J) Gating for doublet discrimination of live cell: FSC W vs FSC H; K) Gating for lineage 
negative single cells using a cocktail of lineage antibodies including CD11b, CD11c, and CD19; 
L) The FACS representation of the lineage depleted cells derived from dissociated thymus gated 
for CD45 and EpCAM. M) The FACS representation of the lineage depleted cells derived from 
dissociated thymus gated for CD45 and EpCAM using the isotype control for EpCAM staining to 
allow proper gating of EpCAM expression. All the experiments were done in three-five replicates. 
Figure 3.12 
 
 Figure 3.12. FACS representation showing the sort purity of Bone-marrow and thymus-derived 
CD45+EpCAM+ cells and the other control cell populations used for RNA isolation. A) The FACS 
representation of the pre-sort population and the gates used for sorting the CD45+EpCAM+cells 
derived from the thymus. B) The FACS representation showing the live gating post sort purity 
obtained for the thymus-derived CD45+EpCAM+ subset; C) The FACS representation showing 
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the purity obtained for the thymus-derived CD45+EpCAM+ sorted subset; D) The FACS 
representation showing the purity obtained for the thymus-derived CD45-EpCAM+ sorted subset; 
E) The FACS showing the purity obtained after sorting the CD45+EpCAM-subset from the 
thymus; F) The FACS representation of the gating strategy  used  for sorting the BM-derived 
CD45+EpCAM+  and CD45+EpCAM- subsets; G-I) The FACS representation showing the purity 
of the live gated (G) and BM-derived CD45+EpCAM+ (H) CD45+EpCAM- (I) subsets. All the 
experiments were done in three replicates. 
Figure 3.13 
 
 Figure 3.13. Presence of a CD45+Pan-keratin+ population in adult thymic sections. 
Dexamethasone treated murine thymuses were sectioned and stained for CD45 and Pan-
Cytokeratin. Panel A showing a Maximum Intensity projection of CD45 staining; Panel B showing 
Maximum Intensity projection of Pan-Keratin staining; Panel C showing Maximum Intensity 
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projection of DAPI staining. Panel D showing Maximum Intensity projection of merged CD45 
and EpCAM staining. CD45 and EpCAM expressing cell of interest are enlarged in the insets to 
show co-expression of both proteins and represent the cell shown in the white boxes. This 




 Figure 3.14. Representative lower magnification image at week 12 post-transplant of a C57BL6 
fetal thymus transplanted under the kidney capsule of an Actin H2BGFP mouse as well as both 
BM and thymic RTOCs transplanted under a nude mouse kidney capsule stained with DAPI and 
Pan- Keratin antibody to show the structure of the transplanted thymus. 200X images of sections 
of transplanted C57BL6 fetal thymus transplanted under the kidney capsule of an Actin H2BGFP 
mouse stained with DAPI (A), PanK (B), and the merged image (C).  Sections of RTOC consisting 
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of C57BL/6 fetal thymus mixed with sorted actin-H2BGFP-expressing bone marrow-derived 
CD45+EpCAM+ cells. A representative 200x image of an RTOC section showing DAPI (D); Pan-
K expression (E), and the merged image of PanK, and DAPI (F). The lower part of each image 
clearly shows the presence of the kidney (D-F). Sections of an RTOC consisting of C57BL/6 fetal 
thymus mixed with sorted actin-H2BGFP-expressing thymic derived CD45+EpCAM+ cells. A 
representative RTOC section showing DAPI staining (G), Pan-keratin staining (H), and the merged 
image of PanK and DAPI (I).  The lower part of each image clearly shows the presence of a kidney. 
(G-I) All the experiments were done in three replicates. 
3.5.  SUPPLEMENTARY INFORMATION 
As an extension of this paper, we did some further analysis. Those results are explained below 
Peripheral cells can differentiate into DEC205  expressing cTECs and UEA1 binding mTECs 
in the thymic stroma. 
Recently, evidence has been mounting that the scavenger receptor CD205 (DEC205) is 
mainly expressed in cTEC, but recent studies have shown that the Dec205+ cell can also define 
the TEPC population (282). Transplanted C57BL/6 fetal thymuses under Actin H2BGFP kidney 
capsules were analyzed for UEA1 (an mTEC marker) and DEC205 (cTEC marker). The thymus 
looked quite disorganized at weeks 3 and 6 ( figure 3.15 A-H), as expected due to the use of a fetal 
thymus for engraftment. However, at weeks 9 and 12, the thymus looks like an adequately 
organized adult thymus with distinct medullary and cortical areas, defined by UEA-1 and DEC205, 
respectively(figure 3.15 I-P). Upon analyzing the data, there seems to be some GFP expressing 
peripheral cells express DEC205 and/ or UEA1. But we observed more GFP+DEC205+ cells 
rather than GFP+UEA1+ cells.  
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Interestingly, at the 9th-week post-transplant, we observed a small number of peripheral 
derived GFP-expressing cells that expressed DEC205 and UEA1 (Figure 3.16 A-D). From this set 
of results, we hypothesize that the Dec205+UEA+GFP+ cell population represents a TEPC 
population that can differentiate into mTEC and cTEC population.  
Peripheral cells can not differentiate into DEC205 and UEA1 expressing cTEC and mTEC 
in the thymic stroma in vivo 
We next wanted to investigate whether the BM and thymic derived CD45+EpCAM+ cells that 
contribute to TECs might also differentiate into DEC205 and UEA1 expressing cTEC and mTEC 
in the thymic stroma. RTOCS composed of sorted CD45+EpCAM+H2BGFP+ BM or thymic cells 
mixed with non-GFP expressing fetal thymic cells were sectioned and stained with DEC205 and 
UEA1 to investigate if CD45+EpCAM+ cells can differentiate into cTEC and mTEC population. 
In BM RTOC, we observed significant Dec205 staining but minimal UEA 1 staining. We also 
observed an insignificant GFP+ DEC205+ cell in BM-derived RTOC. Similarly, in the thymus-
derived RTOC, we observed substantial Dec205 staining (Figure 3.17 A) but minimal UEA1 
staining (figure 3.17 B). But no DEC205+GFP+ cells were observed in thymus-derived RTOCs ( 
Figure 3.17 E).  This data set suggests that the BM-derived CD45+EpCAM+ cells differentiate 
into DEC205 expressing cTEC or DEC205 expressing TEPC population three weeks post-
transplantation. Different time points need to be analyzed for future experiments to observe if this 
population can differentiate into UEA1 binding mTECs.  But for RTOCs with thymus-derived 
CD45+EpCAM+ cells after three weeks post-transplant CD45+EPCAM+ cells differentiated to 
Keratin expressing TECs, but they are not further differentiated into DEC205+ or UEA1+ 
population. Analysis of further time points is necessary to observe if this population can 
differentiate into Dec205+ and /or UEA1+ cells.  
108 
 
Expression of FSP1 at mRNA level and protein level in both the thymus and BM-derived 
CD45+EpCAM+ population. 
 In the previous section, we demonstrated that when we engrafted E14.5 C57BL6 fetal 
thymus under the kidney capsule of Actin-H2BGFP mice, GFP-expressing cells from the periphery 
migrated into the engrafted fetal thymus. Those GFP+ cells mainly contributed to 
CD45+EpCAM+ cells, epithelial cells, and FSP1-expressing cells.  We also demonstrated both the 
BM-derived and thymus-derived CD45+EpCAM+ population could contribute to the FSP1 
expressing thymic stroma in reaggregate thymic organ culture. We hypothesized that the 
CD45+EpCAM+ population could migrate to the thymus and contribute both Pan-keratin 
expressing TECs as well as the FSP1expressing fibroblast population. We wanted to understand if 
the CD45+EpCAM+ cells express FSP1 before migrating to the thymus or acquiring FSP1 
expression due to differentiation. We used flow cytometric analysis to understand if FSP1 is 
expressed at the protein level in both the BM-derived and thymus-derived CD45+EpCAM+ 
populations. To detect FSP1 expression, we used ROSAmT/mG mice with FSP1 cre 
mice.  ROSAmT/mG mouse has a cell membrane-targeted, two-color fluorescent Cre-reporter allele. 
Before Cre recombination, all the tissues express membrane-bound tdTomato, but Cre 
recombinase expressing cells will express membrane-bound EGFP (mG) fluorescence expression 
instead tdTomato expression. FSP1 cre is a transgenic mouse that expresses Cre recombinase 
under the mouse FSP1 (s100A4) promoter's control. We crossed ROSAmT/mG mice with FSP1cre 
to obtain offspring that express membrane-bound GFP in every FSP1 expressing cell. Then we 
used the progeny mice for BM and thymus. FACS analysis of both bone marrow and thymus 
showed a high percentage of the GFP expressing FSP1+ cells in the CD45+EpCAM+ population. 
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89% of the BM-derived cell population express FSP1 on average (figure 3.18 A), whereas thymus-
derived CD45+EpCAM+population had an average of 93% FSP1+ cells (figure 3.18 B).  
Next, we wanted to confirm FSP1 expression at the mRNA level using qRT-PCR and FSP1 
primers to analyze the two CD45+EpCAM+ populations. For that purpose, CD45+EpCAM+ cells 
from adult bone-marrow and thymus were sorted with high purity (~90%). We also sorted 
CD45+EpCAM- cells from the BM and thymus and CD45-EpCAM+ cells from the thymus as 
controls. We also sorted the CD45-EpCAM-PDGFRβ+ thymic fibroblast population as a positive 
control, reasoning that we might expect strong FSP1 expression in this population. Relative levels 
of RNA expression of FSP1 were normalized in each sorted population to the levels of 18s rRNA.  
Interestingly, we observed that the BM CD45+EpCAM- the population had a 25-fold 
higher expression of FSP1 (data not shown), whereas the thymic CD45+EpCAM- the population 
has a 9-fold high level of FSP1 expression than the CD45-EpCAM-PDGFRβ+ cells. Österreicher 
et al.’s findings that bone-marrow-derived and peritoneal macrophages have a high expression 
level of FSP1 (283) can explain our data showing a high level of FSP 1 expression in CD45+ cells. 
That means CD45+ cells also contain macrophages, which can have a high level of FSP1 
expression. The BM-derived DP population has 70-fold lower FSP1 expression than the control 
population. The thymus EpCAM, only the TEC population, has a 0.3-fold higher expression level 
than the control thymic PDGFRβ population. Interestingly, the thymus DP population has 0.1fold 
higher expression of FSP1 than the control population (Figure 3.18 C).  
These results suggest that the CD45+EpCAM+ cell population already express FSP1 in the 
bone marrow. But it seems that after migration to the thymus, these cells have an increased level 
of FSP1 expression. From this unique result, we can hypothesize that when CD45+EpCAM+ cells 
with a low FSP1 expression migrate from the bone marrow to the thymus and undergo an 
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upregulation of FSP1 expression. A small subset of this population can lose FSP1 expression and 
commit toward Pan-keratin expressing TEC differentiation in the thymus. In contrast, most of this 
population retain their FSP1 expression and contribute to the FSP1+ fibroblast population known 





Figure 3.15. A peripheral population can migrate into the thymus and contribute to Dec205 and 
UEA1 1expressing thymic epithelial cells. C57BL6 fetal thymi were transplanted under the kidney 
capsule of Actin H2BGFP mice and analyzed for the presence of GFP-expressing peripheral cells 
3-12 weeks after transplant using IHC. A-D: Week 3 transplanted thymic tissue sections showing 
expression of Dec205 (A), UEA1 (B), GFP+ peripheral cells (C), and Merged image (D). E-H: 
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Week 6 transplanted thymic tissue section showing expression of Dec205 E), UEA1 (F), GFP+ 
peripheral cells (G), and Merged image (H. I-L: Week 9 transplanted thymic tissue section 
showing expression of dec205 (I), UEA1 (J), GFP (K), and Merged image (L). M-P: Week 12 
transplanted thymic tissue section showing expression of Dec205 (M), UEA1s (N), GFP (O), and 





Figure 3.16. A peripheral population can migrate into the thymus and contribute to Dec205 and 
UEA1 1expressing thymic epithelial cells. C57BL6 fetal thymi were transplanted under the kidney 
capsule of Actin H2BGFP mice and analyzed for the presence of GFP-expressing peripheral cells 
3-12 weeks after transplant using IHC.A-D Week 9 transplanted thymic tissue section showing 
expression of dec205 (A), UEA1 (B), GFP (C), and Merged image (D). E-H: Week 12 transplanted 
thymic tissue section showing expression of Dec205 (E), UEA1s (F), GFP (G), and Merged image 
(H). GFP, Dec205, and UEA1 expressing cells of interest are enlarged in the insets to show both 
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proteins' colocalization and represent the cells shown in the white boxes. All the experiments were 





Figure 3.17.  Reaggregate thymic organ cultures show that both bone marrow and thymus-derived 
CD45+ EpCAM+ cells can give rise to DEC205+ thymic stromal cells. (A-C) RTOC consisted of 
C57BL/6 fetal thymus mixed with bone marrow-derived actin H2B-GFP-expressing 
CD45+EpCAM+ cells. A representative RTOC section showing DEC205 expression (A), UEA1 
staining, (B) with GFP expressing cells derived from actin H2BGFP expressing CD45+EpCAM+ 
cells sorted from adult bone-marrow (C); the Merged image of DEC205, UEA1 and GFP (D). (E-
H) RTOC consisting of C57BL/6 fetal thymus mixed with thymus-derived actin H2B-GFP-
expressing CD45+EpCAM+ cells. A representative RTOC section showing Dec205 expression 
(E); UEA1 staining, (F) with GFP expressing cells derived from CD45+EpCAM+ cells sorted 
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from adult bone-marrow (G); the Merged image of DEC205, UEA1 and GFP (H). All the 
experiments were done in three replicates. 
Figure 3.18 
 
Figure 3.18. FSP1 is expressed in both the BM-derived and thymus-derived CD45+EpCAM+ 
populations. Panel A shows FSP1 expression in the BM-derived CD45+EpCAM+ population 
Panel B shows FSP1 expression in the thymus-derived CD45+EpCAM+ population. Panel C 
shows the fold change in FSP1 mRNA expression in both BM and thymus Derived 






Characterizing the CD45+EpCAM+ Bone Marrow derived Thymic Epithelial Progenitor 
Cell Population 
4.1. INTRODUCTION 
Stem cells are a unique self-renewing population of cells that can differentiate into one or 
more mature cell types (148). The tissue-specific adult stem cell populations maintain tissue 
homeostasis for many self-renewing tissues such as the skin, intestinal epithelium, liver, mammary 
gland, and hematopoietic system(149). Recently it has come to light that adult stem cell 
populations can overcome tissue and lineage barriers and differentiate into different cell types(8, 
149). Adult bone marrow cells are one of the most prominent examples of the newfound plasticity 
of adult stem cell populations. Adult bone marrow cells have been shown to contribute to skeletal 
muscle(284), cardiac muscle, skin, hepatocytes (156, 157), lung epithelial cells(183, 276), GI tract 
epithelial cells, renal tubular epithelial cells, the endometrium of the uterus, endocrine cells of the 
pancreas and the central nervous system. Additionally. Krause et al. 2001 have shown that a single 
bone-marrow-derived stem cell can produce progeny that migrate to various organs and 
differentiate into different epithelial cell populations, including gut, lung, liver, and uterine 
epithelial cells(154). Interestingly, most of these studies showed that BM cells contribute to 
different organs in response to injury(8, 154). In the previous chapter we showed evidence of a 
unique BM-derived population that can contribute to the thymic epithelial microenvironment as 
well as a critical FSP-1-expressing fibroblast population known to be important in the maintenance 
of mTECs responsible for self-tolerance. 
Thymic epithelial cells create a unique microenvironment in the thymus that supports and 
regulates the self-tolerant naïve T-cell population's development. Paradoxically thymus undergoes 
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age-related involution, where thymic epithelial cells are transformed into adipose tissue by 
epithelial-mesenchymal transition (EMT)(144). Apart from age-related involution, the thymus can 
also undergo stress-induced atrophy(285). Because of this age and stress-related involution, it was 
believed that the adult thymus did not maintain an epithelial stem/progenitor cell population, 
unlike many epithelial organs and tissues. However, in recent years, few studies have demonstrated 
the thymic epithelial progenitor cell population's presence in the adult thymus(100). Osada et al. 
2013 and later, Wong et al. 2014 defined the thymic epithelial progenitor population with an 
EpCAMloMHCIIloSca1+CD49f+CD29+ phenotype (102, 109). Osada et al. 2013 also demonstrated 
that the EpCAMlo TEC population exhibited mesenchymal stem cell-like multipotency(109). 
Interestingly, Ulcheyanko et al. 2016 later defined the EpCAM+ UEA-BP1+PLET1+ MHCIIhi 
population as adult bipotent TEC progenitors (104). These contradictory phenotypes may represent 
different developmental stages of the thymic epithelial progenitor cell population or different 
populations of cells that, under different experimental conditions, maintain the potential to 
differentiate into both cortical and medullary TECs. These contradictory results suggest the need 
for future research to identify the adult thymic epithelial progenitor cell population. Furthermore, 
it is crucial to locate and fully characterize TEPCs to open up potential avenues for clinical therapy 
to reverse stress and/or age-induced thymic involution and the subsequent loss of thymic function. 
While all the previous TEPC studies were mainly focused on the CD45-EpCAM+ subpopulation, 
this research probed into the CD45+ subpopulation in the search for the adult TEPC for the first 
time. 
 Previously we identified the CD45+EpCAM+ population present in bone marrow and 
thymus and demonstrated its capacity to be a potential thymic epithelial progenitor cell population. 
This study demonstrated that the CD45+EpCAM+ population is derived from hematopoietic stem 
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cells in the BM using adoptive transfer. Additionally, we examined this population's dynamics 
during progressive aging and characterized changes in their stem cell-like surface marker 
expression. Finally, we characterized this population's chemokine expression profile to understand 
how this population can home to the thymus and contribute to the thymic stroma.  
4.2. RESULTS 
Bone-marrow CD45+EpCAM+ cells are derived from hematopoietic stem cells. 
The bone-marrow contains two types of stem cell populations: hematopoietic stem cells 
and mesenchymal stem cells. Previous studies have shown that BM-derived cells can differentiate 
into different tissue-specific populations. A few papers showed the plasticity of the BM-derived 
HSC population (154, 183). In contrast, other studies used whole BM (165, 192) or other more 
defined BM subsets (163). We first hypothesized that the bone-marrow-derived TEPCs are from 
the hematopoietic lineage because this population expresses the pan-hematopoietic cell marker, 
CD45. However, we wanted to determine the lineage of the CD45+EpCAM+ cells to see if they 
are genuinely derived from HSCs or some other stem cell population of the bone marrow. To 
determine if the CD45+EpCAM+ progenitor cells were derived from the HSCs, we sublethally 
irradiated C57BL6 mice with, 1300 cGY using an X-ray irradiator. Subsequently, the HSC 
population was sorted from Actin H2BGFP transgenic mice. Before sorting, the BM cells were 
lineage depleted for CD11b, CD11c, CD19, B220, Ter119 and CD3. Lineage depleted cells were 
further negatively selected for CD11b, CD11c, and CD19-expressing cells. Subsequently, the HSC 
population is defined as c-Kit+Sca1+ in the lineage negative bone marrow cells. 100,000 GFP-
expressing HSCs were sorted to greater than 95% purity and intravenously injected to irradiated 
C57BL6 mice.  Later, these mice were analyzed at different time points from 5- 20 weeks after 
transfer for the presence of GFP-expressing donor derived cells. Irradiated C57BL6 mice were 
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used as a control to determine the GFP gating strategy (see figure 4.1). FACS analysis showed the 
presence of GFP+ cells in both the bone marrow and thymus of these mice after BM transplant. 
At the 5th week post-transplant, the lineage depleted bone marrow had an average frequency of 
75% GFP expressing cells, subsequently the average frequency of GFP+ cells were 58% at the 6th 
week post-transplant bone marrow. At the 20th week post-transplant, the average frequency of the 
donor cell cells in the bone marrow was 66%. The different frequencies of the donor cells at 
different time points in the bone marrow represent the extent of chimerism in the bone marrow. 
Further analysis revealed that the GFP+ donor cells were mainly localized in the CD45+ and the 
CD45+EpCAM+ cell population. 
First, we analyzed the presence of GFP+CD45+ cells in the recipient bone marrow. First, 
the frequency analysis of GFP+ CD45+ cells at different time points revealed that at the 5th week 
post-transplant, the CD45+ population had an average frequency of 80% GFP expressing cells. At 
the 6th week, the average frequency of GFP+ cells was 56 %. At the 20th week post-transplant, the 
average frequency of donor cells in the CD45+ population was 88%. These different frequencies 
of the donor-derived GFP+ cells at different time points in the CD45+ population reflect the extent 
of chimerism in each replicates.  
FACS analysis showed that a very small frequency of the CD45+EpCAM+ cells are 
present in the bone marrow post-transplant, and the frequency gradually increases with progressive 
time points. At the 5th week post-transplant, the average frequency of the CD45+EpCAM+ 
population was 0.1%, whereas, at the 6th week time-point, the average frequency increased to 
0.23%. At the 20th week, the average CD45+EpCAM+ frequency increased to 0.5%. These data 
suggests that the CD45+EpCAM+ population is radiation sensitive. At an earlier time point, the 
frequency is lower due to radiation-induced injury, but the frequency increased as the bone marrow 
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recovers. The CD45+EpCAM+ population in the bone marrow showed the presence of GFP+ 
donor cells at all time points. A gradual increase in the number of CD45+EpCAM+GFP+ cells 
was observed in progressive time following the adoptive transfer. At five weeks post-transplant, 
the average frequency of the GFP+ donor cells in the CD45+EpCAM+ population was 33.7%, 
which increased to an average of 41% at the 6th week post-transplant. , A high frequency of GFP+ 
cells were observed in the 20th week replicates, with an average of 86% in the CD45+EpCAM+ 
population. A representative FACS profile of the frequency of CD45+EpCAM+GFP+ cells at 
different time points is shown in Figure 4.1B. Even though a gradual increase in the frequency of 
GFP+ donor cells was observed, it was important to understand whether this change in the 
frequency only reflects the extent of chimerism in the bone marrow or the donor cell frequency 
indeed increases with the advancing time points.  For that purpose, we normalized the frequency 
of GFP+CD45+EpCAM+ cells to the frequency of total GFP+ cells in the bone marrow. This 
normalization revealed that the average ratio of the GFP+CD45+EpCAM+: GFP+ cells increased 
from 0.4 at the 5th week to 1.4 at the 20th week. This result clearly demonstrates that the 
CD45+EpCAM+ cells are derived from HSC. The CD45+EpCAM+ cells of the bone marrow are 
radiation-sensitive, and this population recovers gradually  post-transplantation. These data also 
revealed a steady increase in the ratio of CD45+EpCAM+GFP+ cells relative to the total GFP+ 
cells, suggest that more donor-derived HSC population differentiate into the CD45+EpCAM+ 
population with progressive time following adoptive transfer. 
CD45+EpCAM+ thymic epithelial progenitor cells are derived from the hematopoietic stem 
cells. 
Next, the goal was to understand if the transplanted HSC can migrate to the thymus and 
give rise to the thymic CD45+EpCAM+ population, as well as the EpCAM+ TEC population. For 
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analysis of the thymic stroma, the same set of mice used for the bone marrow analysis was used. 
The bone marrow analysis described previously proved that adoptive transfer had been successful 
and that the BM CD45+EpCAM+ population was derived from the GFP-expressing HSCs. But to 
determine whether the donor HSC derived CD45+EpCAM+ cell population can migrate to the 
thymus, we analyzed the frequency of GFP+CD45+ cells in the recipient’s thymus. FACS analysis 
of the dissociated thymus showed a substantial presence of donor GFP+ cells in the CD45+ 
population at all time points. With progressive time point, the frequency of GFP+CD45+ cells 
increase in the thymus. At the 5th week, the thymic CD45+ population showed an average 
frequency of 56% GFP+ donor cells, followed by an average frequency of 53% at the 6th-week 
analysis. At the 20th week, an increased frequency of CD45+GFP+ cells, with an average of 72%, 
was observed. 
Additionally, we normalized the thymic GFP+CD45+ cells' frequency to the frequency of 
the total GFP+ cells in the bone marrow. This normalization revealed that the average ratio of the 
GFP+CD45+: GFP+ cells remained almost the same at both the 5th week and 6th-week time point, 
with an average ratio of 0.75 and 0.77, respectively. But in the 20th week, this ratio increased to 
1.1. These results suggest that the HSC derived CD45+ cells can migrate to the thymus. The bar 
graph representation of the GFP+CD45+EpCAM+: GFP+ cells shown in figure 4.2G. FACS 
representation of CD45+GFP+ cells at different time points are demonstrated in Figure 4.2D. 
 Next, FACS analysis of the CD45+EpCAM+ cell population also showed the presence of  
GFP+ cells at all time points. At the 5th week, GFP+ had an The average frequency of GFP+ donor 
CD45+EpCAM+ population was 38%-39% 5 and 6 weeks after adoptive transfer of GFP-
expressing HSCs. A sharp increase in the frequency of GFP+CD45+EpCAM+ donor derived cells 
was observed in the 20th week with an average of 68%. Additionally, we normalized the thymic 
120 
 
GFP+CD45+ EpCAM+ cells' frequency to the frequency of the total GFP+ cells in the bone 
marrow. This normalization revealed that the average ratio of the GFP+CD45+EpCAM+cells: 
GFP+ cells remained almost the same at both the 5th week and 6th-week time point, with an average 
ratio of 0.5 however,  this ratio dramatically increased to 1 in the 20th week, clearly demonstrating 
that donor derived HSCs contribute significantly to the thymic CD45+EpCAM+ subset. 
A small number of donor-derived GFP+ CD45-EpCAM+ TECs were also observed at all 
the time points. The frequency of the GFP+ EpCAM+ cells remained at 1-4% at all time points. 
The ratio of GFP+EpCAM+cells: GFP+ cells remained very low at all time points. But at the 20th-
week analysis, a small increase in this ratio, with an average of 0.1, was observed.   
This set of data indicates that thymic CD45+EpCAM+ cells are HSC derived, and HSC 
derived cell population can differentiate into thymic epithelial cells. Taking both the bone marrow 
and the thymus FACs analysis together, it can be hypothesized both the bone marrow-derived and 
thymus-derived CD45+EpCAM+ populations increase with advancing time point. The steady 
frequency of GFP+ donor cells in the thymic epithelial cell population suggests HSC derived cells 
can migrate to the thymus and differentiate into the thymic epithelial cells.  
The CD45+EpCAM+ population is found in the fetal thymus both before and after bone 
marrow formation. 
Previous studies have suggested that the fetal TEPC population does not retain its self -
renewing properties in the adult thymus (107). We wanted to understand if the CD45+EpCAM+ 
positive population is exclusively an adult TEPC population. Additionally, it is important to 
understand if this cell population is derived from only BM-derived HSCs or if CD45+EpCAM+ 
cells are found in the fetal thymus before bone marrow formation.  During fetal development, the 
first hematopoietic stem cells are found in the fetal liver, and the bone marrow is formed around 
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E17.5.  The first wave of early T-cell progenitors is derived from the fetal liver and arrives in the 
fetal thymus at embryonic day E12.5 prior to BM development. Therefore, we chose three different 
embryonic days E13.5, E15.5, and E18.5, to understand whether the CD45+EpCAM+ cells are 
derived only once the BM is formed or if the fetal HSCs in the fetal liver also contribute this 
population to the developing thymus. For future analysis, fetal liver HSC should be isolated to 
confirm the presence of CD45+EpCAM+ cells in fetal HSC. 
CD45+EpCAM+ population frequency first increases, then achieves a steady-state with 
advancing embryonic days. At E13.5, the fetal thymus showed the lowest frequency of the 
CD45+EpCAM+ cells, with an average of 0.48%(+/-0.05%). E15.5 and E18.5, both the time points 
had the same frequency of CD45+EpCAM+ population with an average of 0.6%(+/-0.5%). FACS 
representation of the frequency of CD45+EpCAM+ cells in the fetal thymus   is demonstrated in 
Figure 4.3. 
  Additionally, we analyzed the CD45+EpCAM+ for expression of a well-established HSC 
marker, as well as postnatal TEPC marker, Sca1 expression.   Sca1 analysis revealed earlier time 
point CD45+EpCAM+ cells in E13.5 thymus had a lower frequency of Sca1+ cells with an average 
of 33%, whereas both E15.5 and E18.5 have the same frequency of Sca1+ cells (an average of 
41%, +/-5%). These data suggest the CD45+EpCAM+ population found in the fetal thymus 
expresses TEPC markers. It was interesting to note that the level of Sca1 expression within the 
CD45+EpCAM+ population was lower in the fetal thymus than that observed in adults. Lower 
Sca1 expression in the fetal CD45+EpCAM+ population suggests that this population might 
represent this population's immature stage. Postnatally this population matures farther and gains a 
higher Sca1 expression level.  Additionally, the presence of CD45+EpCAM+ cells in the fetal 
thymic stroma at early embryonic time points indicates that this population is already present in 
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the fetal thymus and is likely recruited from the fetal liver similar to T cell progenitors before BM 
formation and may contribute to the development of fetal thymic epithelial microenvironment. 
CD45+EpCAM+ cells from Thymus Express TEC Progenitor Characteristics 
Many epithelial tissues maintain a reservoir of tissue somatic stem cells that can repair or 
regenerate those tissues. Several studies have demonstrated that epithelial stem cell populations 
are stored in a unique protective niche and signaled when necessary to proliferate and differentiate. 
Most of these tissue-specific stem cell populations express Sca1 and other stem cell-specific 
markers. Kim et al. 2005 identified CD45-Sca+ cells as the bronchoalveolar stem cell 
population(286). Additionally, Burger et al. 2005 showed prostatic stem cells express Sca1, and a 
fraction of that Sca1+ positive population also had high expression of the α6 integrin/ CD49f(287). 
Jones et al. 1993 and Tani et al. 2000 characterized the skin stem cells with CD49fhi CD29hi 
expression(288, 289). Stingl et al. 2006 showed that the mammary stem cell population is 
characterized by a Sca1loCD49fhiCD29hi phenotype (290). Later, Osada et al. 2013 demonstrated 
that a stem cell-like population exists within the postnatal thymic stroma, which can differentiate 
into multiple mesenchymal lineages, including adipocytes, chondrocytes, and osteoblasts, as well 
as TECs in vivo(109). This TEC progenitor/mesenchymal stem cell-like population was 
characterized by the expression of an EpCAMloMHCIIloSca1hiCD49f+CD29+ phenotype(109). 
Later Wong et al. showed that the adult thymic epithelial progenitor population could also be 
defined with the EpCAM+MHCIIlo Sca1+CD29+CD49fhi phenotype (102). Interestingly, 
Ulcheyanko et al. 2016 later defined the EpCAM+ UEA-BP1+PLET1+ MHCIIhi population as adult 
bipotent TEC progenitor(104). This contradictory result showed that both MHCIIhi and MHCIIlo 
subpopulations could have stem cell-like properties. 
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We wanted to understand if the CD45+EpCAM+ TEPC population expressed the stem cell 
markers described by Osada et al. 2013.  The previous sections described that this population is 
present in the fetal thymus, and it expresses Sca1. Next, we also demonstrated that the mouse 
thymus of all ages has the CD45+EpCAM+ population. This section aims to determine whether 
the CD45+EpCAM+ population found in the thymus possessed the same tissue-specific stem cell-
like properties shown by Osada et al. 2013(109).  Like other TEC progenitors described, the 
thymus-derived CD45+EpCAM+ population expressed Sca1, CD49f, and CD29 providing support 
for their potential as a unique population of TEC progenitors (Figure 4.4).  
Figure 4.4 shows the representative Sca1, MHCII, CD49f, CD29 expression pattern in 
C57BL6 male mice at different time points (4-month, 8-month, 10-month, and 12-month) for the 
CD45+EpCAM+ population. This data set shows that the CD45+EpCAM+ cells contain two 
distinct MHCII expressing populations, MHCIIhi, and MHCIIlo subsets, depending upon MHCII 
expression's intensity. These two MHCII subsets were present at all time points analyzed, even 
though the MHCIIlo subset was more abundant than the MHCIIhi subset. Our data revealed at 
different time points, both MHCIIlo and MHCIIhi cell frequency remained almost the same. The 
MHCIIlo population had an average frequency of 55% (+/-10), whereas the MHCIIhi population 
had an average frequency of 23% (+/-6) at all time points. Both the MHCIIhi and MHCIIlo subsets 
exhibit high levels of Sca1 expression. Again, our data demonstrated higher frequency Sca1+ cells 
in the MHCIIlo population than the MHCIIhi population at all the time points. Additionally, this 
data also revealed that the frequency of Sca1+ cells  in both the MHCIIlo and MHCIIhi subsets 
increases with progressive age. In a 4-month-old thymus, the frequency of the MHCIIloSca1+ 
population was 68% (+/-10%). Subsequently, the MHCIIloSca1+ frequency increased to 94% (+/-
2%) at ten months old and remained the same at 12 months old, with an average frequency of 91%, 
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+/-10%). Next, we analyzed the MHCIIhi population for the frequency of Sca1+ cells at different 
time points. The average frequency of the MHCIIhiSca1+ population in the thymus was 52% (+/-
13%) in 4-month-old mice. This population's frequency increased to an average of 80% (+/-8%) 
in 8-month-old mice.  All the later time points maintained an average of 80% (+/-10) 
MHCIIhiSca1+ cells.  
Next, we wanted to compare the CD49f+CD29+ frequency at all time points in both the 
MHCIIhiSca1+ and MHCIIloSca1+ populations.  Both the MHCIIhiSca1+ and MHCIIloSca1+ cells 
showed the presence of CD49f+CD29+ cells at every time point. Interestingly with progressive age, 
both populations showed a decreasing frequency of the CD49f+CD29+ subset associated with 
progenitor capacity. For the MHCIIloSca1+ population, the CD49f+CD29+ frequency was 
maintained in 4-10 month-old mice, with an average of 55% (+/- 15) in the 4-month-old thymus, 
52% (+/-7) in the 8-month-old thymus, and 57% (+/-7) in the 10-month-old thymus. Interestingly, 
in the thymus of 12-month-old mice, the frequency of the CD49f+CD29+ population decreased 
significantly to an average of 38%(+/-18). In case of the MHCIIhiSca1+ population, the 
CD49f+CD29+ frequency decreased gradually from 63% (+/-20) to 49% (+/-25%) with progressive 
age. Another population, expressing only CD29, was also observed at all timepoints. However, 
unlike the CD49f+CD29+ population, this population maintained a low frequency for all time 
points (14%-25%). 
Additionally, the thymus-derived CD45+EpCAM+ population was analyzed for stem cell 
marker expression in the regenerated thymus (Figure 4.4E i-vi). This set of data revealed that the 
CD45+EpCAM+ population has an average of 54% of MHCIIlo cells.  Analysis of the MHCIIlo 
population showed an abundance of Sca1+ cells, with an average of 86% (+/-9). When we analyzed 
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the MHCIIloSca+ population for CD49f and CD29 expression, we observed a very small frequency 
of CD49f+CD29+ cells with an average of 4.3% (+/-5). 
 CD49f is an evolutionary biomarker for several stem cell populations. It has been 
previously shown that  CD49f or α6 integrin plays a vital role in tethering the stem cell population 
to their protective niche(291). Tumbar et al. 2004 showed that CD49f and CD29 help skin stem 
cells remain quiescent in their niche (292). Other studies have demonstrated that tight regulation 
of CD49f/CD29 in stem cell populations is essential for maintaining the pluripotency of stem cells 
and remaining quiescent in their niche(291). Another study highlighted that a single CD49f+ 
human HSC could generate a long-term multi-lineage graft (293). Additionally, they identified 
that the loss of CD49f expression in HSC causes only temporary engraftment of this population if 
used in the adoptive transfer (293). Keeping these previous findings in mind, it is possible that in 
the aged thymus, the CD45+EpCAM+ population loses its CD49f expression, which reduces the 
differentiation capability of this population and augments involution. Furthermore, the further loss 
of CD49f expression in the castration recovered thymus may be responsible for only a temporary 
recovery of the thymic epithelial cellularity. This hypothesis can be tested using the reaggregate 
thymic organ culture system. MHCIIloSca+CD49f+CD29+ population can be sorted from both 
young and old mouse thymus and be used in the formation of separate RTOCs. If the hypothesis 
is correct, then the CD45+EpCAM+Sca1+CD49f+CD29+ population from the young mouse 
thymus would be expected to differentiate more readily than the same population derived from old 
mice. 
CD45+EpCAM+ cells from the Bone Marrow Express TEC Progenitor Characteristics: 
We wanted to determine whether the BM-derived CD45+EpCAM+ cells express the adult 
TEC progenitor phenotype. Figure 4.5 shows the representative expression pattern for adult TEC 
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progenitor markers Sca1, CD49f, and CD29 within the BM-derived CD45+EpCAM+ cells in 
C57BL6 mice at different time points (4-month to 12-month). We observed that the BM DP cells 
are enriched in Sca1 expression, with an average frequency of 90% for all the time points. 
Interestingly the majority of the Sca1 expressing cells only expressed CD29 rather than both 
CD49f and CD29. We noticed that the Sca1+CD29+CD49f- population undergoes a gradual 
decrease in frequency with progressive age (from an average frequency of 91% for 4-month-old 
to 75% in 12-month-old mice). Our FACS analysis showed that the Sca1+ population has a small 
frequency of cells that expresses both CD49f and CD29. All the time points had an average of 12% 
CD49f+CD29+ cells within the CD45+EpCAM+Sca1+ population.  
Additionally, the BM-derived CD45+EpCAM+ population was analyzed for stem cell 
marker expression in the regenerated thymus (Figure 4.5 M-O). Analysis of the CD45+EpCAM+ 
population showed an abundance of Sca1+ cells, with an average of 90% (+/-9). When we analyzed 
the Sca+ population for CD49f, and CD29 expression, a very small frequency of CD49f+CD29+ 
cells with an average of 0.075, (+/- 0.01) and CD49f-CD29+ cells, with an average of (0.4,+/-0.1) 
was observed.  
Previous studies have shown that CD29/β1intergrin expression is prominent in several 
tissue-specific and mesenchymal stem cell populations (294). Later, it was identified as a 
hematopoietic stem cell homing regulator(295). Previous studies demonstrated that CD29 
expressing cells are responsible for maintaining the stem cell niche, maintaining a stable stem cell, 
and tightly regulating the balance between stem cell renewal and differentiation(294). Such studies 
provide a possible explanation of the unique result that BM-derived CD45+EpCAM+ cells have a 
high frequency of CD29+ cells and the CD29 expression is important for cell migration via blood 
as well as for maintenance of the stem cell population. This result and previous studies together 
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indicate that the abundant CD29+ cell in the BM-derived CD45+EpCAM+ population is important 
for CD45+EpCAM+ cell migration to the thymus.  
The BM-derived CD45+EpCAM+ population expresses CD34 
CD34 is a well-established hematopoietic stem cell marker and a mesenchymal stem cell 
marker(296). Blanpain et al. 2004 demonstrated that the skin epithelial stem cell population also 
expresses CD34(297). The BM-derived CD45+EpCAM+ cell population expresses other 
epithelial stem cell markers, as shown in figure 4.6. Next, we wanted to confirm if this population 
expresses CD34, a marker found in both HSCs and mesenchymal stem cells. Figure 4.6 shows the 
representative data for CD34 expression at different time points. Our data showed that a significant 
number of CD45+EpCAM+ cells was CD34+ (on average 70%, +/-10%). Our data also revealed 
a gradual decrease in CD34 expression with progressive aging. However, in the 12 month-old-
mice, a sharp decrease was observed (8%, +/-5%) (figure 4.6H). These data suggest that with 
progressive aging, the BM-derived CD45+EpCAM+ population loses its stem-cell-like 
characteristics. Analysis of CD34+ cells present in the bone marrow of castrated mice revealed 
that the CD45+EpCAM+ population loses CD34 expression (Figure 4.6 J). From this set of results, 
it can be hypothesized that loss of stem-cell-like properties of the CD45+EpCAM+ population 
with progressive aging may play an instrumental role in age-related thymic involution. 
 Contribution of CD45+EpCAM+ cells to the maintenance of TEC microenvironments with 
progressive age 
It has been observed that with advanced age, the mammalian thymus undergoes distinct 
morphological changes, which include thymic atrophy and thymic adiposity (147, 298).  A 
decreased thymic capacity for thymopoiesis accompanies thymic atrophy and adiposity. With 
progressive aging, the thymus starts losing its epithelial cell populations while the number of non-
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TEC thymic stromal cells increases. We hypothesized that if the thymus undergoes age-related 
involution even though this bone marrow-derived TEPC population is present, it indicates a major 
change in this population, which causes the inhibition of migration of the BM-derived 
CD45+EpCAM+ population to the thymic stroma. Another possibility is that this CD45+EpCAM+ 
steady flow in the thymic stroma contributes to the TECs and FSP1 expressing fibroblast and 
maintaining the thymic medulla throughout life. A preliminary study was done to analyze the 
frequency of these populations with progressive aging. For this purpose, C57BL6 male mice of 
different ages from 2-months old to 12-months old were used for FACS analysis of the bone 
marrow and dissociated thymus. Analysis of the absolute number of BM-derived CD45+EpCAM+ 
cells per animal at different time points revealed a gradual increase in the BM number. (Figure 
4.7A), whereas the absolute number analysis of thymus derived CD45+EpCAM+ cells per lobe at 
different time points revealed a gradual decrease in this population with progressive age (Figure 
4.7B). Other studies have shown that the frequency of HSCs in the bone marrow increases 
significantly with age but interestingly, the self-renewing capacity and pluripotency decreases 
(299-301). Liang et al. 2005 demonstrated that the homing efficiency of HSC in old mice was at 
least 3-fold lower than in young mice (302). It also has been shown that HSC differentiation gets 
more skewed towards myeloid progenitors rather than lymphoid progenitors (303). These previous 
findings can provide a possible explanation as to why the aged bone marrow derived 
CD45+EpCAM+ population increases in number. It might also be possible that the BM 
CD45+EpCAM+ population loses its capacity to differentiate and/or home to thymus, thus 





BM-derived CD45+EpCAM+ can play a role in castration induced recovery of the thymus 
It is known that thymic epithelial cells have a rapid turnover rate, i.e., they proliferate 
extensively during the period of thymic growth. It has been demonstrated that the turn-over rate of 
thymic epithelial cells decreases with thymic aging, suggesting that TEC proliferation might be 
the key regulator of thymus size. These data led to the hypothesis that the decreased turnover rate 
of TECs might be one of the factors contributing to thymic atrophy during aging (147). This study 
also showed that sex steroid ablation could reverse thymic involution. Seven to fourteen days after 
castration surgery, an aged mouse can achieve an expansion of both thymocyte and TEC numbers 
with an increased ratio of mTEC/cTEC (143, 147).  More recent work by Griffith et al. 2015, has 
suggested that although the aging thymus size recovers transiently in response to castration or 
androgen blockade, it still maintains many functional characteristics of the aged thymus (304). 
They also demonstrated androgen blockade or castration recovery does not restore the complexity 
of medullary islets or tissue-restricted antigen expression (304). The previous section showed that 
the CD45+EpCAM+ cells migrate to the thymus in response to radiation-induced injury, and this 
population is present during thymic organogenesis. It was essential to understand if the BM-
derived CD45+EpCAM+ population can migrate to the regenerating thymus in response to 
castration induced thymic recovery.  We hypothesized that this population could migrate to the 
aged thymus following castration and contribute to the involuting thymic stroma's maintenance. 
We also hypothesized that this population loses its capacity to migrate to the thymus and augment 
the thymic involution during aging. 
It was important to decipher how castration affects the frequency and distribution of the 
CD45+EpCAM+ TEPC subset.  The frequency and the absolute number of CD45+EpCAM+ cells 
in the BM and thymus of young (4month old) and old (12-month-old) and regenerating thymus 
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were analyzed to determine how thymic recovery impacted the frequency in 12-month-old 
C57BL6 mice two weeks after they were surgically castrated. It has been previously demonstrated 
that the thymus has the lowest cellularity within four days after castration, followed by restoration 
of thymic cellularity by day 20.  However, such restoration was not permanent and by the 4th-week 
post castration, the restored thymus loses its cellularity (304, 305). It was important to analyze the 
regenerating thymus before it starts to degenerate again. That’s why the castrated thymus was 
analyzed at the 2nd-week post castration. FACS data showed that following castration, the number 
of the CD45+EpCAM+ cells increased significantly in the thymus ( figure 4.8 B) but decreased in 
the BM (Figure 4.8 A). This analysis showed that CD45+EpCAM+ cell number increased by ~2 
fold in the regenerated thymus (an average of 2367,+/-160) then the aged thymus (an average of 
1156, +/- 262). It is important to note that even though this population increased in number post 
castration, it was still not as abundant as that observed in the young thymus (an average of 3631, 
+/-1011). Analysis of the CD45+EpCAM+ population of bone marrow revealed a small decline in 
number from the aged bone marrow (an average of 14504, +/-809) when compared to the castrated 
mouse bone marrow (an average of 11652,+/-306)  
This set of results suggests that castration induces the CD45+EpCAM+ cells in the bone 
marrow to migrate towards the thymus, which results in a higher frequency of CD45+EpCAM+ 
cells in the thymic stroma. It was previously demonstrated that the HSC population loses its 
differentiation capability with age. Even though CD45+EpCAM+ cells migrate to the thymus and 
contribute to the thymic reconstitution, this recovery is not durable. To confirm this hypothesis, 
we need to perform RNA-sequencing of this population from the aged thymus, castration recovery 




The CD45+EpCAM+ population expresses both chemokines and chemokine receptors. 
The results presented in the preceding sections demonstrated that the CD45+EpCAM+ 
cells could migrate to the thymus from bone marrow. It was also shown that CD45+EpCAM+ cells 
migrate to the thymus during castration recovery and irradiation-induced tissue repair. We next 
wanted to determine how the migration of the CD45+EpCAM+ population from the BM to the 
thymus might be facilitated. Early thymic progenitors or T-cell precursors express chemokine 
receptors, which direct the migration from the bone marrow to the thymus that expresses the 
corresponding ligands in thymic epithelial cells. Apart from T-cell precursors, BM stromal cells 
also express a distinct set of chemokines essential for B-cell development.  Wright et al.2002 
demonstrated that the HSC population expresses chemokine receptors CXCR4, CCR3, 
CCR9(306). Plotkin et al. 2003 have previously shown that the CXCL12/CXCR4 signaling axis 
plays a vital role in the migration of T-cell precursors to the thymic cortex. The early progenitors 
express CXCR4, and its ligand Cxcl12 is only expressed in stromal cells of the cortex(36). Other 
studies have shown that stem cells express CXCR4, and they respond chemotactically to CXCl12 
expressing cells. The CXCl12-CXCR4 axis plays an essential role in hematopoiesis(307). Even 
though it is well established that the HSC population expresses chemokine receptors, Ciriza et al. 
2010 did an extensive study on the chemokine and chemokine expression in a pattern of BM-
derived Lineage-Sca1+c-Kit+ (LSK cells) at different developmental stages (308). They showed 
that adult  BM-derived LSK cells express chemokine receptors, but they also express a set of 
chemokine ligands, including Ccl4 and Ccl9 (308). 
When BM-derived cells' newfound plasticity was discovered, a few studies were conducted 
to understand how the BM cells migrate from bone-marrow toward other tissues. Inokuma et al.  
2006 demonstrated that CCl27 is the primary regulator for migration of BM-derived keratinocytes 
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precursors from BM to the skin. They showed CD34+ BM cells express CCR10, the receptor for 
Ccl27(309). Ishiada et al. 2012 showed BM-derived endothelial progenitor cells express CCR5. 
CCR5/CCL5 helps endothelial progenitor cells to migrate from the bone marrow and help in 
neovascularization (310). Hu et al. 2013 showed that the CXCL12/ CXCR4 axis regulates 
mobilization of mesenchymal stem cells from bone-marrow towards tissue injury and promotes 
tissue repair (311). Sordi et al. 2005 showed that human bone-marrow-derived mesenchymal stem 
cells express the chemokine receptors CXCR4, CX3CR1, CXCR6, CCR1and CCR7(312). 
To identify the chemokine/chemokine receptor expression patterns in both the thymic and 
BM CD45+EpCAM+ populations, a chemokine and chemokine receptor RT2 qPCR array from 
Qiagen (PAMM-022Z) was used.  Both BM-derived and thymus-derived CD45+EpCAM+ cells 
were sorted to high purity and utilized for RNA isolation, followed by cDNA synthesis prior to 
performing analysis using the qPCR array. As a control, we used the BM CD45+ population. These 
results were then analyzed using Qiagen's Geneglobe, RT2 profiler PCR array analysis tool. Data 
analysis revealed a set of upregulated genes in BM-derived and thymus-derived CD45+EpcAM+ 
cells compared to the BM CD45+ population.  The results of the comparison of the BM 
CD45+EpCAM+ cell with the BM CD45 cells' is shown in table 1, while the comparison of the 
thymus CD45+EpCAM+ cell with BM CD45 cells is shown in Table 2. We found that CXCL12 
is expressed in both the BM-derived and thymus-derived CD45+EpCAM+ populations. CXCL12 
is essential for maintaining the hematopoietic stem cell niche. Orlic et al. 2001 demonstrated that 
CXCL12 helps in the mobilization of BMCs in response to heart injury (170). CXCL12 also 
mobilizes BM-derived CD34 expressing mesenchymal cells towards burn injury to initiate wound 
healing (311). Additionally, FACS analysis showed a small subset of the BM-derived 
CD45+EpCAM+ population express CD34, and PCR array results indicated upregulated 
133 
 
expression of CCR10 in both the BM-derived and thymus-derived CD45+EpCAM+ populations. 
It has been previously demonstrated that CD34+ expressing BM cells express CCl27 receptor 
CCr10. The same study also highlighted that the CCR10/CCl27 axis helps mobilize BMCs toward 
the injury site to contribute to tissue repair (309).  It is interesting to observe that this population 
expresses both chemokines as well as chemokine receptors.  Expression of CCR7 and CCR9 was 
also observed and suggested that the CD45+EpCAM+ cells might be using the same chemokine-
chemokine receptor axis used by early T-cell progenitors to migrate from the BM to the thymus.  
It has been shown previously that CCL20 and CCL22 both interact with regulatory T-cells 
(Tregs) (313, 314). CCL20 interacts with non-promiscuous chemokine receptor CCR6, which is 
expressed is expressed in B-cell, T-cells, and dendritic cells. CCL20 is mainly expressed in the 
intestine, and upregulation of this chemokine is observed in response to an inflammatory stimulus. 
CCL20 receptor is mainly expressed in Tregs and TH17. This ligand and its receptor play an 
important role in mucosal immunology. Interestingly, this ligand is also expressed in T-helper cells 
(TH17) (313). CCL22 is highly expressed in different lymph nodes. CCL22 is also expressed by 
dendritic cells. It has been demonstrated before that CCL22 deficient mice are more susceptible to 
inflammatory disease. Interaction of dendritic cells with Tregs is promoted by CCL22-CCR4 
interaction (314). Interestingly apart from chemokine receptors, both the BM and thymus-derived 
CD45+EpCAM+ populations also express some chemokine ligands like CCl20 and CCL22. These 
results indicate that this cell population might have some role in Treg activation. The 
CD45+EpCAM+population is expressing the chemokine ligands that are expressed by intestinal 
stroma, it is possible that apart from thymus this population might migrate to the intestine and 
contribute to intestinal epithelial cells. As a follow up experiment, it will be interesting to see after 




We described the identification of a unique postnatal bone-marrow-derived thymic 
epithelial progenitor cell population. This population expressed both the hematopoietic cell marker 
CD45 and epithelial cell marker EpCAM. We also identified this population in the thymus and 
showed that these cells could migrate into the thymus from the bone marrow and differentiate into 
Pan-keratin and Foxn1, expressing true thymic epithelial cells as well as stromal cells that express 
FSP1, a fibroblast specific marker. 
In the current study, we performed hematopoietic stem cell transplantation to determine 
the lineage of the CD45+EpCAM+ population. HSCT data revealed the presence of donor cell-
derived CD45+EpCAM+ cells in both bone marrow and thymus. This set of experiments revealed 
an increased frequency of donor cells in both the CD45+EpCAM+ and EpCAM+ populations in 
the thymic stroma with progressive time following HSCT. These results confirm that the 
CD45+EpCAM+ cells are derived from HSCs and suggest that the CD45+EpCAM+ cells which 
appear in the BM, then migrate towards the thymus under the condition of radiation-induced injury 
and contribute to thymic tissue repair. It will be interesting to analyze earlier time-points to observe 
the serial migration of this population and see if this population travels towards bone marrow first 
or if they migrate towards both BM and thymus at the same time. 
Next, analysis of dissociated fetal thymus at E13.5-E18.5 was performed to determine if 
the CD45+EpCAM+ population is only present after the bone marrow is formed or might also be 
present in the fetal liver and contribute to the early fetal thymic stroma prior to BM formation. We 
used three embryonic days for our analysis, E13.5, E15.5, E18.5. At E13.5 and E15.5, 
hematopoiesis and early thymic progenitors are dependent on HSCs present in the fetal liver (315). 
At E17.5, fetal bone marrow is fully developed. The CD45+EpCAM+ population present in the 
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E18.5 fetal thymic stroma is likely derived from fetal bone marrow. From these results, we can 
hypothesize that the CD45+EpCAM+ population found in the fetal stroma might play an important 
role in fetal TEC development.  
Next, we analyzed mice at different ages for the presence and surface characteristics of the 
CD45+EpCAM+ subset to understand the effect of progressive age on its frequency and stem cell-
like properties.  A time point analysis from (4 months to 12 months) of the CD45+EpCAM+ 
population in both bone marrow and the thymus revealed that the CD45+EpCAM+ population 
increased in number with progressive age in the BM, whereas the number of CD45+EpCAM+ 
cells decreased in the thymus with increasing age. It is well established that with advancing age, 
HSC number in the bone marrow increases, but the cells lose their pluripotency and self-renewal 
capacity (299-301). In line with these findings, it is also established that BM cells lose homing 
efficiency with advancing age (302). These previous findings might explain why an increase in the 
number of CD45+EpCAM+ cells were observed in the BM while, at the same time, it declines in 
the thymus. The CD45+EpCAM+ population in the BM may lose its differentiation and homing 
capacity leading to a reduced capacity to home to the thymus with increasing age. It is also possible 
that this decline in the CD45+EpCAM+ cells may contribute to the progressive loss of mTECs 
and promiscuous gene expression observed during thymic involution.  We have shown that 
CD45+EpCAM+ cells give rise to FSP1-expressing cells in the thymus and maybe the main source 
of the FSP1 expressing fibroblast population in the thymic stroma. Sun et al. have demonstrated 
that FSP1 expressing cells play a critical role in medullary thymic epithelial cell maintenance in 
the adult thymus (need reference here). We have also shown that the CD45+EpCAM+ cell 
population also contributes to the TEC population. Loss of CD45+EpCAM+ cells with progressing 
age may cause loss of FSP1+ cell population, which plays a crucial role in mTEC maintenance in 
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the postnatal thymic stroma. Loss of this TEPC population with progressive age might be 
instrumental in losing thymic epithelial cellularity in the aging thymus and contributing to age-
associated thymic involution.  
Given that we are proposing that the CD45+EpCAM+ subset represents a progenitor or 
stem cell population, we wanted to know if they express surface characteristics used to define stem 
cells. Osada et al.2013 and Wong et al. 2014 have previously characterized the TEPC population 
as EpCAM+MHCIIloCD49f+CD29+ (102, 109). We analyzed thymus-derived and bone marrow 
CD45+EpCAM+ cells for the same set of markers, as shown by Osada et al.2013 (109)  and Wong 
et al. 2014 (102) at different time points (4-month to 12-month-old). This analysis revealed that 
both of these populations express the same set of markers. This data indicates the TMSC 
population defined by Osada et al. 2013, might arise from the CD45+EpCAM+ population.  With 
progressive age, the frequency of the CD49f+CD29+ subset decreases in the MHCIIloSca1+ 
population. CD49f and CD29 are regularly expressed on stem cells and play an essential role in 
the maintenance of the stem cell niche. CD49f is an evolutionary biomarker for several stem cell 
populations. It has been demonstrated that CD49f or α6 integrin plays a vital role in tethering the 
stem cell population to their protective niche (291). Tumbar et al. 2004 showed that CD49f and 
CD29 help skin stem cells remain quiescent in their niche (292). Other studies have demonstrated 
that tight regulation of CD49f/CD29 in the stem cell population is essential for maintaining the 
stem cell's pluripotency and remaining quiescent in its niche (291). Notta et al. 2011 showed that 
a single CD49f+ cell could generate a long-term multi-lineage graft (293). Additionally, they 
identified that the loss of CD49f expression causes transient engraftment of multipotent 
progenitors (293).  Our result shows that the CD45+EpCAM+ population expresses thymic 
epithelial stem cell markers MHCIIloSCA1+CD49f+CD29+, but with progressive age, this 
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population loses expression of these markers. It is probable that the loss of these stem cell markers 
decreases the differentiation capability of this population and contributes to involution. 
 Some studies demonstrated that the bone marrow derived cells can be mobilized towards 
different epithelial organs and contribute to those epithelial tissues only in response to injury. For 
example, Wong et al. 2009 showed that BM-derived cells migrate to the naphthalene-induced 
injured lung tissue and contribute to the alveolar epithelial cell population. In our study, we used 
two different thymic injury models (183, 276).  
BM-derived CD45+EpCAM+ cells were analyzed for expression of Sca1, CD49f, CD29, 
and CD34. Like the thymus-derived DP population, our analysis revealed that the Sca1 expression 
remained almost the same at all time points. Interestingly the CD45+EpCAM+Sca1+ population 
mainly had CD49f-CD29+ cells rather than the CD49f+CD29+ subpopulation observed in the 
thymus. Additionally, we observed that the CD49f+CD29+ population remained almost the same 
throughout the time point, whereas the CD49f-CD29+ population showed a gradual decrease in 
number with progressive aging. This result revealed that a subset of the BM-derived 
CD45+EpCAM+ population expresses thymic epithelial stem cell markers, which strengthens our 
hypothesis the thymus-derived CD45+EpCAM+ population is derived from the bone marrow-
derived CD45+EpCAM+ cells. It is possible that the BM-derived CD45+EpCAM+ cell has a high 
frequency of CD29+ cells, as CD29 expression is important for cell migration via blood, as well 
as for maintenance of stem cell populations. We hypothesized that CD29 expression regulates the 
migration of the CD45+EpCAM+ population to the thymus.  
It has been previously demonstrated that the CD34+ bone marrow cells can contribute to 
the repair of the heart after myocardial infarction in the heart as well as to the hepatocyte of the 
liver. Another study also demonstrated that the CD34+ BM population could be mobilized in 
138 
 
response to skin injury. They also found that this population contributes to injury repair.  In this 
study, CD34 expression was examined in the BM-derived CD45+EpCAM+ cells with age.  It was 
found that a high frequency of CD45+EpCAM+ cells express CD34 in young mice; however, the 
CD34+ frequency decreases significantly in the 12-month-old bone marrow. One possible 
explanation of this result is that with progressive age, the BM-derived DP population loses its stem 
cell-like properties.  
To understand whether the CD45+EpCAM+ population is mobilized when thymic 
reconstitution is necessary, we used castrated mice to analyze the effect of thymic reconstitution 
on CD45+EpCAM+ cells. Our data demonstrated that following castration, the number of the 
CD45+EpCAM+ cells increased significantly in the thymus but decreased in the BM (Figure 4.5). 
We also observed a significant loss of stem cell markers, CD49f, and CD29 expression in these 
two populations. This set of results indicates that castration induces migration of the 
CD45+EpCAM+ cells from bone marrow to the thymus, resulting in the higher frequency of 
CD45+EpCAM+ cells observed in the thymic stroma following castration induced thymic 
reconstitution. Subsequently, the further loss of CD49f expression following castration recovery 
in the thymus may be responsible for the temporary recovery of thymic epithelial cellularity.  
 To understand how BM-derived cells migrate to the thymus, we analyzed both the BM and 
thymic derived CD45+EpCAM+ populations for their chemokine and chemokine receptor 
expression using a qPCR array. These results revealed that both CD45+EpCAM+ populations 
analyzed express both chemokines and their receptors, which is unique.  Both the BM and thymus-
derived CD45+EpCAM+ populations express CCR7 and CCR9, indicating that this population 
might be using the same chemokine ligand-receptor axis as used by immature thymocytes. 
Interestingly, we also found that both CD45+EpCAM+ populations express CCR10 and CXCL12. 
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CXCL12/CXCR and CCL27/CCR10 axis are important for HSC migration.  Previous studies have 
demonstrated that CD34+BM cells express CCR10. CCR10 plays an essential role in the migration 
of the BM-derived stem cells toward injured tissue and contributes to tissue repair (309). CXCL12 
is important for the mobilization of BM cells towards tissue injury(170). It will be interesting to 
investigate which chemokines or chemokine receptors will be upregulated under the injury 
condition. Future study will be interesting to analyze how the chemokine ligand and chemokine 
receptor expression patterns of the CD45+EpCAM+ population change with progressive age. 
To summarize, the CD45+EpCAM+ population is HSC derived unique stem cell-like 
population found in both the bone marrow and thymus. However, with progressive age, both the 
thymic and bone marrow CD45+EpCAM+ population lose their stem cell-like properties. The loss 
of stem cell-like properties by these potential progenitor populations might explain why even after 
this population is present in the thymus, the thymus still undergoes age-related involution and why 
thymic reconstitution is transient. Analysis of mice following hematopoietic stem cell 
transplantation revealed this population is mobilized in response to radiation-induced thymic tissue 
injury. These results indicate that the CD45+EpCAM+ population may play an important role in 
thymic repair.  
 Further analysis of the CD45+EpCAM+ population is necessary to understand if this 
population can migrate to other epithelial organs and contribute to tissue maintenance. Even 
though our chemokine and receptor array analysis revealed upregulation of several chemokines 
and chemokine receptors, it is important to understand which chemokine ligand-receptor pair is 
important for the migration of these cells and if this chemokine and chemokine receptor expression 
pattern remains the same with advancing age. As explained in the previous chapter, the 
CD45+EpCAM+ population in RTOC is mainly found in the cortical region, but not enough 
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evidence was gathered to understand if this population can differentiate into cTECs and /or 
mTECs. But the fetal thymus engraftment experiment showed that at later time points, this 
population could express DEC205, a TEPC marker.  Taking these two results into consideration, 
a future study should be conducted to understand if this population can contribute to both cTEC 
and mTEC or give rise to only one of the TEC population.  
Figures & Figure legends: 
Figure 4.1 
 
Figure 4.1. The CD45+EpCAM+ population in the bone marrow is derived from HSCs. The 
representative figure shows the presence of GFP+ donor cells in the thymus after hematopoietic 
stem cell transplant at different time points (5 weeks – 20 weeks). Panel A-C shows the analysis 
141 
 
of thymus 5 weeks post-transplant: A) shows the frequency of the CD45+EpCAM+population; B) 
Donor cell frequency in CD45+EpCAM+ cells, C) Donor cell frequency in CD45+EpCAM-cells 
Panel D-F) shows the analysis of thymus 6 weeks post-transplant: D) shows the frequency of the 
CD45+EpCAM+population; E) Donor cell frequency in the CD45+EpCAM+ cells, F) Donor cell 
frequency in CD45+EpCAM-cells; Panel G-I) shows the analysis of thymus 20 weeks post-
transplant: G) Shows the frequency of the CD45+EpCAM+population; H) Donor cell frequency 
in CD45+EpCAM+ cells, I) Donor cell frequency in CD45+EpCAM- cells; Panel J-K) compare 
the absolute number of  GFP-expressing donor cells in different subsets following BMT, including 
the CD45+EpCAM+ population (J); the CD45 population (K). Error bars represent SEM. "*" 
indicates a statistically significant difference between any two time points. All the experiments 
















Figure 4.2. The thymic CD45+EpCAM+ population is derived from HSCs. The representative 
figure shows the presence of GFP+ donor cellsin the thymus at various times (5 weeks – 20 weeks) 
following hematopoietic stem cell transplant. Panel A-D shows the analysis of thymus 5 weeks 
post-transplant: A) shows the frequency of the CD45+EpCAM+population; B) Donor cell 
frequency in CD45+EpCAM+ cells, C) Donor cell frequency in CD45-EpCAM+ cells; D) Donor 
cell frequency in CD45+EpCAM- cells; Panel E-H) shows the analysis of thymus 6-weeks post-
transplant; E)shows the frequency of the CD45+EpCAM+population;F) Donor cell frequency in 
CD45+EpCAM+ cells; G) Donor cell frequency in CD45-EpCAM+ cells; H) Donor cell frequency 
in CD45+EpCAM- cells; Panel I-L) shows the analysis of thymus 20 weeks post-transplant; I) 
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shows the frequency of the CD45+EpCAM+population; J) Donor cell frequency in 
CD45+EpCAM+ cells; K) Donor cell frequency in CD45-EpCAM+ cells L) Donor cell frequency 
in CD45+EpCAM- cells; Panel M-O) compare the absolute number of GFP-expressing donor cells 
in different subsets following BMT, including the CD45+EpCAM+ population (M); the EpCAM+ 
population (N); and the CD45+ population(O). All the experiments were done in 3-4 replicates. 





















Figure 4.3. CD45+ EpCAM+ cells are found as early as embryonic day 13.5 and persist throughout 
gestation. Panel A-B shows CD45+EpCAM+ cell frequency (A) and their Sca1 expression level 
in the CD45+EpCAM+ population(B) at E13.5. Panel C-D shows CD45+EpCAM+ cell frequency 
(C) and their Sca1 expression level in the CD45+EpCAM+ population(D) at E15. Panel E-F shows 
CD45+EpCAM+ cell frequency (E)and their Sca1 expression level in the CD45+EpCAM+ 













Figure 4.4. The thymic CD45+EpCAM+ population expresses adult the TEC progenitor markers, 
Sca1, CD49f, and CD29.  Representative figure showing expression of the adult TEC progenitor 
markers MHCII, Sca1, CD49f, and CD29 in the thymus-derived CD45+EpCAM+ population at 
different time points (4 month – 12-month). Panel A (i-vi) stem cell expression profile of 
CD45+EpCAM+ population in 4-month-old thymus. Panel B (i-vi) stem cell expression profile of 
CD45+EpCAM+ population in 8-month old thymus; Panel C (i-vi) stem cell expression profile of 
CD45+EpCAM+ population in 10-month old thymus; Panel D (i-vi) stem cell expression profile 
of CD45+EpCAM+ population in 12-month old thymus; Panel E (i-vi) stem cell expression profile 
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of CD45+EpCAM+ population in CD45+EpCAM+population in post-castration regenerated 




Figure 4.5. The bone marrow CD45+EpCAM+ population expresses the adult TEC progenitor 
markers, Sca1, CD49f and CD29.  Representative figure showing expression of the adult TEC 
progenitor markers MHCII, Sca1, CD49f, and CD29 in the bone marrow-derived CD45+EpCAM+ 
population at different time points (4 month – 12-month) Panel A -C) Bone marrow analysis of 4 
month old mouse A) CD45+EpCAM+ frequency, B) Sca1 frequency in CD45+EpCAM+ cells, C) 
CD49f and CD29 expression in CD45+EpCAM+Sca1+ population.  Panel D -F) Bone marrow 
analysis of 8 month old mouse D) CD45+EpCAM+ frequency, E) Sca1 frequency in 
CD45+EpCAM+ cells; F) CD49f and CD29 expression in CD45+EpCAM+Sca1+ population; 
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Panel G -I) Bone marrow analysis of 10 month old mouse G) CD45+EpCAM+ frequency; H) Sca1 
frequency in CD45+EpCAM+ cells; I) CD49f and CD29 expression in CD45+EpCAM+Sca1+ 
population;  Panel J-L) Bone marrow analysis of 12 month old mouse J) CD45+EpCAM+ 
frequency, K) Sca1 frequency in CD45+EpCAM+ cells, L)CD49f and CD29 expression in 
CD45+EpCAM+Sca1+ population;Panel M-N) Bone marrow analysis of 2 weeks old post 
castration of 12-month-old mouse; M) CD45+EpCAM+ frequency; N) Sca1 frequency in 
CD45+EpCAM+ cells; O) CD49f and CD29 expression in CD45+EpCAM+Sca1+ population. All 
the experiments were done in three to five replicates. 
Figure 4.6 
 
Figure 4.6. The bone marrow CD45+EpCAM+ population expresses the adult thymic 
mesenchymal stem cell marker CD34.  Representative figure showing expression of the adult TEC 
progenitor markers CD34 in the bone marrow-derived CD45+EpCAM+ population at different 
time points (4 month – 12-month) Panel A -B) Bone marrow analysis of 4 month old mouse A) 
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CD45+EpCAM+ frequency, B) CD34 frequency in CD45+EpCAM+ cells; Panel C- D) Bone 
marrow analysis of 8 month old mouse C) CD45+EpCAM+ frequency; D) CD34 frequency in 
CD45+EpCAM+ cells; Panel E -F) Bone marrow analysis of 10-month-old mouse E) 
CD45+EpCAM+ frequency, F) CD34 frequency in CD45+EpCAM+ cells; Panel G-H) Bone 
marrow analysis of 12-month-old mouse G) CD45+EpCAM+ frequency, H) CD34 frequency in 
CD45+EpCAM+ cells. Panel I-J) Bone marrow analysis of 2 weeks old post castration of 12-
month-old mouse G) CD45+EpCAM+ frequency; H) CD34 frequency in CD45+EpCAM+ cells. 





Figure 4.7. Change in CD45+EpCAM+ population frequency with progressive age. A. Graphical 
representation of the absolute number of BM-derived CD45+EpCAM+ cells/lobe at different time 
points. B. Graphical representation of an absolute number of thymus-derived CD45+EpCAM+ 
cells/animal at different time points. All the experiments were done in three to five replicates. Error 








Figure 4.8 A. Graphical representation of the absolute number of BM-derived CD45+EpCAM+ 
cells two weeks after castration of 12-month-old C57BL6 mouse; B. Graphical representation of 
the absolute number of thymus-derived CD45+EpCAM+ cells/lobe after castration of 12-month-
old C57BL6 mouse. All the experiments were done in three to five replicates. Error bars represent 
SEM. "*" indicates a statistically significant difference between any two time points.  
 
Table 2: Genes over-expressed in BM-derived CD45+EpCAM+ population relative to the BM 







A02 Ackr2 5.31 
  
A03 Ccl1 5.52 
  
A04 Ccl11 45.81 A 
 




A08 Ccl2 4.05 A 
 
A09 Ccl20 3.17 
  
A10 Ccl22 8.44 
  
A11 Ccl24 6.35 
  
B01 Ccl26 70.53 
  
B02 Ccl28 98.14 
  
B07 Ccl7 12.46 
  
B08 Ccl8 6.96 
  
B11 Ccr10 136.05 
  
B12 Ccr1l1 288.98 
  
C03 Ccr4 43.67 
  
C05 Ccr6 8.09 
  
C06 Ccr7 11.72 
  
C07 Ccr8 3.03 
  
C08 Ccr9 2.56 
  
C09 Ackr4 2.81 
  
C10 Ccrl2 2.08 A 
 
C11 Cmklr1 41.32 
  
C12 Cmtm2a 13.04 
  
D02 Cmtm4 3.57 
  
D03 Cmtm5 6.62 
  
D04 Cmtm6 12.57 A 
 

























D07 Cxcl1 66.21 
  
D08 Cxcl10 46.29 A 
 
D09 Cxcl11 3.06 
  
D10 Cxcl12 12.19 
  
D11 Cxcl13 25.45 
  
D12 Cxcl14 14.27 
  
E01 Cxcl15 4.51 
  
E02 Cxcl16 3.70 
  
E03 Cxcl2 6.81 A 
 
E04 Cxcl3 64.03 
  
E05 Cxcl5 136.05 C 
 
E06 Cxcl9 14.47 
  
E07 Cxcr1 4.15 
  
E11 Cxcr5 106.66 
  
F01 Ackr3 3389.94 
  
F04 Gpr17 5.62 
  
F05 Hif1a 5.37 A 
 
G04 Ppbp 2.02 
  
G05 Slit2 2.49 
  
G10 Tymp 6.69 
  
H02 B2m 14.68 
  





Table 3: Genes over-expressed in the thymus-derived CD45+EpCAM+ population compared BM-







A02 Ackr2 2.55 
  
A03 Ccl1 5.37 
  
A04 Ccl11 5.75 
  
A05 Ccl12 13.03 
  
A06 Ccl17 6.91 
  
A07 Ccl19 10.42 
  
A09 Ccl20 7.77 
  
A10 Ccl22 13.42 
  
A12 Ccl25 19.17 
  
B02 Ccl28 4.09 
  
B07 Ccl7 21.30 
  
B08 Ccl8 16.36 
  
B11 Ccr10 131.45 
  
B12 Ccr1l1 131.46 
  
C03 Ccr4 7.65 
  
C05 Ccr6 16.28 A 
 




C07 Ccr8 5.22 
  
C08 Ccr9 25.13 A 
 
C09 Ackr4 2.70 
  
D05 Cx3cl1 3.70 
  
D07 Cxcl1 20.49 
  
D08 Cxcl10 10.47 
  
D10 Cxcl12 2.96 
  
D12 Cxcl14 7.21 
  
E02 Cxcl16 14.09 A 
 
E04 Cxcl3 27.71 A 
 
E05 Cxcl5 74.51 
  
E06 Cxcl9 7.99 
  
E11 Cxcr5 6.96 
  
F01 Ackr3 216.18 
  
F04 Gpr17 4.45 
  
G09 Tnf 2.28 
  
G10 Tymp 5.04 
  
G11 Xcl1 2.84 
  
 
A: This gene's average threshold cycle is relatively high (> 30) in either the control or the test 
sample and is reasonably low in the other sample (< 30). 
These data mean that the gene's expression is relatively low in one sample and reasonably detected 
in the other sample suggesting that the actual fold-change value is at least as large as the calculated 
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and reported fold-change result. 
This fold-change result may also have greater variations if the p value > 0.05; therefore, it is 
important to have a sufficient number of biological replicates to validate the result for this gene. 
C: This gene's average threshold cycle is either not determined or greater than the defined cut-off 
(default 35), in both samples meaning that its expression was undetected, making this fold-change 








































Characterization of Active Canonical Wnt Signaling in the Fetal Thymic Stroma During 
Embryogenesis & in the Regenerated Thymic Stroma 
 
5.1. INTRODUCTION 
The thymus is a three-dimensional framework of epithelial cells and fibroblasts essential 
for developing a functional adaptive immune system (111, 316). It generates the naïve, self-
tolerant T-cell population from hematopoietic stem cells. T-cell lineage commitment and 
development is heavily dependent on the interaction with the two distinct epithelial 
microenvironments found in the thymic stroma: the cortex and the medulla. Early thymocyte 
progenitors commit to T-cell fate in the cortex and undergo molecular processes to express 
functional T-cell receptors (260).  Cortex is also responsible for T-cell lineage ( CD4+ and CD8+ 
SP T-cells) determination. The thymic medulla is responsible for the negative selection of SP T-
cell to develop a self-tolerant T-cell repertoire (260).  
The development of thymic epithelial microenvironments from the third pharyngeal pouch 
endoderm is a complex process and is still not fully understood. Organogenesis of the thymus is 
linked to the parathyroid gland (86). The co-expression of a group of transcription factors that 
consists of homeobox A3 (Hoxa3), paired box gene 1 (Pax1), Pax9, eyes absent 1 homologue 
(Eya1), and sine oculis-related homeobox 1 homolog (Six1) are crucial for the formation and 
patterning of the thymus/parathyroid rudiment from the 3rd pharyngeal pouch endoderm (317). 
Additionally, proper separation of the thymus and parathyroid primordia from the common 
bilateral primordium is driven by two transcription factors, Gcm2 (glial cells missing homolog 2) 
and FoxN1 (Forkhead family transcription factor).  Gcm2 was expressed in the pharyngeal 
endoderm's parathyroid specific region, whereas the thymus specific region expressed FoxN1 
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(Forkhead family transcription factor) (13).  Apart from separation from the parathyroid 
primordium, FoxN1 is also important for the thymus' proper development (96). Previous studies 
demonstrated that FoxN1 expression in thymic primordia is regulated by the Wnt signal 
transduction pathway (31).  
The canonical Wnt signaling pathway also plays an important role in the development and 
proliferation of thymic stroma (245). Wnt ligands are evolutionarily conserved glycoproteins that 
regulate cell fate, polarity, migration, and growth (206). The canonical Wnt signaling pathway is 
activated when the Wnt ligands interact with Frizzled (Fzd receptors) and co-receptors, low-
density lipoprotein receptor-related protein (LRP )- 5 or -6. The destruction complex, which 
comprises adenomatous polyposis coli (APC), Axin, and glycogen synthase kinase-3β (GSK-3β), 
releases Axin from the destruction complex. By inhibiting the phosphorylase activity of GSK-3β, 
β-catenin is no longer phosphorylated and marked for degradation. After accumulating in the 
cytoplasm, it is eventually imported into the nucleus and is able to form a complex with 
transcription factors LEF-1 (Lymphoid Enhancer Factor) and T cell factors such as TCF-1, TCF-
3, or TCF-4 (200, 205). The binding of β-catenin to the TCF and LEF transcription factors activates 
the expression of β-catenin-dependent responsive genes (214).  
Canonical Wnt Signaling plays an essential role in thymocyte development. Tcf1−/− mutant 
mice show a severe reduction of thymic cellularity. This transgenic mouse also shows a partial 
block in CD4+CD8+ double-positive (DP) thymocyte production (318). Tcf1−/− mice showed a 
severe decrease in thymocyte proliferation capability (319). Several studies have shown that the  
Wnt signaling has an extensive role in hematopoietic stem cell self-renewal, maturation of 
dendritic cells, T-cell development, activation, and peripheral T-cell migration (205, 239-242).  
157 
 
Apart from its role in thymocyte development, Wnt signaling also has a role in developing 
and maintaining the thymic epithelium. Lymphostromal crosstalk is essential for the development 
and maintenance of the thymic epithelial architecture. For instance, the absence of Wnt4 ligand 
down-regulates fetal thymic expansion, which causes a decrease in TEC numbers, early thymic 
progenitor cells, and DN2 thymocytes (320). Another study found that mice with a FoxN1 specific 
deletion of APC can stabilize canonical β-catenin-Wnt signaling. They also demonstrated that 
these transgenic mice are unable to form a proper thymus (243). It has been previously shown that 
the constitutive activation of Wnt-signaling via a gain-of-function mutation of β-catenin changes 
the earlier commitments of the endodermal epithelial cells to thymic fate (246). This mutation also 
disrupts the thymic stroma organization as well as thymocyte recruitment by TECs (246). 
Our lab previously demonstrated that inhibiting canonical β-catenin-Wnt signaling also 
disrupts the thymus architecture (241). In this study, double transgenic (tetO-Dkk1; K5rtTA) mice 
were used, which in the presence of doxycycline produce high levels of Dkk1 in both mTECs and 
cTECs, which leads to the inducible inhibition of the canonical Wnt signaling, and subsequently a 
decrease in the TEC proliferation. Inducible inhibition of canonical Wnt signaling also causes a 
reduction in all the TEC subsets (including the K5+K8+DP TECs thought to contain TEPCs) and 
a rapid premature thymic degeneration similar to that observed in very old mice.  
Thymic involution is the biggest paradox of immunology. Thymic involution is roughly 
characterized by loss of the thymic size, decreased TEC number, adipogenesis, and loss of thymic 
function.  Inducing regrowth, albeit transient, is possible by castration, which has long been 
considered a possible intervention in age-related degeneration of the thymus (146). However, the 
regrown thymus' qualitative nature is far more similar to an aged thymus than a young thymus (7). 
Most importantly, the canonical Wnt signaling pathway is the most significant pathway 
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characterized by down-regulated genes in both aged and regenerated cortex compared to a young 
cortex (7). Some studies demonstrated that the suppression of β-catenin-Wnt signaling is one of 
the parameters involved in the complex process of thymic involution (6). This supports a vital role 
for Wnt signaling in the maintenance of the thymus. 
Despite the knowledge of thymic organogenesis and the role of canonical Wnt signaling in 
the maintenance of the adult thymus and its role in the degeneration of the aged thymus, the role 
and significance of canonical WNT signaling in fetal thymic development is unknown. Moreover, 
no mapping of active Wnt signaling has been performed in either the postnatal, fetal or regenerated 
thymus. 
This study aims to use a relatively novel Wnt reporter mouse model, TCF/LEF: H2B-GFP, 
to identify cells undergoing active WNT signaling. The TCF/Lef: H2B/GFP Wnt transgenic 
reporter mouse has six copies of a TCF/Lef responsive element and an hsp68 minimal promoter in 
front of a fluorescent protein fusion comprising human histone H2B fused to GFP. Nuclear-β-
catenin and its transcriptional co-activators, TCF/Lef, interact with the TCF/Lef responsive 
elements to initiate GFP expression (321). This transgenic model affords the ability to assess real-
time changes in canonical Wnt signaling in individual cells in the thymic stroma. Preliminary 
analysis using this model identified active canonical Wnt signaling in the postnatal thymus. It 
showed that Wnt signaling is primarily restricted to the thymic medulla characterized by 
UEA1+K14+ mTECs in addition to Aire-expressing mTECs essential for self-tolerance (data not 
shown). These results suggest a previously unknown role for canonical Wnt signaling in the 
development of this critical TEC subset. Thus, this study aims to identify specific cell types 
undergoing active Wnt signaling during fetal development at specific timepoints and in the 
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regenerated thymus. This study provides a roadmap of active Wnt signaling during fetal thymus 
development.  
5.2. RESULTS 
This study utilized the TCF/Lef: H2B/GFP Wnt transgenic reporter mouse to characterize 
which cells were undergoing canonical Wnt signaling during crucial stages during the fetal thymic 
stroma development.  
Canonical Wnt Signaling in the Fetal thymic stroma. 
We wanted to understand whether Wnt signaling plays a role in mTEC development in the 
fetal thymus or whether the Wnt signaling that is mostly restricted to mature mTECs in adult mice 
represents a postnatal phenomenon.  Given the critical role of mature mTECs in PGE and self-
tolerance, it is important to understand what role Wnt signaling might play in the initial development or 
maintenance of Aire and Fezf2 expressing mTECs. We used the fetal thymus from embryonic day 
13.5 (E13.5) to embryonic day 19.5 (E19) for flow cytometric analysis to focus on the time where 
the TECs transition from bipotent progenitor cells at E13.5 to defined cortical and medullary 
regions with mature mTECs and Aire-expressing cells beginning at E16.5-19.5.  In the FACS 
analysis of fetal thymic stroma, thymic epithelial cells were identified as the CD45, a 
hematopoietic cell marker, negative, and EpCAM, a well-established thymic epithelial cell marker, 
positive population. Nuclear H2B-GFP expression identified the cells undergoing canonical Wnt 
signaling. C57BL6 mouse fetal thymus was used as a control for GFP expression in the Wnt 
reporter mice.   
 To analyze whether the fetal thymic stroma undergoes Wnt signaling, the frequency and 
absolute number of GFP expressing cells in single-cell suspensions derived from enzymatically 
dissociated thymic stroma was analyzed using flow cytometry. Analysis of the E13.5-E19.5 fetal 
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thymus revealed that the overall frequency of cells undergoing Wnt signaling in the fetal thymic 
stroma decreases with progressive embryonic age. We analyzed both the frequency and absolute 
number of GFP expressing cells in the fetal thymic stroma (includes both EpCAM+ and EpCAM- 
population) at different time points. At E13.5 and E14.5, the average frequency of cells undergoing 
Wnt signaling in the thymic stroma remained 14% (+/-2.9). The GFP frequency started to decrease 
from E15.5, with an average of 5.0% (+/-2) followed by an average of 1.8% (+/-1.2) at E16.5. At 
E17.5, GFP expression frequency decreases further with an average of 0.74%(+/ 0.1). At E18.5 
and E19.5, the average frequency of GFP expressing cells was observed to remain the same, 0.4(+/-
.2). Even though the frequency of cells undergoing Wnt signaling decreased with advanced fetal 
age, the absolute number of those cells per lobe revealed a different pattern. The absolute number 
of GFP expressing cells increases from an average of 947(+/- 105) at E13.5 to an average of 
7575(+/-2212) at E16.5. Interestingly, from E17.5, the number of GFP expressing cells starts to 
decline to show an average of 7066(+/-1112). The cell number remained almost the same, with an 
average of 966 (+/-365) at E18.5 and 996 (+/-468) at E19.5. From this result, it is evident that 
during embryonic day E13.5 -E15.5, a large frequency of TECs undergo active Wnt signaling, but 
the number rapidly decreases from E16.5. It has been previously demonstrated that during the 
E16.5-E19.5 developmental period, a defined cortical and medullar region with mature mTECs 
and Aire-expressing cells started to appear. So, we hypothesized that Wnt signaling is essential for 
thymic epithelial cell patterning.  The bar graph representing the number of cells undergoing Wnt 
signaling per thymic lobe at different time points is shown in Figure 5.1X. In the CD45-expressing 
hematopoietic cells, the GFP expression was negligible (data are not shown). This result suggests 
that the Wnt reporter gene is not expressed within the thymocyte subset or that active Wnt signaling 
does not occur in the fetal thymocytes. 
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Next, the frequency of EpCAM+ thymic epithelial cells in the thymic stroma at different 
embryonic days was analyzed.  This analysis showed that from E13.5 to E17.5, TEC frequency 
decreased gradually. At E13.5, the average TEC frequency was 11% (+/-5), which subsequently 
reduced to an average of 1.1% ( +/-0.3) at E17.5. But at E18.5 and E19.5, the TEC frequency 
increased to an average of 4% (+/-1.5) (Figure 5.1). With progressive embryonic age, the thymus 
is populated with an increasing number of thymocytes. Because of the rising number of 
thymocytes, the epithelial cell frequency decreases.   At E18.5 and E19.5, the CD45+ population 
was depleted to enrich the thymic epithelial cell population resulting in an increase in the frequency 
of EpCAM+ cells at those time points. 
Additionally, the absolute number of thymic epithelial cells per lobe was also analyzed. As 
expected, the total number of thymic epithelial cells increases with the progressive embryonic day. 
The thymus dramatically grows during fetal development, ranging from an average as low as 950 
(+/-355) cells at E13.5 to an average of as high as 7085(+/-3700) cells at E19.5. The Bar graph 
representation of the absolutes number of Epithelial cells per lobe at different time points is shown 
in Figure 5.1V.  
Next, we analyzed both the frequency and the absolute number of GFP expressing TECs 
in the thymic stroma at different time points. At E13.5 and E14.5, the average frequency of TECs 
undergoing active Wnt signaling was 78.65% (+/-15.1). The GFP frequency started to decrease 
gradually from E15.5. At E18.5 and E19.5, a sharp decrease in the frequency of GFP expressing 
cells was observed. At E18.5, GFP+ cell frequency had an average of 16.83% (+/-6.7), and at 
E19.5, the average frequency was 17.14% (+/-4.1). But when the absolute number of TECs 
undergoing Wnt signaling was analyzed, it gradually increased with progressive timepoint from 
an average of 958 (+/-221) cells at E13.5 to an average cell number of 6615 (+/-2500) at E16.5. 
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The number of EpCAM+cells undergoing Wnt signaling started to decrease from an average of 
5088, +/- 1116 cells at E17.5 to an average of 2023, +/-937 cells at E19.5.  From this analysis, it 
is evident that, like the total stromal cells undergoing Wnt signaling, active Wnt signaling in the 
TECs first increases in the early embryonic stage (E13.5-E16.5) followed by a decrease in the late 
embryonic stage (E17.5-E19.5). This result indicates TECs are the primary source of Wnt 
signaling in the fetal thymus. FACS representation of EpCAM+ GFP+ population at different 
embryonic days are shown in the second column of figure 5.1. Figure 5.1 W shows the bar graph 
representing the number of epithelial cells undergoing Wnt signaling at different time points. 
Next, we wanted to understand which TEC population undergoes active Wnt signaling 
during fetal thymus development. In the adult thymus, active Wnt signaling was primarily 
observed in the medulla, specifically in the AIRE expressing mature mTEC.  In the fetal thymus, 
the AIRE expressing mature mTECs appear during late embryogenesis (from E16.5). Few studies 
have demonstrated that mature mTECs are developed from the bi-potent TEPCs (92, 106). Bi-
potent TEPCs are observed in the thymic stroma as early as embryonic day 11.  A previous study 
has shown that at E12.5, the fetal thymus has a homogeneous population of TECs. They also 
demonstrated that if a single TEC from the E12.5 thymic stroma is transplanted in the fetal thymus, 
it differentiates into cTECs and mTECs (92).  Later, other studies explained that in the early stages 
of thymic development, at E11.5-E12.5, a subpopulation of FoxN1 expressing TEPCs express 
CD205, a cTEC marker. At a later embryonic day, E13.5, this CD205+ population upregulates 
expression of mTEC marker CD40. This distinct population at E13.5 expressing both cTEC and 
mTEC marker undergoes a further change of phenotype in the following embryonic days. At 
E14.5, a subset of this population mentioned above downregulates CD205 expression and only 
express CD40. These CD40+ mTEC progenitor cells then interact with SP thymocyte to develop 
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into mature mTECs in later embryonic days. CD205+CD40+ progenitor cells in E14.5 get further 
differentiated into mature cTECs. Interaction between DN thymocytes and immature 
CD205+CD40+ immature cTECs is necessary for cTEC maturation.  We wanted to understand at 
what point during the crosstalk dependent stages of fetal development that result in the formation 
of distinct functional regions of the thymic stroma, and Wnt signaling became restricted to mTECs. 
For that purpose, FACS data of the fetal CD45-EpCAM+ TEC population was further analyzed to 
distinguish between cortical and medullary TECs, by using BP1 as a cTEC marker and UEA1 as 
an mTEC marker. The BP1 and UEA1 staining pattern of the EpCAM+ TECs revealed the 
existence of four distinct populations:1) BP1+UEA1- (cTEC), 2) BP1-UEA1+(mTEC), 3) 
BP1+UEA1+, and 4) BP1- UEA1-. Previous work by others analyzing TECs using these two 
markers has shown these four populations but have not discussed their significance. 
Active Wnt signaling is first observed in EpCAM+BP1-UEA1- population 
First, we analyzed both the frequency and the absolute number of the EpCAM+BP1-
UEA1- population. We observed a decrease in the frequency of the EpCAM+BP1-UEA1-cells 
with advanced embryonic age. At E13.5, BP-UEA1- cells had the highest frequency, with an 
average of 85% (+/-16.5). The EpCAM+BP1-UEA1- population's frequency gradually decreased 
to an average of 10.54% (+/-3) at E16.5. But from E17.5 to E19.5, the frequency of the 
EpCAM+BP1-UEA1- population remained the same, with an average of 14.8% (+/- 5). Next, the 
EpCAM+BP1-UEA1- cell number revealed that at E13.5 and E14.5, the highest number of BP1-
UEA1- cells were present, with an average of 4128, +/-1200, and the number gradually decreased 
till E16.5, with an average of 963 (+/- 655). Interestingly, beginning at E17.5 BP1-UEA1- cell 
numbers started to increase again. At E19.5, the BP1-UEA1- cell number increased to an average 
of 2157,+/-1138 cells/lobe (figure 5.3A). From these results, it can be hypothesized that even 
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though from E17.5 to E19.5, the frequency of BP1+UEA1+ population remained the same, the 
absolute number of this population increased because the overall thymic epithelial cellularity 
increased with progressive embryonic age (figure 5.2).  
Next, the GFP expression in these cells was analyzed. At E13.5, an average of 590, +/-227 
cells in this population express GFP, followed by an increased average of 3332, +/-519 at E14.5. 
But at E15.5, the GFP+ cell number decreased, showing an average of 1476, +/-289 cells. From 
E16.5 to E19.5, the number remains very low and almost the same. FACS representation of 
GFP+BP1-UEA1- cells at different time points are shown in figure 5.2 v(A-G).  The Bar graph 
representation of total BP1-UEA1- cells undergoing Wnt signaling is demonstrated in Figure 5.3E. 
The frequency of GFP+ cells in the BP1-UEA1- population was also analyzed. We observed an 
average of 70% (+/-11) GFP+ cells at E13.5 and E14.5. From E15.5, the frequency of GFP 
expressing cells within the BP1-UEA1- population decreased gradually.  At E19.5, this population 
had an average of 9.46% (+/-8.33) GFP+ cells. 
To summarize, this analysis revealed that the EpCAM+BP1-UEA1- population had the 
highest frequency of cells undergoing Wnt signaling at early embryonic days E13.5 and E14.5, 
and this frequency decreased with progressive embryonic days. As explained before, EpCAM+ 
cells of the early fetal thymus differentiate into both cTECs and mTECs.  The EpCAM+BP1-
UEA1- population in this study might represent the same thymic epithelial progenitor population. 
From this result, it can be hypothesized that the EpCAM+ thymic epithelial progenitor population 
undergoes active Wnt signaling at the early stage of thymic organogenesis. This population 
becomes rare later, and these cells stop undergoing Wnt signaling as more defined TEC lineages 




Cortical thymic epithelial cells undergo active Wnt signaling in the fetal thymic stroma 
BP1 vs. UEA1 staining in FACS analysis revealed that EpCAM+ cells were mainly BP1-
UEA1- at E13.5 and E14.5. But from E15.5 majority of the EpCAM+ cells started to express BP1, 
shifting the cell density toward BP1+ cTECs (figure 5.2 i). So, the BP1+  cTEC population was 
analyzed for cells undergoing active Wnt signaling. Frequency analysis of the GFP+ cells in the 
EpCAM+BP1+UEA1- cTEC population revealed that from E13.5 to E16.5, an average of 61.67% 
(+/-10.87) was maintained (Figure 5.2 ii (A-D)). From E17.5, the frequency of GFP+ cTECs 
started to decrease with advancing embryonic age. E19.5 had the lowest frequency of GFP+ 
cTECs, with an average of 21.81(+/-9.4) (Figure 5.2 ii (E-G)). When the number of GFP 
expressing cTECs was analyzed, a gradual increase of the absolute cell number was observed with 
progressive embryonic age.  At E13.5, GFP+ cells had an average of 49, +/- 20.  GFP+ cells 
gradually increased to an average of 3936, +/-491 at E17.5. But the number started to decrease 
with an average of 1916, +/-965 at E18.5, followed by an average of 1562, +/-970 at E19.5(figure 
5.3F).  
The frequency and the absolute number of cTECs were also analyzed. We observed that 
with advancing embryonic day, the frequency of the BP1 expressing cTEC population increased 
gradually, from an average of 9.1% (+/-5) at E13.5 to an average of 80%(+/-5) at E19.5. Additional 
analysis of the BP1+ cell number revealed that from E13.5 to E19.5, BP1+ cTECs increased in 
number with progressive embryonic age (figure 5.3B).  
Baik et al. showed that at E11.5- E12.5, the fetal thymic epithelial progenitor cell 
population expresses CD205. At E13.5 this CD205-expressing population also starts expressing 
CD40, an mTEC marker (106, 270, 322). Additionally, another study has shown that a subset of 
CD205+ cells also express BP1 during fetal development. We hypothesized that the BP1+ cTEC 
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population also represents at least in part the CD205+ TEPCs. The shift of frequency in the FACS 
data showed that the BP1-UEA1- population progresses toward the BP1+ cortical epithelial cell 
population. Interestingly, in the early stages of thymic organogenesis (E13.5 to E16.5), this 
population has a high frequency of cells undergoing active Wnt signaling (~61%), which then 
started declining from E17. It is worth noting that during this period ( E13.5-E16.5) of thymus 
development, the first wave of thymocytes undergoes their developmental process,(315). It has 
been demonstrated previously that interactions with DP T-cells play a critical role in cTEC 
development (269). Taking our result and previously found information together, we can 
hypothesize that Wnt signaling might play a crucial role in the lymphostromal interaction essential 
for thymus development. It has been previously demonstrated that in response to inhibition of Wnt 
signaling, specifically Wnt4 expression, fetal and early postnatal thymic expansion is suppressed. 
Wnt4 suppression also decreases TEC numbers, early thymic progenitor cells, and thymocytes in 
the DN2 stage (320). It has also been demonstrated that suppression of canonical Wnt signaling 
disrupts thymic epithelial architecture (6). Keeping these previous findings in mind, it can be 
hypothesized that Wnt signaling in cortical thymic epithelial cells from E13.5 to E16.5 might be 
important for driving thymic epithelial progenitor cell differentiation toward different TEC 
lineages, particularly cTECs. 
Medullary thymic epithelial cells undergo active Wnt signaling in the fetal thymic stroma.  
Preliminary analysis using the TCF/LEF H2BGFP Wnt reporter model identified that 
active canonical Wnt signaling is primarily restricted to the thymic medulla characterized by 
UEA1+K14+ mTECs in addition to Aire+ mTECs essential for self-tolerance in the postnatal 
thymus. It is crucial to understand whether the Wnt signaling expression pattern changes in the 
fetal thymus to regulate mTEC development.  To analyze Wnt signaling during mTEC 
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development, medullary thymic epithelial cells were analyzed to identify mTECs undergoing 
active Wnt signaling in the fetal thymus. The mTEC population was defined as the EpCAM+BP1-
UEA1+ subset of TECs (figure 5.2 i). Analysis of both the frequency and the absolute number of 
EpCAM+BP1-UEA1+ cells revealed that this population expanded gradually with progressive 
embryonic age. It should be noted that this population emerged beginning at E15.5.  Analysis of 
the frequency of GFP+ mTECs revealed that it increases with progressive embryonic age. At 
E13.5, mTECs had the lowest frequency of GFP+ cells, with an average of 24% (+/-27), followed 
by a gradual increase to an average frequency of 51% (+/-13) at E16.5 (figure 5.2 iii). From E16.5 
to E19.5, the frequency of GFP+ mTECs remained the same, with an average of 52% (+/-16). 
Furthermore, when we analyzed the absolute number of GFP+ cells in the mTEC population, we 
observed that with progressive embryonic age, the number of GFP expressing mTEC increased 
gradually. At E13.5, very few GFP+ mTECs were observed. But with the progressive embryonic 
age, the number of GFP+ mTECs increased to an average of 555, +/-290 at E19.5 (figure 5.3G).   
Apart from the BP1-UEA1+ population, another UEA1 binding population, BP1+UEA1+, 
was observed in the fetal thymic stroma.  Frequency analysis of this small population revealed this 
population fully appeared from E15.5, with an average of 1.5% (+/-0.8), and this population 
maintained a steady frequency from E17.5-E19.5, with an average of 6% (+/-1). Frequency 
analysis of GFP+ cells in the BP+UEA1+ population revealed that this population maintains a 
steady frequency of GFP+ cells at all embryonic days, with an average of 25% (+/5). Additionally, 
the GFP+ cell number in the BP1+UEA1+ population revealed a gradual increase with progressive 
embryonic age. Previous work by others analyzing fetal TECs using BP1 and UEA1 has shown 
the presence of this population, but its significance was never discussed in detail before. Thymic 
epithelial cells expressing both cTEC and mTEC markers have been considered as TEPC 
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population before. Klug et al. showed the presence of this population in the MTS24+ fetal thymic 
stromal cell population, and they hypothesized the BP1+UEA1+ population represents potential 
TEPCs. But no further studies have been performed to confirm the validity of this hypothesis.   Our 
result demonstrated that this population appeared around the same time the BP1-UEA1+ mTEC 
population started to emerge. It is important to note that this population undergoes active Wnt 
signaling at the late embryonic stage along with the BP1-UEA1+ population.  Additionally, both 
this population maintained a steady frequency of GFP expressing cells from E16.5 to E19.5. 
Keeping this data in mind, we hypothesized BP1+UEA+ population might represent an immature 
mTEC population. We also hypothesized the small frequency of GFP+BP1+UEA1+ cells is 
undergoing active differentiation to contribute to the BP1-UEA1+ population. In future 
experiments, the BP1+UEA1+ population needs to be investigated more thoroughly to decipher if 
this population truly represent mTEC progenitor cells. 
To summarize the FACS analysis of changes in active Wnt signaling in the four TEC 
population defined by UEA1 and BP1, GFP expression is first observed in the EpCAM+BP1-
UEA1- and EpCAM+BP1+UEA- populations at E13.5 and E14.5.  At E15.5, the GFP+ cell 
frequency decreased in the BP1-UEA1- population and increased in the BP1+UEA1-, cTEC 
population. At E16.5, the GFP+ cTEC frequency started to decline, and the GFP+ BP1-UEA1+, 
mTEC, and GFP+BP1+UEA1+ cell frequency reached a steady state. Comparison between GFP+ 
cTECs and GFP+ mTECs revealed that during the early stage of embryogenesis, at E13.5-E15.5, 
the cortical epithelial compartment had a higher frequency of cells undergoing Wnt signaling than 
the medullary epithelial population (Figure 5.4). Previous studies have shown that EpCAM1+ cells 
of E12 thymic stroma represent the TEPC population. The EpCAM+BP1-UEA1- population in 
this analysis likely represent the same population mentioned above. Other studies have previously 
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shown that fetal epithelial cells expressing cTEC markers can give rise to cTECs and mTECs. The 
EpCAM+BP1+UEA1- population might include the TEPC population as well as cTECs. Our 
results indicate that the BP1-UEA1- and subsequently, the BP1+UEA1- TEPCs mainly undergo 
Wnt signaling in the fetal thymic stroma at early embryonic days. At the later stages of thymic 
development, cells undergoing active Wnt signaling were more frequent in medullary thymic 
epithelial cells. It is important to mention that even though the frequency of cells undergoing Wnt 
signaling decreased at the later stage of embryogenesis in BP1+cTECs, a small frequency of 
GFP+BP1+ cells was still observed in this population. From this analysis, it can be hypothesized 
that a high frequency of potential thymic epithelial progenitor cells undergoes active Wnt signaling 
to regulate differentiation of TEPCs to mature mTECs and cTECs.  
CD205 expressing fetal epithelial cells undergo active Wnt signaling. 
CD205/ DEC205 is a cortical thymic epithelial progenitor cell marker. Previously it has 
been demonstrated that the CD205+ cells also represent the bi-potent thymic epithelial progenitor 
population (106). In our FACS analysis, BP1 was used as a cTEC marker. As explained in the 
previous section, the BP1+UEA1-, cTEC population undergoes active Wnt signaling at the early 
stages of thymic development. It has been previously demonstrated that a subset of IL7 expressing 
TECs also expressed CD205 and BP1. They also demonstrated as the frequency of this 
IL7+CD205+BP1+ population started to decrease, mTEC development started to unfold (128). 
This data led us to hypothesize the BP1+UEA1- population observed in FACS analysis may also 
include a DEC205+BP+ subpopulation.  It would have been interesting to observe both BP1 and 
DEC205 staining patterns, but we could not achieve that due to technical limitations. So, we did 
the immunohistochemical analysis with both DEC205 and UEA1 to understand the relationship 
between DEC205+ cells undergoing active Wnt signaling and UEA1+ mature mTECs undergoing 
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active Wnt signaling. The next question was if the CD205+ fetal cells undergo active Wnt 
signaling during thymus development. Fetal thymic tissue was sectioned and analyzed using 
immunohistochemical analysis with CD205 antibody to characterize Wnt signaling changes within 
the DEC205-expressing TECs during fetal development. Those fetal thymic tissues were 
simultaneously stained for UEA1 to visualize thymic epithelial cell patterning during 
development. After staining and imaging the fetal thymic tissues derived from different embryonic 
days, we manually counted UEA1, DEC205, and GFP expressing cells (figure 5.5 & 5.6). 
Immunohistochemical data demonstrated that the number of CD205+GFP+ cells gradually 
increase from E13.5 to E16.5, followed by a gradual decrease in this cell number from E17.5 and 
E19.5. Additionally, histochemical analysis of the UEA1 binding mTECs showed that the 
UEA1+GFP+ mTECs started to appear around E15.5, and the cell number increased with 
advancing embryonic age as the medulla became more apparent. Both FACS analysis and 
histochemical analysis showed that UEA1+GFP+ cell number increased with progressive 
embryonic age.  
  Comparison between the analysis of BP1+GFP+ cell number and the CD205+GFP+ cell 
number showed that both populations had an increasing number of cells undergoing active Wnt 
signaling until E16.5. Even though the DEC205+GFP+ cell number started to decrease from 
E17.5, interestingly, BP1+GFP+ cell number began to decline from E18.5. From this data set, it 
can be hypothesized that CD205+ TEPCs undergo active Wnt signaling during E13.5-E16.5. 
Immunohistochemistry data showed from E17.5 DEC205+GFP+ number started to decrease, and 
more UEA1+GFP+ cells began to appear. From this result, it can be hypothesized that 
DEC205+GFP+ cells present in early development were downregulated at the late stage of thymic 




FoxN1 and AIRE expression are dependent on Wnt signaling. 
FoxN1 is a transcription factor critical for thymus development. It is well established that 
in a FoxN1 null mouse, after the thymic primordium's initial development, further development of 
the thymus is arrested (around E12.5) (323). FoxN1 expression is also essential for thymic 
epithelial lineage differentiation and maturation (324). It has been previously demonstrated that 
FoxN1 expression is regulated by Wnt4 signaling (22). Another study also showed that induced 
expression of DKK1, a canonical Wnt signaling inhibitor, causes rapid loss of FoxN1+ and AIRE+ 
TECs.  However, none of these studies directly determined if FoxN1 expressing cells undergo 
canonical Wnt signaling during fetal thymus development. Analysis of TCF/LEF H2BGFP Wnt 
reporter mice was used to understand the relationship between active Wnt signaling and the 
expression of FoxN1 during fetal thymic development.  
Suppression of canonical Wnt signaling causes a loss of AIRE+ TECs. AIRE+ mature 
mTECs play an essential role in ensuring the development of a self-tolerant T-cell population 
through the process of promiscuous gene expression and as well as the development of regulatory 
T cells. In short, the AIRE+ mTECs are a vital cell population of the thymus. In the previous 
sections, a relationship between UEA1+ mTECs and Wnt signaling was established, so we 
hypothesized that the AIRE+ mTECs in the fetal thymus also undergo active Wnt signaling. 
Thymic tissues from different embryonic ages were analyzed for AIRE expression.  The fetal 
thymic sections derived from TCF/LEFH2BGFP  Wnt signaling reporter mice were stained with 
AIRE and FoxN1. After staining and imaging the fetal thymic tissues from different embryonic 
days, we manually counted FoxN1, AIRE, and GFP expressing nuclei. Analysis of GFP + AIRE+ 
cells revealed a negligible number of these cells at E13.5 and E14.5, which was expected as the  
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E13.5 and E14.5 fetal thymus had very few AIRE+ cells. Beginning at E15.5, when the first 
medulla begins to form, both AIRE+ and AIRE+ GFP+ cells started to increase with progressive 
embryonic age (Figure 5.8 N). It is important to mention that both UEA1+ GFP+ cells and 
AIRE+GFP+ cells followed the same Wnt expression pattern. It has been demonstrated before that 
both cTECs and mTECs are derived from a bi-potent TEPC. Different models have been proposed 
in the explanation of fetal TEC development. One of those popular models, the Serial progression 
model, describes TEPCs first give rise to transitional thymic epithelial progenitors, which express 
both cTEC and mTEC traits. These transitional thymic epithelial progenitors eventually commit 
to either cTEC fate or mTEC fate.  Taking FACS data and immunohistochemistry data together, 
it can be hypothesized that probable thymic epithelial progenitor cell population undergoes active 
Wnt signaling during the early stage of thymic development to drive the development of UEA1+ 
mTECs and subsequently more mature AIRE+ mTECs. 
Next, analysis of histochemical images for FOXN1+GFP+ cells revealed a progressive 
increase in GFP-expressing cell numbers with increasing embryonic age from E13.5 to E15.5. 
From E16.5, the number of FoxN1+GFP+ cells started to decrease with advancing embryonic age. 
From E17.5 to E19.5(8A, 8F, and 8J), a negligible number of FoxN1+GFP+ cells were observed. 
The primary purpose of this set of experiments was to understand the relationship between FoXN1, 
the key transcription factor of TEC development, AIRE, a mature mTEC marker, and active Wnt 
signaling. This set of results demonstrated that from E16.5, when the GFP+ mature mTECs 
population started expanding (figure 5.8N), FoxN1+GFP+ cell, as well as FoxN1+ cell numbers, 
were down-regulated (figure 5.8M). From this result, it can be hypothesized that TECs undergoing 
active Wnt signaling upregulates the FoxN1 expression, which drives the TECs to differentiate 
into mature mTECs. Expansion of mature mTECs downregulates the expression of FoxN1 and 
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Foxn1+GFP+ Cells. It is possible that both Wnt signaling and FoxN1 expression is tightly 
regulated during TEC development.  
Wnt Signaling is upregulated in thymic epithelial cells during castration recovery. 
The thymus undergoes age-related involution characterized by a loss of thymic size, a 
decrease in TEC number, an increase in adipogenesis, and a loss of thymic capacity to support 
functional development of naïve T cells (139). A role for Wnt signaling has been implicated in 
age-induced thymic involution (7). Inducing regrowth, albeit transient, is possible by castration, 
which has long been considered a possible intervention in age-related degeneration of the thymus 
(146). However, the regrown thymus' qualitative nature is far more similar to an aged thymus than 
a young thymus (7). The canonical Wnt signaling pathway is the most significant pathway 
characterized by down-regulated genes in both aging and regenerated cortex compared to a young 
cortex (7). A preliminary relationship between thymic epithelial cells and Wnt signaling has been 
established in the previous sections, and a possible connection between downregulation of Wnt-β-
catenin signaling and age-induced atrophy has been demonstrated (7). We hypothesized that 
canonical Wnt signaling would be upregulated in the thymic epithelial cell population in the 
recovering thymus. To investigate this hypothesis, we analyzed Wnt signaling in the thymic 
epithelial cells of the aged thymus as well as the regenerated thymus following castration. 
12-month-old Wnt reporter mice were castrated, and after two weeks, their thymic 
epithelial cells were analyzed for the presence of cells undergoing active Wnt signaling using 
FACS. Additionally, FACS analysis of the 12-month-old mouse thymus was also performed to 
observe the thymic epithelial cells undergoing active Wnt signaling in the aged thymus.  C57BL6 
mouse thymus was used to establish GFP expression gating in this set of experiments. Both the 
samples were analyzed for active Wnt signaling in four thymic epithelial compartments, 1) 
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BP1+UEA1- (cTEC), 2) BP1-UEA1+(mTEC), 3) BP1+UEA1+, and 4) BP1-UEA1-. As discussed 
with the fetal thymus FACS result, BP1+UEA1+ and BP1-UEA1- TEC populations represent 
potential TEPCs. It is crucial to understand if this population undergoes any changes in active Wnt 
signaling in response to thymic regeneration. Comparison between aged and regenerated thymus 
revealed that the number of cells undergoing Wnt signaling in both cTEC and mTEC population 
is upregulated in the regenerated thymus than the aged thymus. It is worth noting that the mTEC 
population had a higher number of cells undergoing active Wnt signaling than the cortical 
epithelial cells undergoing Wnt signaling in the fetal thymus. This data set suggests that Wnt 
signaling might play a role in mTEC regeneration in the reconstituted thymus.  
5.3. DISCUSSION 
Canonical Wnt signaling plays an essential role in thymus development (245). It has been 
previously demonstrated that Wnt signaling regulates FoxN1 expression in both fetal and adult 
thymus(22). Wnt signaling is also involved in the maintenance and regulation of progenitor cells 
in the adult thymus, which are needed to maintain functional thymic tissue(6). Given its’ role in 
TEC progenitor maintenance, we hypothesize that Wnt signaling will be more critical during fetal 
thymic development. However, no characterization of Wnt signaling in the fetal thymic epithelial 
cell had been previously performed. During embryogenesis, fetal T-cell development happens in 
two phases: first, during embryonic development from E12.5 to E19.5, second, during postnatal 
days 3-6. It is well established that fetal thymic epithelial cell development is regulated by critical 
lymphostromal crosstalk. Given the essential role of thymic crosstalk in TEC development, we 
analyzed thymic epithelial cells during E13.5 to E19.5. It would have been ideal to explore the 
fetal thymus at E12.5, but due to technical limitations, we could not achieve that.  
175 
 
This study demonstrates that ~95% of the thymic stromal cells undergoing Wnt signaling 
are EpCAM+ thymic epithelial cells during thymus development. FACS and IHC analysis 
revealed that during early embryogenesis, from E13.5-E14.5, cells undergoing active Wnt 
signaling were mainly present in the EpCAM+BP1-UEA1-, DEC205+ TEC population. It has been 
previously demonstrated that the DEC205+ cells in the fetal thymus represent a bi-potent thymic 
epithelial progenitor cell population (106). Another study showed that EpCAM1+ cells present 
during early thymic development also represent the TEPC population (92). From our result, it is 
evident that during early embryogenesis, TEPCs undergo active Wnt signaling. It will be 
interesting for future analysis to see if the DEC205+ cells are part of the EpCAM+BP-UEA1- 
population. At E15.5, cells undergoing active Wnt signaling were mostly found in the DEC205+, 
EpCAM+, and the BP1+UEA1-, cTEC population. But from E16.5 cells undergoing active Wnt 
signaling started to decrease in the DEC205+ population and predominantly transitioned to the 
EpCAM+ BP1+UEA1-, cTEC population and newly emerging UEA1 binding AIRE+ mature 
mTEC population. During the late embryogenesis stage E17.5-E19.5, most of the UEA1+ AIRE+ 
mTECs and small frequency BP1+ and DEC205+ cTECs undergo active Wnt signaling. 
To summarize, it appears that active Wnt signaling in thymic epithelial compartments 
follows the thymic epithelial cell developmental model of serial progression given in Figure 5.10. 
It is important to mention that FoxN1 expressing cells undergo active Wnt signaling during the 
early developmental stage. Downregulation of FoxN1 cells and FoxN1+GFP+ cell number is 
observed from E16.5 when the mature mTEC population started increasing in number. Our result 
indicated that the FoxN1+ TECs undergo active Wnt signaling to go through developmental stages 
to give rise to mature TEC lineages during fetal thymic development.  Future analysis will be 
necessary to see which Wnt ligands and receptors are expressed in the cells undergoing active Wnt 
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signaling. It is also essential to compare the Wnt ligand profile of different thymic epithelial 
populations at different time points to understand which Wnt signaling components play a role in 
TEC development. 
It has been previously demonstrated that suppression of Wnt-β-catenin signaling causes 
thymic involution. This information led us to hypothesize that during recovery of the aged thymus 
following castration, there will be an upregulation of cells undergoing active Wnt signaling in the 
thymic stroma. It is possible Wnt signal transduction pathway can promote thymic epithelial 
expansion, due to which thymic cellularity can be recovered. FACS analysis of recovered thymus 
following castration revealed an upregulation of the number of cells undergoing active Wnt 
signaling in every TEC compartment. This result indicates castration may promote Wnt signaling 
in the thymic epithelial stroma, which induces thymic size recovery. It is also important to mention 
that more mTECs were undergoing active Wnt signaling than the cTEC population in the 
regenerated thymus. It has been demonstrated before that during castration induce thymic 
regeneration, mainly expansion of the mTEC population was observed, and the cTEC population 
frequency started to decrease(147). It is possible that during regeneration, a higher number of 
mTECs undergo active Wnt signaling, due to which the mTEC compartment can undergo 
expansion. As a smaller number of cTECs undergo Wnt signaling, their expansion was less or 
negligible. 
This study sets up a roadmap of active Wnt signaling during fetal thymus development. 
Fetal thymus data and the regenerated thymus data together indicate that Wnt signaling might play 
a critical role in medullary thymic epithelial cells development and maintenance.  But this data is 
not sufficient to prove the active role of Wnt signaling in TEC development. Future studies need 
to perform analysis of active Wnt signaling TEC population to understand which Wnt ligands are 
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Figures & Figure Legends: 
Figure 5.1 
 
Figure 5.1. FACS representation of Epithelial cells at different embryonic days. A) FACS 
representation of CD45 vs. EpCAM staining in the fetal thymus at different time points; B) FACS 
representation of EpCAM+ cells undergoing Wnt signaling at different time points; C) FACS 
representation of cells undergoing Wnt signaling at different time points. D) Bar graph 
representation of total EpCAM+ epithelial cells at different time points; E) Bar graph 
representation of EpCAM+ cells undergoing Wnt signaling at different time points; F) Bar graph 
representation of the thymic stromal cells undergoing Wnt signaling at different time points; All 
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Figure 5.2. FACS representation of BP1, UEA1 staining at Different embryonic days. i A-G) 
FACS representation of BP1 vs. UEA1 staining in the fetal thymus at different time points; ii A-
G) FACS representation of BP1+ cells undergoing Wnt signaling at different time points; iii A-G) 
FACS representation of UEA1+ cells undergoing Wnt signaling at different time points; iv A-G) 
FACS representation of BP1-UEA1- cells undergoing Wnt signaling at different time points; v A-
G) FACS representation of BP1-UEA1- cells are undergoing Wnt signaling at different time 




Figure 5.3. Cellularity of the Thymic epithelial compartments. A) Bar graph representation of BP1-
UEA1- cells in the fetal thymus at different time points; B) Bar graph representation of BP1+ cells 
in the fetal thymus at different time points; B) Bar graph representation of UEA1+ cells in the fetal 
thymus at different time points; C) Bar graph representation of BP1+UEA1+ cells in the fetal 
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thymus at different time points; E) Bar graph representation of BP1-UEA1- cells undergoing Wnt 
signaling at different time points; F) Bar graph representation of BP1+ cells undergoing Wnt 
signaling at different time points; G) Bar graph representation of UEA1+ cells undergoing Wnt 
signaling at different time points; H) Bar graph representation of BP1+UEA1+ cells undergoing 
Wnt signaling at different time points. All the calculations were done for the absolute number of 




Figure 5.4. Bar graph representation of BP1-UEA1-, BP1+ UEA1-, BP1-UEA1+, BP1+UEA1+ 










Figure 5.5. DEC205 and UEA1 staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal 
thymus section at different Embryonic days (E13.5-E16.5): A-D) DEC205& UEA1 staining at 
E13.5; A) DEC205, B) UEA1,C) GFP+ cells undergoing Wnt signaling D) Merged image of 
DEC205, UEA1, and GFP; E-H) DEC205& UEA1 staining at E14.5; E)DEC205, F)UEA1,G) 
GFP+cells undergoing Wnt signaling H) Merged image of DEC205, UEA1, and GFP; I-L) 
183 
 
DEC205& UEA1 staining at E15.5; I) DEC205, J) UEA1,K) GFP+ cells undergoing Wnt signaling 
L) Merged image of DEC205, UEA1, and GFP; M-P) DEC205& UEA1 staining at E13.5; M) 
DEC205, N) UEA1,O) GFP+ cells undergoing Wnt signaling P) Merged image of DEC205, 
UEA1, and GFP staining. All the experiments were done in 4-10 replicates 
Figure 5.6 
 
Figure 5.6. DEC205 and UEA1 staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal 
thymus section at different Embryonic days (E17.5-E18.5):  A-D) DEC205& UEA1 staining at 
E17.5; A) DEC205, B) UEA1,C) GFP+ cells undergoing Wnt signaling D) Merged image of 
DEC205, UEA1, and GFP; E-H) DEC205& UEA1 staining at E18.5; E) DEC205, F) UEA1,G) 
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GFP+ cells undergoing Wnt signaling H) Merged image of DEC205, UEA1, and GFP; I) Bar graph 
representation of FOXN1+ cells undergoing Wnt signaling at different time points. J) Bar graph 
representation of AIRE+ cells undergoing Wnt signaling at different time points. All the 






















Figure 5.7. FoxN1 and AIRE staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal thymus 
section at different Embryonic days (E13.5-E16.5):  A-D) FoxN1& AIRE staining at E13.5; A) 
FoxN1, B) AIRE,C) GFP+ cells undergoing Wnt signaling D) Merged image of FoxN1, AIRE, 
and GFP; E-H) FoxN1& AIRE staining at E14.5; E) FoxN1, F) AIRE, G) GFP+ cells undergoing 
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Wnt signaling H) Merged image of FoxN1, AIRE, and GFP; I-L) FoxN1 & AIRE staining at 
E15.5; I)FoxN1, J)AIRE, K) GFP+cells undergoing Wnt signaling L) Merged image of FoxN1, 
AIRE, and GFP; M-P) FoxN1 & AIRE staining at E16.5; M)FoxN1, N)AIRE, O) GFP+ cells 
undergoing Wnt signaling P) Merged image of FoxN1, AIRE, and GFP staining. All the 
experiments were done in 4-10 replicates. 
Figure 5.8 
 
Figure 5.8. FoxN1 and AIRE staining of the TCF/Lef: H2B-GFP Wnt reporter mouse fetal thymus 
section at different Embryonic days (E17.5-E19.5):  A-D) FoxN1& AIRE staining at E17.5; 
A)FoxN1, B)AIRE, C) GFP+cells undergoing Wnt signaling D) Merged image of FoxN1, AIRE, 
and GFP; E-H) FoxN1& AIRE staining at E18.5; E)FoxN1, F)AIRE, G) GFP+cells undergoing 
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Wnt signaling H) Merged image of FoxN1, AIRE, and GFP; I-L) FoxN1 & AIRE staining at 
E19.5; I)FoxN1, J)AIRE, K) GFP+ cells undergoing Wnt signaling L) Merged image of FoxN1, 
AIRE, and GFP; M) Bar graph representation of the Dec205+ cells undergoing Wnt signaling at 
different time points. N) Bar graph represents the UEA1+ cells undergoing Wnt signaling at 
different time points. All the experiments done in 4-10 replicates. 
Figure 5.9 
 
Figure 5.9. Thymic epithelial compartments undergo canonical Wnt signaling upregulation in the 
regenerated thymus. FACS representation of thymic stromal cell at 12-month-old mouse and 
castration recovery mouse. The upper panel of the figure represents a 12-month-old mouse's data, 
and the lower panel shows the analysis of the Castration Recovery thymus. A) FACS 
representation of EpCAM vs. CD45 staining in the thymus; B) FACS representation of EpCAM+ 
cells undergoing Wnt signaling; C) FACS representation of BP1 vs. UEA1 staining in the fetal 
thymus; D) FACS representation of BP1+ cells undergoing Wnt signaling; E) FACS representation 
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of UEA1+ cells undergoing Wnt signaling; F) FACS representation of BP1+UEA1+ cells 
undergoing Wnt signaling; G) FACS representation of BP1+UEA1+ cells undergoing Wnt 
signaling. H) Bar graph representation of EpCAM + cells undergoing Wnt signaling I) Bar graph 
representation of BP1+ cells undergoing Wnt signaling; J) Bar graph representation of UEA1+ 
cells undergoing Wnt signaling; K) Bar graph representation of BP1+UEA1+ cells undergoing 
Wnt signaling; L) Bar graph representation of BP1-UEA1- cells undergoing Wnt signaling at 
different time points. All the calculations were done for the absolute number of cells/lobe. All the 
experiments were done in 3-4 replicates 
Figure 5.10 
 
Figure 5.10. Panel A is adapted from Alves et al. 2014. In the “serial progression” model, TEPs 
transverse through a “transitional TEC progenitor” stage (tTEP) that expresses phenotypic and 
molecular traits associated with cTECs before the commitment into a cTEC or mTEC fate. tTEPs 
are more closely linked, at the phenotypic and molecular levels, with cTEPs and have the potential 
to generate both mTEC progenitors and mature cTECs, with the cortical lineage being the “default” 
pathway(322). Panel B, shows serial progression of active Wnt signaling During fetal thymus 








This current study is mainly motivated by the works of Osada et al.2013 and Krause et al. 
2001. Recently it has come to light that adult stem cell populations can overcome tissue and lineage 
barriers and differentiate into several other cell types(8, 149). Adult bone marrow cells are among 
the most prominent examples of the new plasticity apparent in adult stem cells. Adult bone marrow 
cells have been shown to contribute to the skeletal muscle(284), cardiac muscle(165), skin 
epithelial cells(178), hepatocytes(156, 157), lung epithelial cells (183, 276), epithelial cells of the 
GI tract(176), renal tubular epithelial cells (186), the endometrium of the uterus(155), endocrine 
cells of the pancreas(184) and cells of the central nervous system(192). Even though the thymus 
is epithelial tissue, no previous studies were performed to understand whether the BM-derived 
stem cell population could contribute to the thymic epithelial cell populations. 
Previous studies have demonstrated that the adult thymus maintains either bi-potent or 
unipotent thymic epithelial progenitor cell populations. But interestingly, none of these studies 
came to a consensus about the phenotype of the adult thymic epithelial progenitor population. 
That’s why the identification of TEPCs represents an exciting field of research. While looking for 
the TEPCs, all the previous studies limited their search to the CD45-EpCAM+ population; 
however, in the current study, we explored the CD45+ populations of thymic stroma and BM as a 
potential source for TEPCs.  
This study identified a unique postnatal bone marrow population that can migrate to the 
thymus and contribute to the non-hematopoietic component of thymic stroma, including TECs. 
This population is also present in the adult thymus and expresses both the pan-hematopoietic cell 
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marker, CD45, and the definitive thymic epithelial cell marker, EpCAM. IHC and qRT-PCR 
analysis done with a highly pure CD45+EpCAM+ population from bone marrow and thymus 
revealed that this population truly expresses both the markers.  No expression of CD11c at both 
the mRNA and protein levels in these populations confirmed that they are not thymic nurse cells 
or thymic DCs as previously reported (50) or an artifact derived from enzymatic dissociation of 
closely associated TECs and thymocytes.  Additional qRT-PCR and FACS analysis showed that 
both BM-derived and thymus-derived CD45+EpCAM+ populations express FSP1 in both mRNA 
and protein levels.  We also demonstrated that this unique population is present in the fetal thymus 
during embryogenesis. 
Our study challenged the established dogma of thymus development by demonstrating that 
the CD45+EpCAM+ population from the periphery can migrate to the thymus and contribute to 
the thymic epithelial cell pool. This data also revealed that a peripheral cell population could 
differentiate into cortical and medullary thymic epithelial cells. Additionally, we confirmed that 
the BM-derived CD45+EpCAM+ cells could migrate to the injured thymus and contribute to the 
thymic stroma by injecting the CD45+EpCAM+ cells population into partially irradiated C57BL6 
mice. The CD45+EpCAM population can contribute to the pan-keratin and FoxN1 expressing TEC 
population and FSP1 expressing fibroblast population in a reaggregated thymic organ. The 
CD45+EpCAM+ population appears to contribute to thymic stroma by directly giving rise to the 
EpCAM and keratin expressing epithelial cells. FSP1 expression in these populations indicates 
that these peripheral cells might be the source of FSP1 expressing fibroblasts in the thymic stroma. 
A recent study has revealed FSP1 expressing fibroblasts support the maintenance of the medullary 
thymic epithelial cell population(280).  It is still not clear how the CD45+EpCAM+ population 
differentiates into these two different cell lineages. Lineage relationships between the FSP1+ cells 
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and the true keratin expressing TECs derived from the CD45+EpCAM+ population need to be 
determined in future studies.   
The CD45+EpCAM+ population is derived from the hematopoietic stem cells. 
Interestingly, post-HSCT progressive time point analysis revealed an increased frequency of the 
donor cells in the CD45+EpCAM+ population in the bone marrow and the thymus. This data 
indicated more donor-derived HSC differentiated to the CD45+EpCAM+ population in the bone 
marrow and successfully migrated to the thymus with a prolonged chase period. HSCT analysis 
also revealed that the HSC derived cell population could contribute to the EpCAM+ population of 
the thymic stroma. It will be important to analyze earlier time-points to observe if the HSC 
population differentiates into the CD45+EpCAM+ population, leading to the recovery of the 
CD45+EpCAM+ pool of the bone marrow and then migrate towards the thymus, or if they migrate 
towards the injured thymus first and contributes to thymic recovery following radiation damage.  
Frequency analysis of the BM-derived and the thymus-derived populations at different time 
points revealed that, like the HSC population, the BM-derived CD45+EpCAM+ population 
increases in number with progressive age. However, analysis of the thymic CD45+EpCAM+ 
population revealed a decrease in number with progressive age.  These results might be caused by 
the loss of differentiation and migration capacity of this population due to aging. It is possible that 
the decline in the CD4+EpCAM+ cells may contribute to age-associated thymic involution. Our 
study also revealed that in the castration induced regenerated thymus, the CD45+EpCAM+ 
population increases in frequency while the frequency of the same population decreases in the 
bone marrow. This result indicates that even though the bone marrow-derived CD45+EpCAM+ 
population gradually decreases their homing capacity due to aging, castration induces this cell 
population to migrate towards the thymus again to contribute to the thymic recovery.  
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Next, it was important to understand if this population expresses the same set of surface 
markers that are were used to define thymic stem cells by Osada et al.2013 (6). Our data showed 
that both the BM-derived and thymus-derived CD45+EpCAM+ cell populations express Sca1, 
CD49f, and CD29. This result hypothesized that the adult TEPC population identified by Osada et 
al. 2013 could be a downstream population derived from the CD45+EpCAM+ population. Our 
data also revealed that with progressive age, the CD49f and CD29 expression decreases in the 
thymus. Loss of these stem cell markers likely correlates with a reduced capacity to differentiate 
and augment thymic involution. We also observed a significant loss of CD49f and CD29 
expression in this population following castration induced recovery of the thymus. This set of 
results indicates that castration induces migration of CD45+EpCAM+ from the bone marrow to 
the thymus, which results in a higher frequency of CD45+EpCAM+ cells in the thymic stroma. It 
is possible, further loss of CD49f expression in the recovered thymus is responsible for the 
transient recovery of the thymic epithelial cellularity. Another possibility is that as these cells are 
induced for the thymic recovery, they lose CD49f and CD29 expression to leave the stem cell 
niche and differentiate into the thymic epithelial cell pool. 
Chemokine and chemokine receptor analysis of both the BM-derived and thymus-derived 
CD45+EpCAM+ population expresses CCR7, CCR 9, and CCR10 chemokine receptors as well 
as the chemokine ligands CXCL12, CCL20, and CCL22. Expression of CCR7 and CCR9 indicated 
this cell population might use the same chemokine receptor-ligand axis as used by T-cell 
progenitors to migrate to the thymus. CCR10 is also involved in cell mobilization in response to 
injury. Future studies will analyze how this chemokine ligand and chemokine receptor expression 
pattern of the CD45+EpCAM+ changes with progressive age. In the future, particular chemokine 
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ligand knock-out mice can be used to determine which ligand-receptor pair is essential for 
migration CD45+EpCAM+ population.  
This study essentially revealed the potential role of hematopoietic stem cells in the 
maintenance of the thymic epithelial microenvironment. The role of Wnt signaling in the 
maintenance of quiescence and pluripotency of HSC in the bone marrow is well established (325). 
Previous studies also confirm the role of Wnt signaling in T-cell development (325) and 
maintenance of the thymic microenvironment (4). The role of canonical Wnt signaling in the 
maintenance of the adult thymus (5, 6) and the degeneration of the aged thymus (7) is well 
documented. Still, it is not clear if Wnt signaling plays any role in the TEC development.  As we 
explore the new avenue of research, which indicates the role of HSC in the maintenance of the 
thymic microenvironment, it is important to understand the characteristics of Wnt signaling in the 
thymic stroma. So as a secondary line of research, we also focused on characterizing what cells 
were undergoing Wnt signaling in the fetal thymic stroma. Our study showed that the fetal thymic 
epithelial cells undergo active Wnt signaling. This data sets up a roadmap of TEC development 
and Wnt signaling dependency. Future studies need to analyze active Wnt signaling in TEC 
populations to understand which Wnt ligands are being expressed in each thymic epithelial 
population.  Knockout mice of those active Wnt ligands can demonstrate their role in TEC 
development.  It is important to note that the regenerated thymus' Wnt signaling data showed that 
this signal transduction pathway is upregulated in the TECs of the regenerated thymus. Taking this 
data set and our CD45+EpCAM+ population analysis of the regenerated thymus, we hypothesized 
that castration induces upregulation of the Wnt signaling in the regenerating thymus, which 
induces migration of the CD45+EpCAM+ population of bone marrow to the thymus to contribute 
to the thymic recovery. But as this population loses its stem cell-like properties with progressive 
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age, this thymic recovery is not permanent.   Preliminary analysis of fetal thymic stroma has 
revealed that a small number of fetal CD45+EpCAM undergo active Wnt signaling throughout 
embryogenesis. We need to link these two studies together and investigate CD45+EpCAM+ cells 
undergoing active Wnt signaling for further studies. We need to understand if the fetal 
CD45+EpCAM+ population expresses the same Wnt ligands expressed by fetal TECs. It is also 
important to understand if the adult CD45+EpCAM+ population also undergoes active Wnt 
signaling. This study can demystify the elusive relation between Wnt signaling and TEPC 
development.  
In summary, this study demonstrates that the bone marrow-derived population expressing 
both CD45 and EpCAM can migrate and contribute to the thymic stroma and can give rise to two 
different non-hematopoietic cell populations there, including both FSP1-expressing fibroblasts and 
keratin/FoxN1- expressing TECs under the condition of demand. The CD45+EpCAM+ population 
is HSC derived unique stem cell-like population express several chemokine ligand and receptor, 
which are probably necessary for its migration towards thymus. With advanced age, both thymic 
and bone CD45+EpCAM+ population lose their stem cell-like properties. Loss of stem cell-like 
properties of these populations might be why even after this population is present, the thymus still 
undergoes age-related involution, and the thymic reconstitution is transient. This population is 
mobilized in response to radiation-induced thymic tissue injury, and castration induces thymic 
microenvironment repair of the aged thymus. These results indicate that the CD45+EpCAM+ 
population may play an important role in thymic tissue repair. This hypothesis is parallel to the 
finding of many other bone marrow plasticity studies.  It was demonstrated that the BM-derived 
cells are only mobilized in response to tissue injury to contribute to the tissue repair. Further 
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analysis of this population is necessary to understand if this population can migrate to other 
epithelial organs and contribute to other tissue maintenance.  
Although a progenitor cell population is present in BM that can contribute to TECs, the 
thymus still undergoes age-related involution. Understanding mechanisms responsible for the 
migration of the BM-derive CD45+EpCAM+ population to the thymus and how they contribute 
to TEC maintenance will be critical in counteracting age-associated involution, particularly cancer 
patients' enhanced degeneration in response to therapy.  It should provide an additional target for 
overcoming thymic atrophy and developing more strategic treatments for immunological-based 
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